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Dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal 
phosphoprotein (DARPP-32) is a critical mediator of neuroplasticity in striatal medium 
spiny neurons (MSNs). The work presented in this thesis used a global gene knockout 
(KO) construct to investigate the role of DARPP-32 in reward-based learning and 
performance.  
Global deletion of the DARPP-32 gene disturbed performance during the 
intertemporal (delay) discounting procedure. DARPP-32 KO mice were less sensitive 
than their wildtype (WT) littermates during long delays to reinforcement. In comparison 
to WT mice, DARPP-32 KO mice also developed a risk-sensitive pattern of choices 
during a probability discounting task. Unlike the effects of DARPP-32 deletion on 
reinforcement along dimensions of time and risk, DARPP-32 knockout did not affect the 
degree of effort that subjects were willing to invest during food-reinforced progressive 
ratio testing.  DARPP-32 KO mice also failed to exhibit Pavlovian-to-instrumental 
transfer and this impairment could not be rescued by administering methylphenidate prior 
to test. Finally, DARPP-32 KO mice were indistinguishable from WT mice during an 
amphetamine psychomotor sensitisation study. 
 Overall, the data in this thesis suggest DARPP-32 is involved in adaptive reward-
based learning and performance.  
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Chapter 1 
Introduction 
Introduction 1.1 
Disturbances in brain circuits underpinning motivated behaviours are thought to be 
implicated in the pathogenesis of addiction (Robinson & Berridge, 1993/2001/2003), 
pathological gambling (Reuter et al., 2005), eating disorders (Broft et al., 2012; 
Oberndorfer, Kaye, Simmons, Strigo & Matthews, 2011; Wagner et al., 2010), 
schizophrenia (Abi-Dargham et al., 1998; Das et al., 2007; Sorg et al., 2013; Weinberger, 
Berman & Zec, 1986), bipolar disorder (Strakowski, DelBello & Adler, 2005), obsessive 
compulsive disorder (OCD) (Menzies et al., 2008) and depression (Rogers et al., 2004). 
Elucidating the biopsychological basis of these disorders is therefore a major aim of 
affective neuroscience. Historically, great emphasis has been placed on disturbances in 
neurotransmission and the history of psychiatry during the past 60 years is founded on 
the discovery of effective drugs to ameliorate debilitating psychiatric symptoms. Indeed, 
in the modern age, it is not unusual to encounter popular media outlets discussing the 
efficacy of selective-serotonin reuptake inhibitors in the treatment of depression, the 
contribution of dopamine (DA) receptor antagonists to the treatment of schizophrenia or 
the potential development of a ‘silver bullet’ to liberate compulsive drug users from the 
burden of addiction. Much insight and clinical benefit has been gained from such 
compounds. However, with the aim of stimulating novel treatments, increasing emphasis 
is being placed on the intracellular pathways that reside downstream from the receptors 
where traditional psychiatric treatments exert their clinical effects. The work contained 
in this thesis aims to contribute to our understanding of how a DA and glutamate sensitive 
intracellular signalling molecule, dopamine and 3’, 5’-cyclic adenosine monophosphate-
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regulated neuronal phosphoprotein, 32 kDa (DARPP-32) contributes to incentive 
motivational processes that are relevant to addiction and impulse control disorders. 
1.2 Incentive motivation 
In its normal state, brain incentive motivation circuits facilitate adaptive motivated 
behaviours by allowing animals to flexibly modify their behaviour under environmentally 
and physiologically changing conditions in order to acquire food, water and to gain access 
to mates or to overcome aversive states by evading threat. Complex motivated behaviours 
can be guided by prior experience (learning) and physiological demand states which 
channel appropriate motivated behaviours towards relevant goals by enhancing the 
salience of reward-predictive cues (Berridge, 2004; Dickinson & Balleine, 2002; Toates, 
1986). In the disturbed state, however, incentive motivation circuits are thought to 
underpin behavioural aberrations such as drug addiction by hyper-inflating the incentive 
value of drugs and drug-associated cues and by predisposing individuals to damaging 
reward-based decision making/cognitive styles (e.g. impulsivity/cognitive control) 
(Carter & Tiffany, 1999; Jentsch & Taylor, 1999; Robinson & Berridge, 1993/2001). 
Thus, understanding how reward value is psychologically and biologically encoded is of 
great interest to affective neuroscientists. 
1.2.1 Basic Pavlovian learning mechanisms in incentive motivation 
Two distinct, though often interacting, learning mechanisms are routinely recruited in 
laboratory settings to isolate the biological and psychological determinants of reward 
value. The first, Pavlovian/associative learning, is normally described in text book 
fashion as a mechanistic process involving the contingent pairing of initially neutral 
stimuli with biologically relevant stimuli such as food or water - termed unconditioned 
stimuli (US). Through their repeated pairing, these initially neutral stimuli are 
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incrementally transformed into conditioned stimuli (CS) capable of eliciting conditioned 
responses (CRs) resembling the unconditioned response (UR) (Pavlov, 1927). Konorski, 
however, fractionated the conditioned response topography by distinguishing between 
consummatory and preparatory CRs (Konorski, 1967). Consummatory CRs are US 
specific responses, such as a reflex or consuming food. However, preparatory CRs are 
not as US specific and might include conditioned approach behaviour or conditioned 
potentiation of instrumental responding (Dickinson & Balleine, 2002). 
CSs are motivationally rich phenomena which can contain representations of the 
temporal, hedonic, sensory, and affective and response eliciting properties of USs 
(Delamater & Oakeshott, 2007). The representational topography of CSs, therefore, 
provides sufficient information to guide responses adaptively in an experience-dependent 
fashion. In fact, CSs are themselves capable of acquiring rewarding properties, such that 
they become highly valued reinforcers, capable of sustaining high levels of work in the 
absence of the presentation of the US with which they were previously paired. Thus, 
Pavlovian/associative learning is a potent psychological mechanism that dynamically 
stimulates and sustains sophisticated goal-directed behaviour. 
1.2.2 Instrumental learning  
The second kind of learning mechanism, instrumental learning, involves the 
experience-dependent modification of one’s behaviour in response to the consequences 
produced by one’s actions. For example, a rodent in an operant box that receives a food 
reward in return for manipulating a response device will increasingly direct responses 
toward that device and increase its reward seeking behaviour when placed in the box. 
This form of reinforcement is termed positive reinforcement on the basis that the positive 
outcome strengthens lever responding. On the other hand, negative reinforcement 
involves the omission of responses that produce negative outcomes. For instance, an 
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animal in an operant box may learn to omit a response at a particular time to avoid 
receiving a mildly aversive stimulus such as shock. Thus, the behavioural output of the 
animal is conditioned to avoid negative outcomes. The distinction between these two 
forms of instrumental learning was first formalised by the behaviourist Edward Thorndike 
in his “law of effect” which states that actions which produce desirable outcomes are 
likely to re-occur during similar circumstances, whereas actions which produce 
undesirable outcomes are likely to be omitted during similar circumstances (Thorndike, 
1911). Owing to the nature of the studies that form the basis of this thesis, we will limit 
our discussion to positive reinforcement. This is not to neglect the importance of negative 
reinforcement or to devalue the influence such studies have had in informing our 
understanding of basic learning mechanisms.  
Initial explanations of instrumental learning rules relied heavily on stimulus-response 
(S-R) theories to account for the increasing behavioural output of the animal when placed 
in close proximity to response-paired stimuli (Thorndike, 1911). For example, the box in 
which the animal is placed to perform the response, or the response device (lever/chain 
etc.) itself, are stimuli that precede reward receipt. Through the repeated pairing of the 
response with the rewarding outcome, the stimulus association between the stimulus and 
the response is strengthened and the likelihood of the subject reproducing that behaviour 
in the presence of the stimulus increases. Although such theories have provided 
substantial insights into how learning and habit formation occur, S-R accounts fail to 
capture the entire repertoire of learning that can occur during instrumental associations. 
For example, Balleine and Dickinson (1998a) suggest that S-R explanations of learning 
claim that animals lack knowledge about the outcomes produced by their actions. 
However, animals can use information to guide responses following explicit changes in 
the reward value of the reinforcer (e.g. reinforcer devaluation) suggesting that animals do 
5 
 
 
acquire knowledge about the relations between their actions and the outcomes they 
produce (Adams, 1982; Balleine & Dickinson, 1991). This form of learning, termed 
action-outcome/response-outcome learning, suggests that animals can encode multiple 
attributes about the relations between the response and its outcome and use that 
information to flexibly modify behaviour. In addition to this, many species of animal can 
use information about the relative costs of reinforcement (e.g. time, risk and effort) to 
make subjective reward value decisions and guide their behavioural output accordingly 
in order to optimise reward acquisition under environmentally fluctuating conditions 
(Cardinal & Howes, 2005; Evenden & Ryan, 1996; Floresco, Tse & Ghods-Sharifi, 
2008). We will revisit this idea in greater depth below. For the time being let us return to 
the proposal that incentive value can be encoded via associative principles.  
1.3 Pavlovian mechanisms and the attribution of incentive salience  
Kent Berridge, in expanding on the work of Robert Bolles, Dalbir Bindra and 
Frederick Toates, has developed an incentive salience model of motivated behaviour to 
elaborate the psychological mechanisms by which conditioned stimuli become attractive 
and compelling motivational magnets which energise and captivate behaviour. In this 
model, conditioned stimuli, by virtue of their predictive relationship with highly valued 
USs, acquire motivational properties through stimulus-stimulus associations. 
Motivational states/deficit signals interact with CSs to enhance their incentive salience 
by inducing shifts in the hedonic and motivational properties of incentive stimuli (e.g. 
alliesthesia) in order to drive behaviour in a goal-directed fashion (Berridge, 2000; 
Berridge 2004; Robinson & Berridge, 1993; Toates, 1986). Berridge extended this 
principle by fractionating the hedonic aspects of conditioned reward which he terms 
“liking” from the motivational aspects of conditioned reward which he refers to as 
“wanting”. In this formulation, conditioned incentive stimuli are highly valued, 
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hedonically appealing incentives in their own right. This model of incentive motivation 
has been adapted to provide a highly influential model of addiction to drugs of abuse 
(Robinson & Berridge, 1993).  
Animal behaviour assays such as conditioned reinforcement (CRf), the Pavlovian-to-
instrumental transfer (PIT) test or the autoshaping/sign-tracking procedure provide 
significant supporting evidence for Berridge’s claim that conditioned stimuli do acquire 
incentive motivational properties in the manner proposed by him and others (Berridge, 
2000/2004; Toates, 1986). Berridge (2000) lists these as follows: 1) In the CRf assay, a 
discrete CS is repeatedly paired with a US during a training phase until animals acquire 
asymptotic responding to the presentation of the CS. Then, during a test phase, animals 
are placed into a conditioning chamber in the presence of an instrumental device which, 
when manipulated, generates the presentation of the CS but never the US. Animals will 
exert significant levels of effort to acquire the presentation of the CS, even though it no 
longer predicts the US. Thus the CS is imbued with conditioned reward value to such a 
profound extent that the animal will work for it, even though it has no inherent biological 
value. 2) During the autoshaping procedure, a stimulus such as a lever is used as a CS 
and repeatedly paired with an appetitive stimulus. During training, animals will come to 
approach the CS and direct US modality appropriate consummatory CRs (e.g. biting food 
predictive cues, licking water predictive cues) toward the CS even though such responses 
are unnecessary to achieve reinforcement. Thus CSs become highly attractive stimuli that 
animals will approach and even attempt to consume. 3) Reward associated stimuli will 
potentiate instrumental responding in a purely motivation driven fashion (e.g. in the 
general PIT test). During PIT, animals are trained in one phase to associate a CS with an 
appetitive US and in a separate phase to manipulate a response device (e.g. a lever, a 
chain pull or a nosepoke) to acquire the same US/reinforcer. Then, during an extinction 
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test, the CS is superimposed over the presence of the lever. When this occurs, animals 
will significantly increase the number of lever responses they make relative to when the 
cue was not present. Thus, CSs acquire incentive salience properties that can enhance 
reward value in multiplicative fashion. In an outcome-selective variation of this 
procedure, subjects are trained to associate 2 distinct CSs, CS1 & CS2, with 2 distinct 
USs, US1 & US2 and, in a separate phase of training to make 2 distinct responses, R1 & 
R2, to acquire those reinforcers. In the test phase, outcome-selective PIT is established 
when CS1 elevates R1 significantly more than R2 and when CS2 potentiates R2 more 
than R1. It was recently shown that pre-feeding rodents prior to a PIT test abolishes the 
general motivating effects of associative cues on instrumental responding (e.g. the general 
PIT effect) providing additional support for the idea that deficit signals interact with 
conditioned associations to enhance incentive salience and cue-driven reward seeking 
(Corbit, Janek & Balleine, 2007). 
1.3.1 Glutamatergic and dopaminergic modulation of incentive salience 
Significant focus has been placed on the biological basis of the abovementioned 
behaviours. We will discuss this in greater detail below. However, one consistent finding 
is that pharmacological or genetic manipulations aimed at disrupting normal DA or 
glutamate tone can enhance, attenuate or even abolish incentive salience. For example, 
acute or repeated amphetamine treatment enhances PIT (Wyvell & Berridge, 2000; 
Wyvell & Berridge, 2001) and similar findings have been observed in the autoshaping 
(Doremus-Fitzwater & Spear, 2011) and CRf assays (Mead, Crombag & Rocha, 2004; 
Robbins, Watson, Gaskin & Ennis, 1983). Mice with genetic mutations to glutamate 
receptor subunits additionally display disturbances in conditioned reward behaviours 
(Crombag, Sutton, Takamiya, Holland, et al., 2008; Crombag, Sutton, Takamiya, Lee, et 
al., 2008) and acute treatment with glutamate receptor antagonists disrupts many 
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Pavlovian incentive motivational processes including autoshaping (Dalley et al., 2005), 
PIT (George, Huston & Stephens, 2009) and CRf (O’Connor, Crombag, Mead & 
Stephens, 2010). Repeated administration of drugs of abuse stimulates long-term changes 
in DA and glutamate neurotransmission with the behavioural consequences of these 
changes being the sensitisation of locomotor output (Vanderschuren & Kalivas, 2000) 
and, in certain instances, the sensitisation of incentive salience/conditioned reward 
(Wyvell & Berridge, 2000; Mead et al., 2004). The findings of these studies are consistent 
with the predictions outlined in the incentive-sensitisation theory of addiction (Robinson 
& Berridge, 1993/2001/2003) in which it is postulated that stimuli consistently present 
during drug administration acquire incentive salience in the manner proposed by Berridge 
and that, through repeated use of drugs, disturbances in mesolimbic DA signalling 
promote the sensitisation of incentive salience. 
1.4 Action-outcome learning and the attribution of reward value 
Although Pavlovian principles provide fascinating insights into the associative basis 
of reward, the processes by which animals come to attribute reward value is complex, and 
other researchers such as Dickinson & Balleine have emphasised the role of instrumental 
action-outcome incentive learning in guiding how an animal can come to learn that an 
action leads to a specific outcome (Dickinson & Balleine, 2002; Dickinson & Balleine, 
1994). Dickinson and Balleine suggest that in certain instances, it is not enough to simply 
alter the motivational state of an animal or to reduce the incentive value of the food in 
order for these manipulations to affect behaviour, animals must first learn that reward 
value has been altered in order to modify their responses. For instance, research has 
shown that when a reinforcer is paired with illness by administering lithium chloride 
(LiCl), an animal will continue to work for that reinforcer until it re-experiences the 
reinforcer following its pairing with illness (Balleine & Dickinson, 1991). Pre-feeding 
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subjects prior to test, instead of pairing the reinforcer with LiCl, produces similar 
reinforcer devaluation effects (Balleine & Dickinson, 1998b). Studies such as these 
suggest that, under certain conditions, incentive learning is required for animals to 
flexibly alter their behaviour following changes in incentive value.  
The prevailing view is that A-O learning is evident during the formative phases of 
learning, though it transitions to a more habitual S-R profile as a function of experience 
(Dickinson, 1985; Yin & Knowlton, 2006). For example, with experience, animals 
become increasingly rigid and insensitive to devaluation as a function of the amount of 
training/experience they have between the action and the outcome. Animals that have 
been relatively ‘overtrained’ will persist in responding on a lever associated with the 
delivery of food, even though the reward value of that food has been devalued by being 
paired with illness or by the animal being pre-fed prior to the test (Adams, 1982; 
Coutureau & Killcross, 2003). DAergic lesions of the substantia nigra pars compacta and 
dorsal striatum disrupt habit formation when rodents are subjected to variable interval 
instrumental training (Faure, Haberland, Conde, Massioui, 2005) and repeated exposure 
to DAergic drugs such as amphetamine speeds habit formation during random interval 
schedule instrumental training (Nelson & Killcross, 2006). 
1.4.1 Cost-benefits computations and action-outcome like instrumental choices 
In addition to using sensory associations to ascribe subjective reward value, animals 
can use a multitude of reward-related cost-benefit representations, such as the delay to 
reinforcement, the probability of reinforcement, and the effort needed to achieve 
reinforcement to make goal-directed instrumental cost-benefits computations about the 
subjective value of incentives. For example, many species, including humans (Bickel, 
Odum & Madden, 1999; Field, Christiansen, Cole & Goudie, 2007; Johnson & Bickel, 
2002), non-human primates (Freeman, Green, Myerson & Woolverton, 2009; 
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Woolverton, Myerson & Green, 2007), rats (Cardinal, Robbins & Everitt, 2000; Evenden 
& Ryan, 1996; Winstanley, Dalley, Theobald & Robbins, 2003), mice (Mitchell, Reeves, 
Li & Phillips, 2006; Oberlin & Grahame, 2009; Wilhelm, Reeves, Phillips & Mitchell, 
2007) and birds (Green, Myserson, Holt, Slevin & Estle, 2004) can perform complex 
computations about subjective reward value as a function of the length of time that one 
must wait in order to receive that reward. For example, when provided with an option of 
choosing between a small reward and a large reward that are both delivered immediately, 
subjects will ordinarily prefer the large reward. However, if a delay to reinforcement is 
associated with the large reward, subjects will choose that reward less and less as the 
delay increases, even when it is beneficial to continue to choose that reward. In other 
words, delays to reinforcement devalue the incentive value of the large reward. Human 
(Rachlin, Ranieri & Cross, 1991; Rasmussen, Lawyer & Reilly, 2010) and rodent (St 
Onge & Floresco, 2009; St Onge, Stopper, Zahm & Floresco, 2012) subjects can also 
perform complex probabilistic calculations to decide whether to choose a large but 
probabilistically fluctuating reward or a small certain reward. In similar fashion to the 
effects of delay on reinforcement choices, animals will prefer the large reward when it is 
certain but will come to choose it less when the probability of reinforcement diminishes. 
In addition to time and risk investment costs, animals incur motivational (e.g. effort) costs 
for achieving reinforcement. Instrumental motivation can be directly assessed by 
establishing the willingness of an animal to progressively increase its motivation to press 
for reinforcement as the effort costs associated with reinforcement are progressively 
increased (Crombag, Ferrario & Robinson, 2008; Richardson & Roberts, 1996; Zhang, 
Balmadrid & Kelley, 2003) or by providing subjects with a choice between a low-effort 
small reward and a high-effort large reward (Botvinick, Huffstetler & McGuire, 2009; 
Bardgett, Depenbrock, Downs, Points & Green, 2009; Floresco et al., 2008; Ghods-
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Sharifi & Floresco, 2010; Salamone, Cousins & Bucher, 1994). As with delay to 
reinforcement or uncertain reinforcement, animals will initially prefer the large reward 
when effort costs are low but, as effort costs are increased, they will begin to modify the 
subjective reward value and increasingly direct their choices toward the low-effort choice. 
Inefficient choice patterns in cost-benefits tasks, though particularly inefficiencies in 
delay-based reinforcement choices, are considered an endophenotype for impulse-control 
disorders such as addiction and pathological gambling (Gray & MacKillop, 2014; 
MacKillop, 2013).  
1.4.2 Cost-benefits computations are not wholly guided by A-O principles 
The extent to which behaviour in such tasks is wholly guided by action-outcome 
principles is controversial. For example, animals will take a significant number of 
sessions to assimilate the contingencies in cost-benefits choice tasks in accordance with 
the idea that they are modifying their actions in response to unfamiliar outcomes until an 
optimal pattern of responding is established. However, if the task parameters are 
reorganised, animals can take as long to adjust their responses following changes in task 
parameters as they did to initially learn the task. This suggests that both S-R and A-O 
principles may be present during discounting tasks. In being cognisant of this perspective, 
Cardinal, Robbins & Everitt (2003) developed a composite model of non-human 
discounting, in which it is asserted that Dickinsonian A-O principles are present and that 
animals are able to make decisions about instrumental relations and their relative reward 
value. However, it is suggested that weak S-R associations are also present and that these 
associations strengthen with experience. The authors also propose that stimuli present in 
the experimental arrangement enter into Pavlovian-to-instrumental interactions to modify 
choices. The extent to which such processes are present in other forms of instrumental 
choice arrangements such as the probability discounting task is unknown, however, it is 
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entirely likely that S-R and A-O learning occurs similarly during this task and that 
uncertainty may influence choices in a similar fashion to how delay to reinforcement 
does. This is not to suggest, however, that delay and uncertainty are indistinct 
psychological processes.  
1.4.3 Glutamatergic and dopaminergic modulation of cost-benefits computations 
As with the attribution and/or enhancement of incentive salience, reward value and/or 
its relationship with the investment costs (e.g. time, risk, effort etc.) associated with 
achieving reinforcement is/are sensitive to pharmacological interference with the DA and 
glutamate systems. Systemic amphetamine bi-directionally alters intertemporal 
reinforcement choices, promoting delay tolerance in some studies (Cardinal et al., 2000; 
Wade, de Wit & Richards, 2000) or delay aversion (Cardinal et al., 2000) in others, and 
systemically administered DA antagonists increase delay aversion (Koffarnus, Newman, 
Grundt, Rice & Woods, 2011; Wade et al., 2000). Systemically administered glutamate 
receptor antagonists have also recently been shown to increase delayed choices (Yates, 
Batten, Bardo & Beckmann, 2014). There is some evidence to suggest that nucleus 
accumbens (NAc) DA transmission and its interactions with the serotonin (5-HT) system 
are important aspects of delayed reinforcement choices (Winstanley, Dalley, Theobald & 
Robbins, 2003). Probabilistically constrained reinforcement choices are affected by 
discrete administration of DA antagonists into the medial prefrontal cortex (mPFC) St 
Onge, Abhari & Floresco, 2011) or the NAc (Stopper, Khayambashi & Floresco, 2013) 
and by systemically administered glutamate antagonists (Yates et al., 2014). A wealth of 
data have established a role for DA (Aberman & Salamone, 1999; Aberman, Ward & 
Salamone, 1998; Denk, Walton, Jennings, Sharp, Rushworth & Bannerman, 2005; 
Ishiwari, Weber, Mingote, Correa & Salamone, 2004; Floresco et al., 2008; Sokolowski 
& Salamone, 1998; Trifilieff et al., 2013; Zhang et al., 2003) and glutamate (Floresco et 
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al., 2008; Paterson & Markou, 2005; Stephens & Brown, 1999) transmission in effortful 
procedures. Evidence has identified a role for nucleus accumbens DA in the provision of 
instrumental motivation (Aberman & Salamone, 1999; Aberman et al., 1998; Ishiwari et 
al., 2004; Sokolowski & Salamone, 1998; Trifilieff et al., 2013; Zhang et al., 2003). 
1.5 Conclusion 
In summary, we have discussed how Pavlovian associative mechanisms can transform 
(initially) motivationally neutral stimuli into highly valued incentive stimuli capable of 
prompting hedonic responses and sustaining high levels of work, and also how they are 
capable of multiplicatively enhancing motivation to seek reward. We have also discussed 
how animals can use action-outcome like representations to direct instrumental choices 
on the basis of reward value and also on the basis of the investment costs (e.g. costs 
benefits computations). Lastly, we have explored how DA and glutamate transmission in 
forebrain regions including the accumbens and prefrontal cortex support many of these 
processes. In subsequent sections of this introduction we will examine the 
neurobiological circuits which facilitate Pavlovian conditioned reward behaviour and 
complex intertemporal and probabilistic choice procedures and how DA and glutamate 
signalling converge in striatal regions at DARPP-32.  
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1.6 Motivational circuits: a simplified description of incentive motivational 
neurocircuitry and its functions 
 
Fig. 1.1. Simplified schematic of incentive motivational circuits. 
Black = unknown transmitter profile of projection neurons; Blue = inhibitory GABA projections; Green 
= excitatory glutamate projection; Red = neuromodulatory dopamine projection. Abbreviations: BLA 
basolateral nucleus of the amygdala; CeA central nucleus of the amygdala; CPu caudate putamen; GPe 
globus pallidus externa; GPi globus pallidus interna; HIPP hippocampus; PFC prefrontal cortex; SNc 
substantia nigra pars compacta; SNr substantia nigra pars reticulata; STN subthalamic nucleus; THAL 
thalamus; VP ventral pallidum; VTA ventral tegmental area. 
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Motivational assays, including a variety of tasks designed to assess incentive salience 
attribution (e.g. CRf, autoshaping and PIT) and tasks aimed at examining reinforcement 
choices along dimensions of time and uncertainty, and also the performance of 
instrumental motivation, are underpinned by topographically organised re-entrant circuits 
consisting, in part, of the prefrontal cortex (PFC), the striatum, the basal ganglia, the 
amygdala, the hippocampus, the thalamus and the midbrain. The rodent PFC, consisting 
of the orbitofrontal cortex (OFC), the mPFC (consisting of the infralimbic and prelimbic 
cortices) and the anterior cingulate cortex (ACC), is comprised of principally pyramidal 
glutamatergic neurons. Some of the most important glutamatergic projections from the 
PFC in the area of incentive motivation extend to the striatum (Sesack, Deutch, Roth & 
Bunney, 1989; Vertes, 2004), the amygdala (Mcdonald, 1998; Sesack et al., 1989) and 
regions of the midbrain, including the DAergic cells of the ventral tegmental area (VTA) 
(Carr & Sesack, 2000; Sesack & Pickel, 1992). The PFC in turn receives DA innervation 
from the VTA, thus these 2 regions are engaged in a reciprocal modulatory relationship 
(Wise, 2004).  
Disturbances in glutamate and DA innervated circuits downstream of the PFC, 
particularly the basal ganglia, which consists of the dorsal (caudate putamen) and ventral 
striatum (NAc and the olfactory tubercle (OT)), globus pallidus interna (GPi), the globus 
pallidus externa (GPe), the ventral pallidum (VP), the substantia nigra pars compacta 
(SNc), the substantia nigra pars reticulata (SNr) and the subthalamic nucleus (STN), are 
associated with a range of neuropsychiatric and neurodegenerative disorders including 
obsessive compulsive disorder, schizophrenia, pathological gambling, drug addiction, 
Parkinson’s disease, and Huntington’s disease.  
Basal ganglia circuits have traditionally been segregated on the basis of opioid peptide 
expression patterns and DA receptor subtypes that are present on striatal neurons within 
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distinct striatal pathways. The predominant (~90%) neuronal morphology of the striatum 
is the GABAergic medium spiny neuron (MSNs). MSNs expressing the opioid peptide 
substance P and the DA D1 receptor project directly to the internal capsule of the globus 
pallidus and the substantia nigra pars reticulata (SNr) (Gerfen, 1992; Gerfen et al., 1990). 
SNr cells are also GABAergic and their projections to the thalamus cast an inhibitory 
influence on thalamic glutamate projections to cortical regions. Activity within direct 
striatal MSNs disinhibits the influence that the SNr has on the thalamus, resulting in the 
generation of goal-directed behaviour (Gerfen, 1992). In contrast, MSNs within the so-
called indirect striatopallidal pathway express the opioid peptide enkephalin, the DA D2 
and adenosine A2A receptors and activity within this circuit strengthens the inhibitory role 
of the thalamus leading to a reduction in motor behaviour (Gerfen, 1992). For example, 
indirect striatal neurons project to the globus pallidus externa which, in turn, projects to 
subthalamic nucleus of the thalamus; the STN then extends projections back to the SNr. 
Activity within the indirect pathway inhibits behavioural responding. Thus, the traditional 
view of the direct and indirect striatal pathways are as behavioural opponent processes. 
Additionally, and more recently, some studies have identified a complementary or even 
synergistic role of these pathways in mediating the acute behavioural effects of different 
drugs of abuse, and their ability to induce plasticity (Badiani et al., 1999; Badiani, Belin, 
Epstein, Calu & Shaham, 2011; Lobo & Nestler, 2011). 
1.6.1 The connections of the striatum  
The striatum consists of the caudate and putamen (CPu) in its most dorsal region and 
the NAc and OT in its ventral portion. The ventral striatum has been described as an 
interface between frontal, limbic and motor regions which allows these regions to 
integrate high-order computations relating to the planning and affective components of 
goal-directed behaviour (Day & Carelli, 2007; Mogenson, 1987; Sesack & Grace, 2010). 
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The NAc has been anatomically segregated into 3 subdivisions, comprising a core 
(NAcC) region, a shell (NAcSh) region and a rostral pole region. Most focus has been 
directed toward the core and shell subdivisions which, in turn, have largely functionally 
segregated behavioural roles (see below) (Zahm & Brog, 1992). The NAc receives dense 
DA innervation from the VTA and a modest DA input from the substania nigra, as well 
as significant glutamate innervation from the basolateral nucleus of the amygdala (BLA), 
the thalamus, the hippocampus and the pre-limbic, infralimbic, medial orbital frontal and 
anterior cingulate cortices (Beckstead, Domesick & Nauta, 1979; Sesack & Grace, 2010; 
Voorn, Vanderschuren, Groenewegen, Robbins & Pennartz, 2004). The precise nature of 
the glutamate inputs to the subdivisions of the NAc differ in a subtle but important way. 
For example, the NAcC receives glutamatergic innervation from the prelimbic cortex, the 
anterior cingulate, the dorsal subiculum, the thalamus and the basolateral nucleus of the 
amygdala (BLA), whereas the NAcSh receives dense glutamate inputs from the 
prelimbic, infralimbic and orbito frontal cortices, the ventral subiculum, the thalamus and 
the BLA (Sesack & Grace, 2010; Yin, Ostlund & Balleine, 2008; Vertes, 2004; Voorn et 
al., 2004). The NAcC projects to the dorsolateral VP, the SNr and also the entopeduncular 
nucleus (Sesack & Grace, 2010). Thus whilst the NAcSh projects to the lateral 
hypothalamus, the ventromedial VP, the VTA, the SNc and the brainstem, the NAcC 
projects to basal ganglia output nuclei (Deniau, Menetrey & Thierry, 1994; Kelley, 2004; 
Sesack & Grace, 2010). NAc circuitry therefore maintains a direct and indirect-like 
segregation, with the NAc extending a direct-like projection to the SNr and an indirect 
projection to the VP which, in turn, extends to the STN and from there to the SNr (Sesack 
& Grace, 2010). The OT is another ventral striatal nuclei which has an important role in 
mediating motivated behaviour. The OT receives dense DAergic innervation from the 
VTA and significant glutamate innervation from cortical regions. The dorsal striatum 
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receives its primary DA input from the SNc and its principle glutamate inputs from the 
mPFC and sensory and motor cortices (Yin et al., 2008). Overall, corticostriatal glutamate 
projections from the OFC, infralimbic, prelimbic and anterior cingulate cortices convey 
information to the striatum relating to higher order cognitive functions and reward value 
appraisals to allow for the generation of appropriate and efficient behavioural responses. 
However, rather than exerting a simple hierarchical top-down influence on striatal tone, 
the re-entrant nature of fronto-striato-limbic motivational circuits provides basal ganglia 
nuclei with a mechanism to influence activity within cortical regions by a feedback 
mechanism involving the mediodorsal thalamus.  
1.6.2 Amygdaloid connections 
The amygdala interacts, mainly via its central (CeA) and BLA nuclei, with cortical, 
striatal and midbrain regions to modulate reward related behaviours by conveying 
conditioned affective and sensory information. The CeA has a predominantly medium 
spiny-like neuronal morphology, although there are aspiny neurons, whereas the cells of 
the BLA are principally pyramidal (Sah, Faber, Lopez De Armentia & Power, 2003). The 
CeA receives sensory input from the major sense modalities, as well as inputs from PFC, 
thalamus, hypothalamus and brainstem (Sah et al., 2003). The BLA similarly receives 
sensory and PFC inputs, as well as thalamic and hypothalamic inputs. In addition to these 
inputs, the CeA and BLA receive DA inputs from the VTA (Beckstead et al., 1979; Sah 
et al., 2003). The CeA extends to the bed nucleus of the stria terminalis, the hypothalamus, 
the brainstem, the substantia nigra pars compacta, the VTA and the thalamus whilst the 
BLA extends projections to the infralimbic, prelimbic and orbitofrontal cortices, the 
nucleus accumbens, the hippocampus, the bed nucleus of the stria terminalis and the CeA 
(Conzales & Chesselet, 1990; Robbins & Everitt, 2002; Stamatakis et al., 2014; Sun, Yi 
& Cassell, 1994). Although the CeA has a significant population of GABA expressing 
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neurons, it also has populations of neurons expressing peptides such as corticotrophin 
releasing factor (Beckerman, Van Kempen, Justice, Milner & Glass, 2013). 
1.6.3 Conclusion 
In summary, glutamate inputs from the PFC, the amygdala converge with DA inputs 
originating from the substantia nigra pars compacta or the ventral tegmental area at 
striatal GABAergic MSNs to coincidentally modulate the throughput of motivational 
signals through the basal ganglia. The next section therefore examines some of the more 
specific motivational functions mediated by the abovementioned circuit.  
1.7 Prefrontal cortex function in motivated behaviour 
The rodent PFC is involved in high order executive functions such as planning and 
working memory (Dalley, Cardinal & Robbins, 2004) and also in updating reward value 
and optimising reinforcement choices (Churchwell, Morris, Heurtelou, & Kesner, 2009; 
Dalley et al., 2004; Schoenbaum, Roesch, Stalnaker & Takahashi, 2009; St Onge & 
Floresco, 2010; Walton, Bannerman, Alterescu & Rushworth, 2003; Winter, Dieckman 
& Schwabe, 2009). The OFC signals outcome-expectancy information relating to 
changes in reward value by processing salient motivational features such as the sensory 
properties of reinforcers and relevant conditioned outcome-expectancy information 
(Schoenbaum et al., 2009). For example, lesions to or pharmacological inactivation of the 
OFC disrupts selective PIT (Ostlund & Balleine, 2007), Pavlovian reinforcer devaluation 
(Gallagher, McMahan & Schoenbaum, 1999), intertemporal (Winstanley, Theobald, 
Cardinal & Robbins, 2004) and probabilistic reinforcement choices (Abela & 
Chudasama, 2013), and reversal learning (Boulougouris, Dalley & Robbins, 2007), thus 
suggesting that the OFC is critically involved in modifications of reward value and the 
mediation of reinforcement choices by using reward value information to make optimal 
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choices. Some of the motivational functions of the rodent mPFC include reinforcer 
devaluation (Corbit & Balleine, 2003; Ostlund & Balleine, 2005), delay discounting 
(Churchwell et al., 2009) and probability discounting (St Onge & Floresco, 2010). 
Interference with the ACC impairs autoshaping, indicating that this PFC nucleus has a 
facilitative role in stimulus reward learning (Cardinal et al., 2002). The ACC also has a 
role in mediating effort-related reinforcement choices (Floresco & Ghods-Sharifi, 2007; 
Holec, Pirot & Huston, 2014; Hosking, Cocker & Winstanley, 2014; Schweimer & 
Hauber, 2005; Walton et al., 2003). In summary, the PFC is involved in modifying 
complex reward-based decision making processes along dimensions of time, 
uncertainty/risk and effort and, also in using conditioned sensory associations to guide 
instrumental actions. 
1.7.1 Ventral striatal function in motivated behaviour 
The NAc is a motivational hub involved in the provision of drug and food-associated 
behaviours or in drug-stimulated modifications to motivated behaviour. The behavioural 
functions of the NAc include unconditioned feeding responses (Maldonado-Irizarry, 
Swanson & Kelley, 1995; Stratford & Kelley, 1997), autoshaping (Cardinal et al., 2002), 
Pavlovian approach behaviour (Parkinson, Olmstead, Burns, Robbins & Everitt, 1999), 
pharmacological potentiation of CRf (Parkinson et al., 1999; Wolterink et al., 1993), PIT 
(Corbit & Balleine, 2011), intertemporal discounting (Acheson et al., 2006; Cardinal et 
al., 2001), probability discounting (Cardinal & Howes, 2005; Stopper & Floresco, 2011), 
probabilistic reversal learning (Dalton, Phillips & Floresco, 2014) and a multitude of 
effortful behaviours including effort-based choice (Cousins, Atherton, Turner & 
Salamone, 1996), effort discounting (Ghods-Sharifi & Floresco, 2010) and food-
reinforced progressive ratio schedules of reinforcement (Aberman et al., 1998). The NAc 
also has a well-defined role in mediating drug related behaviours such as psychomotor 
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sensitisation (Vanderschuren & Kalivas, 2000), drug self-administration (Hutcheson, 
Parkinson, Robbins & Everitt, 2001; Zito, Vickers & Roberts, 1985) and conditioned drug 
reward (Sellings & Clarke, 2003).  
NAc injections of indirect DA agonists such as amphetamine can enhance PIT (Wyvell 
& Berridge, 2000) and CRf (Taylor & Robbins, 1984), and intra-accumbal DA 
antagonists can attenuate PIT (Lex & Hauber, 2008), CRf (Wolterink et al., 1993) and 
autoshaping (Di Ciano, Cardinal, Cowell, Little & Everitt, 2001; Saunders & Robinson, 
2012). Intra-accumbal injections of glutamate antagonists have been shown to disrupt 
autoshaping (Di Ciano et al., 2001) and the response potentiating effects of amphetamine 
during CRf (Burns, Everitt, Kelley & Robbins, 1994). In addition to this, intra-accumbal 
injections of DAergic compounds modify choices in probabilistic (Stopper, Khayambashi 
& Floresco, 2013) and effort-based (Farrar et al., 2010) cost-benefits tasks and the 
motivation to exert effort in progressive ratio schedules (Zhang et al., 2003). Furthermore, 
NAc DA release occurs in response to reward associated cues conveying information 
about the temporal and effort associated costs of reinforcement (Day, Jones, Wightman 
& Carelli, 2010). Overall, these findings suggest that accumbal DA and glutamate 
transmission interact to coincidentally modulate many important incentive motivational 
processes. 
1.7.1.1 Nucleus accumbens: the core vs shell distinction  
Many of the behavioural functions of the nucleus accumbens can be dissociated along 
anatomical lines. The NAcSh underpins conditioned drug associations such as 
conditioned place preference (CPP), as well as unconditioned responses to primary 
reinforcers (e.g. feeding) (Ikemoto, 2007; Kelley, 2004). Ikemoto (2007) suggested that 
the NAcSh is involved in stimulus-outcome learning and it has additionally been 
suggested that the NAcSh is involved in response suppression during conditions of 
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instrumental uncertainty (Floresco, 2015). NAcSh lesions abolish the outcome-selective 
form of PIT (Corbit & Balleine, 2011), as well as the response-potentiating effects of 
amphetamine on CRf (Parkinson et al., 1999), and inactivation of the NAcSh impairs 
reinforcement choices constrained by probabilistic contingencies (e.g. probability 
discounting, probabilistic reversal learning) (Dalton et al., 2014; Stopper & Floresco, 
2011). The nucleus accumbens core, on the other hand, mediates distinct aspects of CS-
US associations (autoshaping, incentive salience), response vigour and effort in 
instrumental tasks and, in addition to this, promotes delay tolerance in intertemporal 
choice procedures. For example, lesions of or pharmacological interference with the 
NAcC disrupts autoshaping (Parkinson, Willoughby, Robbins & Everitt, 2000), interferes 
with performance on effortful tasks (Sokolowski & Salamone, 1998; Ghods-Sharifi & 
Floresco, 2010), promotes delay aversion in intertemporal choice tasks (Cardinal et al., 
2001), disrupts general PIT (Corbit & Balleine, 2011), and enhances context-specific 
psychomotor sensitisation (Kelsey, Gerety & Guerriero, 2009).  
In summation, the nucleus accumbens appears to promote purposeful motivated 
behaviour by integrating signals from cortical, midbrain and amygdaloid regions involved 
in the processing of reward value and associated affective signals.  
1.7.2 Caudate putamen function 
The caudate-putamen resides dorsally to the NAc and is functionally implicated in 
behavioural flexibility and both action-outcome and stimulus-response/habit learning. 
Lesions to the dorsomedial striatum impair behavioural flexibility during instrumental 
reversal learning (Castañé, Theobald & Robbins, 2010). Lesions to the dorsolateral 
striatum also impair habit formation (Yin, Knowlton & Balleine, 2004). For example, 
extended instrumental training for food reinforcers renders subjects insensitive to 
outcome devaluation manipulations but lesions of the dorsolateral striatum (DLS) 
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maintain outcome-devaluation in subjects trained under habit promoting variable interval 
schedules of reinforcement (Yin et al., 2004). Conversely, lesions to the dorsomedial 
striatum (DMS) impair the ability of subjects to maintain action-outcome relations 
following outcome devaluation (Yin, Ostlund, Knowlton, & Balleine, 2005). It was 
recently shown that connections between the BLA and the dorsomedial striatum are 
necessary for reinforcer devaluation; lesions or temporary inactivation of these 
connections prevents the devaluation effect (Corbit, Leung & Balleine, 2013). The CPu 
is also implicated in the Pavlovian enhancement of instrumental responding. Temporary 
inactivation of the dorsolateral striatum leaves the selective-outcome PIT effect intact, 
however, the magnitude of this effect is significantly attenuated (Corbit & Janak, 2007). 
When the dorsomedial striatum is temporarily inactivated, however, outcome-selective 
PIT is abolished (Corbit & Janak, 2007). The CPu, therefore, facilitates the acquisition of 
relevant instrumental processes by mediating action-outcome learning and the encoding 
of habits. In addition to this, the CPu mediates the modification of instrumental 
responding following changes in reward value by, more generally, integrating sensory 
information and reward value information to guide instrumental choices. 
1.7.3 Ventral pallidum function in motivated behaviour 
The VP is a basal ganglia node that has been described as a ‘common pathway’ for 
mesocorticolimbic projections which is involved in the generation of motivated 
behaviour (Smith, Tindell, Aldridge & Berridge, 2009). Reversible inactivation of the VP 
simultaneously reduces high-effort responses to obtain a highly palatable reward but 
increases consumption of a less-preferred, concurrently available reward (Farrar et al., 
2008). The firing profile of VP neurons following CS presentation indicates that VP 
neurons encode the incentive-sensitisation of such stimuli in response to repeated 
amphetamine treatment (Tindell, Berridge, Zhang, Peciña, & Aldridge, 2005). 
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Furthermore, reversible inactivation of the VP blocks selective outcome PIT and this 
selective outcome promoting effect of Pavlovian stimuli most likely involves projections 
from the NAcSh to the ventromedial VP (Leung & Balleine, 2013; Root, 2013).  
1.7.4 Ventral tegmental area function 
The VTA provides the most substantial DA inputs to the ventral striatum, the 
amygdala and the frontal cortex. The functional basis of these connections is the focus of 
intense speculation. However, one general feature of its function is that it is involved in 
the encoding of stimulus-outcome associations. Investigators such as Schultz (2002) have 
suggested that VTA DA neurons forming connections with the NAc function as a 
teaching-signal that encodes the predictability of reward associated cues, whilst others 
such as Robinson & Berridge (1993) suggest that VTA DA neurons encode the incentive 
salience of conditioned associations. Although speculation surrounding the precise 
psychological functions of VTA DA remains, it is widely accepted that VTA DA is 
involved in associative processes. Consistent with this idea, temporary inactivation of the 
VTA disrupts both the general and outcome-selective forms of PIT (Corbit, Janak & 
Balleine, 2007).  
1.7.5 Amygdala function in reward learning 
Deep within the medial temporal lobe lies an almond-like structure, termed the 
amygdaloid complex, which has a well-defined role in reward learning. The amygdala, 
particularly the basolateral (BLA) and central (CeA) nuclei, are of particular importance 
to reward-related motivation and decision making. It has been suggested that, in the 
domain of fear conditioning, the BLA is involved in a serial circuit with the CeA. 
However, in the domain of appetitive motivation, the CeA and BLA exist in a parallel 
circuit to promote distinct motivational functions (Balleine & Killcross, 2006). In this 
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scheme then, the CeA adds affective tone to conditioned associations, imbuing 
conditioned stimuli with motivational resonance/incentive salience (Corbit & Balleine, 
2005). The BLA, however, mediates the formation of sensory CS-US associations (Corbit 
& Balleine, 2005), as well as the mediation of instrumental reward devaluation following 
sensory-specific satiety (Balleine, Killcross & Dickinson, 2003). Lesions to, or 
pharmacological inactivation of, the BLA disrupts intertemporal (Winstanley et al., 
2004), probabilistic and effort-based (Ghods-Sharifi, St. Onge & Floresco, 2009) 
reinforcement choices, selective outcome PIT (Corbit & Balleine, 2005), and both 
instrumental (Balleine et al., 2003; Johnson, Gallagher & Holland, 2009) and Pavlovian 
reinforcer devaluation (Johnson et al., 2009), whereas lesions of the CeA disrupt general 
PIT (Corbit & Balleine, 2005), autoshaping (Parkinson, Robbins & Everitt, 2000) and the 
ability of intra-accumbal injections of amphetamine to potentiate CRf (Robledo, Robbins 
& Everitt, 1996). Recent work has also revealed a critical role of the CeA in the 
development of habit formation (Lingawi & Balleine, 2012).  
1.7.6 Conclusion 
In summary, complex motivated behaviours are underpinned by cortical and 
amygdaloid glutamate fibres involved in the processing of cognitive and affective 
processes and midbrain DA fibres which converge at striatal GABAergic MSNs to 
modulate neural activity in the basal ganglia and, subsequently, the generation or 
inhibition of goal-directed behaviour. Inherently, motivated behaviour involves careful 
and seemingly complex cost-benefits computations, balancing risks, energy expenditure 
with expected gains based on integrating a variety of learned information about reward 
value and incentive salience signals to guide the selection of appropriate choices during 
any given moment. We will next explore how DARPP-32 is an important integrator of 
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DA and glutamate signalling in striatal regions involved in many of the aforementioned 
behaviours.  
1.8 DARPP-32: a complex neuronal phosphoprotein  
DA and glutamate axons form synapses with MSNs on dendritic spines and spine 
heads to modulate MSN excitability. For example, coincident activity at striatal DA and 
glutamate receptors can induce certain forms of electrophysiological plasticity such as 
long-term potentiation (LTP) and long-term depression (LTD) (Gerfen & Surmeier, 2011; 
Surmeier, Ding, Day, Wang & Shen, 2007). DA exerts opposite effects on MSN 
excitability in the direct and indirect pathways. D1-family (D1, D5) receptors are Gs/Golf 
G-protein coupled receptors which stimulate adenylyl cyclase (AC) resulting in the 
accumulation of cyclic adenosine monophosphate (cAMP) and the subsequent activation 
of cAMP-dependent protein kinase (PKA), whereas D2-familiy (D2, D3, D4) receptors are 
Gi/Go G-protein coupled receptors which inhibit cAMP formation and PKA activation 
when stimulated. The intracellular distinction between D1-family and D2-family receptors 
has profound consequences for the excitability of MSNs. D1 receptor stimulation 
enhances strong glutamate signals, promoting the so-called up-state in the direct pathway 
and the induction of LTP whereas D2 receptor stimulation dampens the sensitivity of 
MSN populations in the indirect pathway to endogenous glutamate, thus promoting the 
induction of LTD (Gerfen & Surmeier, 2011; Surmeier et al., 2007). Gerfen & Surmeier 
(2011) suggest that these D2-mediated up-state opposing events are orchestrated by 
reduced activity through Na+ and Ca2+ ion channels which promote membrane 
depolarisation, and via increased activity through K+ channels which promote membrane 
hyperpolarisation. D1 receptors via PKA, on the other hand, increase depolarising Na
+ 
and Ca2+ channels and diminish hyperpolarising K+ channels. D1-mediated PKA 
activation also promotes gene transcription and the phosphorylation of glutamate receptor 
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subunits which modify the responsiveness of cells to glutamate, either by directly 
promoting the phosphorylation of glutamate receptor subunits, or by interacting with 
intracellular proteins such as DARPP-32 which also influence gene transcription and the 
phosphorylation of glutamate subunits.   
DARPP-32 is a complex, bi-functional integrator of neurotransmission in the majority 
of dopaminoceptive brain regions, which is intimately involved in the regulation of key 
neuronal processes, including neurotransmitter receptor and ion channel phosphorylation, 
which are directed toward controlling neuronal excitability and gene expression 
(Svenningsson et al., 2004). DARPP-32 is abundantly enriched in striatal MSNs and 
discrete regions of the amygdala (Ouimet, Miller, Hemmings, Walaas & Greengard, 
1984; Walaas & Greengard, 1984; Perez & Lewis, 1992). In the cortex, DARPP-32 is 
expressed less intensely and its profile is limited to sparse populations in layers III and 
layers VI (Ouimet et al., 1984). We will discuss the regional distribution of DARPP-32 
within motivational circuits in greater detail in chapter 2.  
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1.8.1 DARPP-32 is influenced by protein kinases and protein phosphatases 
 
Fig. 1.2. DARPP-32 phosphorylation residues and their effectors. Adapted from Yger & Girault (2011).  
DARPP-32 possesses an intricate phosphorylation profile consisting of both serine and 
threonine residues; these residues include Thr34, Thr75, Ser45, Ser97 (Ser102 rat), Ser130 
(Ser137 rat) and a Ser192 in the mouse brain. Thr34-DARPP-32 phosphorylation is 
stimulated most potently by PKA, however, cyclic-guanosine monophosphate-dependent 
protein kinase (PKG) additionally promotes Thr34-DARPP-32 phosphorylation 
(Hemmings, Williams, Konigsberg & Greengard, 1984). Dephosphorylation of Thr34 is 
most strongly influenced by Ca2+-dependent protein phosphatase 2B (PP2B/calcineurin) 
(King et al., 1984). However, protein phosphatase 2A (PP2A) also contributes to this 
event (Nishi, Snyder, Nairn & Greengard, 1999). Thr75 phosphorylation is prompted by 
cyclin-dependent protein kinase 5 (cdk5) (Bibb et al., 1999) and its dephosphorylation is 
stimulated by PP2A (Nishi et al., 2000). Ser45 and Ser97 phosphorylation are prompted by 
casein kinase II (CK2) and both of these residues are dephosphorylated by PP2A (Girault, 
Hemmings, Williams, Nairn & Greengard, 1989). PP2A-mediated dephosphorylation of 
Ser97 has been shown to involve a cAMP-PKA dependent mechanism (Stipanovich et al., 
2008). Ser130 phosphorylation is stimulated by casein kinase 1 (CK1) (Desdouits, Cohen, 
Nairn, Greengard & Girault, 1995). Ser130 dephosphorylation is prompted by PP2A and 
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protein phosphatase 2C (PP2C) in vitro, however, dephosphorylation of Ser130 is not 
disturbed by the PP2A inhibitor okadaic acid in vivo, indicating that PP2C may have a 
greater role in dephosphorylating this residue than PP2A in the brain (Desdouits, 
Siciliano, Nairn, Greengard & Girault, 1998).  
1.8.2 DARPP-32: a molecular interface for postsynaptic neurotransmission 
 
Fig.1.3. Simplified diagram of major signalling pathways involved in Thr34 & Thr75 phosphorylation. Green 
indicates an increase in activity whilst red equates to a reduction in activity. Not all pathways represented. 
Adapted from Nishi et al, 2005; Svenningsson et al, 2002/2004. 
DARPP-32 integrates postsynaptic signals from the DA, glutamate, serotonin, GABA, 
norepinephrine and opioid systems, in addition to neuromodulators such as adenosine and 
nitric oxide (NO) (Svenningsson et al., 2004). We will, however, primarily focus on the 
effects of those neurotransmitter systems that are the most significant effectors of 
DARPP-32, such as DA or glutamate, or those systems which have been identified as 
making a significant and consistent contribution to the behaviours contained in 
subsequent chapters (e.g. 5-HT & adenosine) (see Fig. 1.3). With regards to the 
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contribution made by these other neurotransmitter and neuropeptide systems, the reader 
is referred to any of the numerous excellent reviews to have elaborated all of the 
signalling pathways and their direct effects on DARPP-32 phosphorylation and its 
downstream targets (Greengard, Allen & Nairn, 1999; Svenningsson et al., 2004; Yger & 
Girault, 2011).  
1.8.3. Thr34-DARPP-32 phosphorylation and PP-1 inhibition 
 D1 receptor activation promotes the PKA-stimulated phosphorylation of Thr
34- 
DARPP-32 and the subsequent inhibition of protein phosphatase 1 (PP-1) (Hemmings, 
Greengard, Tung & Cohen, 1984; Nishi, Snyder & Greengard, 1997). PP-1 inhibition, as 
we will later discuss, has important consequences for transcriptional events and the 
electrophysiological properties of MSNs. Glutamate induced nitric oxide signalling, via 
either α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-methyl-d-
aspartate (NMDA) or metabotropic glutamate (mGluR) type 5 receptors, stimulates cyclic 
guanosine monophosphate (cGMP) and the subsequent activation of PKG which also 
elevates Thr34-DARPP-32 phosphorylation (Nishi et al., 2005). Thr34-DARPP-32 
phosphorylation is also affected by adenosine transmission in the indirect pathway. 
Adenosine A2A receptors form heteromers with D2 receptors (Fuxe et al., 2005) and their 
activation promotes Thr34-DARPP-32 phosphorylation in indirect striatopallidal MSNs. 
The adenosine A2A receptor agonist CGS 21680 stimulates increases in Thr
34-DARPP-32 
via a mechanism involving cAMP and PKA (Svenningsson et al., 1998). A2A mediated 
increases in Thr34-DARPP-32 phosphorylation require the co-activation of mGluR5 
receptors by glutamate (Nishi et al., 2003). mGluR5 receptor activation also stimulates 
increases in Thr34-DARPP-32 phosphorylation and it does so via an extracellular signal-
regulated protein kinase (ERK)/AC/cAMP/PKA pathway (Nishi et al., 2005). mGluR5-
stimulated increases in Thr34 phosphorylation require the co-activation of A2A receptors 
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(Nishi et al., 2003). GABA activation increases Thr34-DARPP-32 by opposing its 
dephosphorylation by PP2B (Snyder, Fisone & Greengard, 1994) whilst 5-HT directly 
increases the phosphorylation of Thr34-DARPP-32 DARPP-32 via the 5-HT4 and 5-HT6 
receptors (Svenningsson Tzavara, Liu, et al., 2002).  
1.8.4 Dopamine and glutamate mediated dephosphorylation of Thr34-DARPP-32 
As mentioned above, the dephosphorylation of Thr34-DARPP-32 occurs most potently 
by PP2B. However, PP2A also makes a minor contribution toward Thr34-DARPP-32 
dephosphorylation. Ionotropic, fast excitatory AMPA and NMDA receptors (Nishi et al., 
2002) and also D2 receptors (Nishi et al., 1997) contribute to the dephosphorylation of 
Thr34-DARPP-32 by elevating intracellular calcium levels which, in turn, activates PP2B. 
D2 receptor activation additionally contributes to the dephosphorylation of Thr34-
DARPP-32 by directly opposing cAMP formation (Nishi et al., 1997). Indeed, D2 
receptors are negatively coupled to cAMP in the indirect striatopallidal pathway and their 
activation therefore opposes PKA.  
1.8.5 Thr34-DARPP-32 phosphorylation is fine-tuned by activity at serine residues 
Activity at Thr34-DARPP-32 is fine-tuned by Ser97 and Ser130 phosphorylation. Ser97 
phosphorylation increases the potency by which PKA can phosphorylate Thr34-DARPP-
32 (Girault et al., 1989) and Ser130 assists in maintaining DARPP-32 in its Thr34 
phosphorylated form by opposing the dephosphorylation of Thr34-DARPP-32 by PP2B 
(Desdouits, Sicilliano, Greengard & Girault, 1995). Ser130-DARPP-32 phosphorylation 
can be stimulated by 5-HT2C receptors and involves phospholipase c (PLC) and CK1 and 
therefore likely opposes PP2B-mediated dephosphorylation of Thr34-DARPP-32 
(Svenningsson, Tzavara, Liu, et al., 2002). In addition to 5-HT2C receptor activation, 
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mGluR5 activation increases the phosphorylation of Ser
130-DARPP-32 via CK1 (Liu et 
al., 2001).  
1.8.6 DARPP-32 mediates nuclear processes 
Although DARPP-32 is largely described as a cytoplasmic phosphoprotein, Ser97-
DARPP-32 phosphorylation regulates the passage of DARPP-32 from the nucleus to the 
cytoplasm. Whilst Ser97-DARPP-32 phosphorylation stimulates the transfer of DARPP-
32 from the nucleus to the cytoplasm, D1/PP2A mediated dephosphorylation of the Ser
97 
residue maintains DARPP-32 in the nucleus, during which DARPP-32 can assist in the 
phosphorylation of Ser10-histone H3 by inhibiting PP-1 (Stipanovich et al., 2008).  
1.8.7 Thr75-DARPP-32 phosphorylation and PKA inhibition  
Although many of DARPP-32’s phosphorylation residues generate positive feedback 
signals which either directly enhance Thr34-DARPP-32 phosphorylation or indirectly by 
preventing the dephosphorylation of this residue, Thr75-DARPP-32 exerts an antagonistic 
influence over the PKA-Thr34-DARPP-32 pathway. Thr75-DARPP-32 phosphorylation is 
stimulated by cdk5 and because this phosphorylated form of DARPP-32 is antagonistic 
to Thr34-DARPP-32 and the function of PKA, it enhances PP-1 activity and likely opposes 
the facilitative actions of Thr34-DARPP-32 on downstream targets such as AMPA, 
NMDA and GABA receptors, as well as gene expression (Bibb et al., 1999). DARPP-32, 
therefore, is both a PKA and PP-1 inhibitor (Bibb et al., 1999). This dual-functioning 
capacity of DARPP-32 can be explained, in part, by the bidirectional effects of DA 
signalling. For example, whilst D1 receptor stimulation increases Thr
34-DARPP-32 
phosphorylation it also stimulates a simultaneous decrease in Thr75-DARPP-32 
phosphorylation and, in contrast to this, D2 receptor activation stimulates a concomitant 
increase in Thr75-DARPP-32 and a decrease in Thr34-DARPP-32 phosphorylation (Nishi 
33 
 
 
et al., 2000). The phosphorylation of Thr75-DARPP-32 also involves activity at mGluR1 
and mGluR5 receptors. The mGluR1/5 agonist 3,5 dihydroxyphenylglycine (DHPG) 
increases Thr75-DARPP-32 phosphorylation in striatal slices and this effect is blocked by 
the cdk5 inhibitor butyrolactone or CK1 inhibitors CK1–7 and IC261, indicating that 
Thr75-DARPP-32 phosphorylation involves mGluR1/5 stimulated increases in CK1 which 
subsequently promote cdk5 stimulated increases in Thr75-DARPP-32 (Liu et al., 2001). 
Conversely, the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) 
reduces tonically elevated levels of Thr75-DARPP-32 phosphorylation induced by 
repeated cocaine administration, suggesting that tonic activity at mGluR5 receptors assists 
in maintaining DARPP-32 in its Thr75-DARPP-32 phosphorylated form in certain 
instances (Scheggi, Raone, De Montis, Tagliamonte & Gambarana, 2007). Thr75-
DARPP-32 dephosphorylation is stimulated by D1 receptor activation and PKA mediated 
stimulation of PP2A (Nishi et al., 2000) or by 5-HT4/6 mediated activation of the PKA 
pathway (Svenningsson, Tzavara, Liu, et al., 2002). PKA subsequently stimulates PP2A 
activation resulting in the dephosphorylation of Thr75 (Ahn, McAvoy, Rakhilin, et al., 
2007) and, in addition to this, Ca2+-dependent activation of PP2A also promotes the 
dephosphorylation of Thr75 (Ahn, Sung, McAvoy, et al., 2007). This latter mechanism 
most likely involves the NMDA & AMPA receptors, which stimulate increases in 
intracellular Ca2+ levels and the subsequent dephosphorylation of Thr75-DARPP-32 by 
PP2A (Nishi et al., 2002). A2A receptor activation by CGS 21680 also stimulates the 
dephosphorylation of Thr75-DARPP-32 and these increases in the dephosphorylation of 
the Thr75-DARPP-32 substrate involve PP2A (Lindskog et al., 2002).  
1.8.8 Summary  
Depending on its phosphorylation pattern, DARPP-32 can inhibit either PP-1 or PKA. 
D1 receptors promote PKA-dependent increases in Thr
34 phosphorylation and the 
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subsequent inhibition of PP-1. In contrast, cdk5-mediated Thr75-DARPP-32 
phosphorylation inhibits PKA. The Ser97 and Ser130 residues assist in Thr34-DARPP-32 
phosphorylation.  Finally, the effect of glutamatergic activity on these processes is 
complex.    
1.9 DARPP-32 is a molecular regulator of MSN receptor phosphorylation and 
electrophysiology 
The net effect of DARPP-32 phosphorylation is the regulation of ion channels and 
receptor subunit (AMPA GluR1, NMDA NR1, GABAA,) phosphorylation and nuclear 
events such as gene and immediate early gene (IEG) expression or histone 
phosphorylation which are associated with neuronal excitability (Dell’Anno, Pallottino 
& Fisone, 2013; Flores-Hernandez et al., 2000; Flores-Hernandez et al., 2002; 
Håkansson, Galdi, Hendrick, Snyder, Greengard & Fisone, 2006; Snyder, Fienberg, 
Huganir & Greengard, 1998; Stipanovich et al., 2008; Svenningsson et al., 2000/2004; 
Yan et al., 1999). Many of these processes are directly affected by PKA or PP-1, thus 
DARPP-32 has a pivotal role as a mediator of many key neuronal processes. 
1.9.1 DARPP-32 and AMPA receptor phosphorylation 
Striatal AMPA ser845 GluR1 receptor subunits are dephosphorylated by activation of 
AMPA and NMDA receptors involving a calcineurin-dependent mechanism which 
occurs independently of DARPP-32 and PP-1 (Snyder et al., 2003). However, in vivo 
phosphorylation of the AMPA GluR1 Ser
845 subunit occurs via PKA and requires 
DARPP-32 to maintain normal functioning. Acute psychostimulant mediated increases 
in striatal Ser845 GluR1 phosphorylation are significantly lower in DARPP-32 KO mice 
(Snyder et al., 2000). Ser845 GluR1 phosphorylation occurs equally between wildtype 
(WT) & DARPP-32 knockout (KO) mice in response to the PP2A/2B inhibitor okadaic 
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acid, thus suggesting that the D1-PKA-Thr
34-DARPP-32 pathway modifies AMPA 
subunit phosphorylation by opposing PP-1 (Snyder et al., 2000). In contrast to the effects 
of D1 receptor stimulation on Ser
845GluR1 phosphorylation, D2 receptor activation 
decreases Ser845-GluR1 phosphorylation, whereas the D2 receptor antagonist haloperidol 
increases Ser845-GluR1 phosphorylation (Håkansson, Galdi, Hendrick, Snyder, 
Greengard & Fisone, 2006). This latter effect requires the co-activation of A2A receptors, 
and either global deletion of DARPP-32 or replacement of Thr34-DARPP-32 with a non-
phosphorylatable alanine residue abolishes this effect. mGluR5 activation was recently 
shown to contribute to increased Ser845 GluR1 phosphorylation and this effect also 
depended upon coincident activation of A2A receptors in the striatopallidal pathway 
(Dell’Anno, Pallottino & Fisone, 2013). In the same study, the ability of the mGluR1/5 
agonist DHPG to increase Ser845-GluR1 phosphorylation is blocked by either the mGluR5 
antagonist MPEP or by deletion of striatopallidal DARPP-32. Thus, in D1-expressing 
MSNs, D1 receptor activation stimulates increases in Ser
845-GluR1 whereas, the 
phosphorylation of this subunit in the D2-expressing indirect pathway is attenuated by 
activity at D2 receptors but increased by the co-incident activation of mGluR5 and A2A 
receptors. 
1.9.1.1 DARPP-32 modulates AMPA channel currents 
 In addition to the regulation of AMPA subunit phosphorylation, AMPA channel 
currents are enhanced in vitro by the application of D1 receptor agonist SKF 81297 or a 
phosphorylated form of DARPP-32, p-D32. For example, application of either SKF 
81297 or p-D32 prevents AMPA channel run down in striatal slices (Yan et al., 1999). 
However, SKF 81297 mediated increases in AMPA channel currents are severely 
diminished when applied to striatal slices extracted from DARPP-32 KO mice (Yan et 
al., 1999). Spinophilin, a PP-1 binding peptide, anchors PP-1 in close proximity to 
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AMPA receptors and interference with this protein by application of a spinophilin 
competitive peptide significantly reduces the binding of spinophilin to PP-1 and prevents 
the rundown of AMPA channel currents (Yan et al., 1999). 
1.9.2 DARPP-32 and NMDA receptor phosphorylation 
 NMDA NR1 receptor phosphorylation at a Ser
897 residue is similarly stimulated in 
vitro by PKA and its dephosphorylation is also regulated by the D1-PKA-DARPP-32-
PP-1 pathway (Fienberg et al., 1998; Snyder et al., 1998). DA plus the DA reuptake 
inhibitor nomifensine, or D1 agonists (SKF 81297 or SKF 85256), stimulate NMDA NR1 
phosphorylation. Co-application of the D2 agonist quinpirole blocks the ability of SKF 
81297 to increase Ser897 NR1 phosphorylation (Snyder et al., 1998). Directly inhibiting 
PP-1/2A with calyculin A increases NR1 phosphorylation, and inhibiting calcineurin, 
blocks the ability of D2 receptor agonists to reduce D1 increases in NR1 phosphorylation. 
Finally, NR1 phosphorylation following the application of DA plus nomifensine or the 
adenylyl cyclase activator forskolin is severely attenuated in DARPP-32 KO mice 
(Fienberg & Greengard, 2000). 
1.9.2.1 DARPP-32 modulates NMDA channel currents 
Striatal DA activity also exerts a significant influence over NMDA currents. NMDA 
currents are increased in MSNs by the application of SKF 81297. Co-application of SKF 
83566, a D1 receptor antagonist, dampens these electrophysiological effects (Flores-
Hernandez et al., 2002). Co-application of the D2 agonist quinpirole also reduces SKF 
81297-stimulated increases in NMDA currents, again indicating that D1 vs D2 receptors 
differentially affect the electrophysiological properties of MSNs (Flores-Hernandez et 
al., 2002). SKF 81297-mediated NMDA currents are lower in DARPP-32 KO mice than 
in WT mice (Flores-Hernandez et al., 2002). SKF 81297 mediated increases in NMDA 
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currents are normalised in DARPP-32 KO mice when it is co-applied with PP-1 inhibitor 
okadaic acid (Flores-Hernandez et al., 2002). These findings suggest that similar 
mechanisms (e.g. D1-PKA-DARPP-32-PP-1) regulate the phosphorylation and 
dephosphorylation of both AMPA GluR1 and NMDA NR1 subunits and the 
electrophysiological properties associated with these receptors in DARPP-32 expressing 
regions. 
1.9.3 DARPP-32 and GABAA receptors 
β1/β3 subunits of the GABAA receptor are phosphorylated by PKA (McDonald et al., 
1998) and this event requires DARPP-32 to occur normally (Flores-Hernandez et al., 
2000). D1 agonist (SKF 81297) induced phosphorylation of β1/β3 subunits is severely 
affected in DARPP-32 KO mice and disturbances in this function have important 
consequences for the electrophysiological properties of GABAA currents. For example, 
D1 receptor stimulation dampens GABAA currents and this effect is similarly disturbed 
in DARPP-32 KO mice (Flores-Hernandez et al., 2000). 
1.9.4 DARPP-32 and ion channel regulation 
In addition to the direct regulation of AMPA GluR1, NMDA NR1 and GABAA subunit 
phosphorylation, DARPP-32 influences the activity of other key determinants of 
neuronal excitability such as the Na+, K+ ATPase ion pump and voltage-dependent N/P-
Q-type Ca2+ channels and Na+ channels. The Na+, K+ ATPase pump maintains the 
potential gradient and influences the hyperpolarisation of neurons. D1 receptor activation 
by SKF 82526 reduces Na+, K+ ATPase activity and this effect is abolished in DARPP-
32 KO mice (Fienberg et al., 1998). N/P-type Ca2+ channels currents are also reduced by 
a D1-PKA dependent pathway following the application of SKF 81297 and this effect is 
significantly reduced in DARPP-32 KO mice (Fienberg et al., 1998). D1 receptor 
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activation reduces sodium channels current via a PKA-mediated mechanism 
(Schiffmann, Lledo & Vincent, 1995). This process also involves the inhibition of PP-1 
by DARPP-32 (Schiffmann et al., 1998) and DARPP-32 KO mice display impairments 
in D1 receptor mediated changes in Na+ currents (Fienberg et al., 1998).  
1.9.5 DARPP-32 is a critical mediator of striatal synaptic plasticity 
DARPP-32 is not only an effector of discrete ion channel currents but also a critical 
determinant of long-term experience-dependent changes in the electrophysiological 
properties of MSNs. Stimulation of corticostriatal glutamate fibres can induce 2 distinct 
forms of synaptic plasticity, LTD and LTP depending on whether magnesium is present 
or absent in the solution respectively. Both of these forms of synaptic plasticity are lost 
in striatal neurons of DARPP-32 KO mice, however, inhibition of PP-1 returned both 
LTD and LTP in DARPP-32 KO mice (Calabresi et al., 2000). Moreover, both LTD and 
LTP were blocked by the D1 antagonist SCH 23390 but the intracellular mechanisms by 
which this occurred appear to differ. For example, LTD but not LTP was blocked by the 
NO donor SNAP or the cGMP inhibitor zaprinast whereas LTP but not LTD was blocked 
by the PKA inhibitor H89. 
Whilst D1 receptors are involved in the induction of LTP and D2 receptors in the 
induction of LTD, LTP and LTD can be induced in both D1-expressing striatonigral and 
D2-expressing striatopallidal pathways. Moreover, local deletion of DARPP-32 in either 
the striatonigral or striatopallidal pathways prevents the induction of LTP (Bateup et al., 
2010). One possible explanation for this apparent contradiction in the induction of LTP 
in both striatonigral and striatopallidal pathways may relate to the presence of adenosine 
A2A receptors on striatopallidal MSNs. As mentioned previously, A2A receptors like D1 
receptors, are positively coupled to PKA and A2A blockade prevents the induction of LTP 
(Shen, Flajolet, Greengard & Surmeier, 2008). Therefore, whilst D1 and NMDA 
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activation induce LTP in striatonigral MSNs, A2A and NMDA activation induces LTP in 
striatopallidal neurons. The authors of this study also showed that LTD in the 
striatopallidal pathway is induced by the activation of D2 and mGluR5 receptors and Cav 
1.3 Ca2+ channels whereas, in the striatonigral pathway, LTD is dependent on the 
activation of mGluR5 and Cav 1.3 Ca
2+ channels. The well-defined role DARPP-32 has 
in mediating striatal synaptic plasticity most plausibly explains, at least in part, the 
relationship it has in mediating the behavioural effects of drugs of abuse - see below - and 
it also suggests that it might have important functional consequences for reward-related 
instrumental and associative learning. 
1.9.6 DARPP-32 is located in MSN spine heads and necks 
A recent study using a combined cell culture and stimulated emission depletion 
microscopy (STED) approach precisely outlined the spatial distribution of DARPP-32 in 
dendritic spines of MSNs and, in doing so, provided insight into the possible spatial role 
DARPP-32 has in regulating the synaptic properties of these neurons (Blom et al., 2013). 
Clusters of DARPP-32 were reported in MSN spine heads with additional groups present 
in the spine neck. The authors suggest that the position of DARPP-32 within MSN spine 
heads bequeaths DARPP-32 with the molecular responsibility of modulating synaptic 
properties and the secondary clusters in the spine neck may confer DARPP-32 with the 
ability to modulate other functions such as ion dynamics and other intracellular signalling 
proteins. 
1.9.7 Conclusion 
Thus far we have seen how midbrain DA and cortical and amygdala glutamate 
signalling converging at MSNs is post-synaptically integrated, in part, by DARPP-32. 
The major consequence of these integrative effects is the fine-grained tuning of MSN 
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electrophysiology which is partially mediated by the inhibition of PP-1 or PKA, 
depending on the phosphorylation profile of DARPP-32 and the DA receptor type 
expressed on MSNs. The net effect of these processes involves changes in the 
phosphorylation of NMDA and AMPA glutamate receptor subunits and also of GABA 
receptor subunits, as well as the phosphorylation of Na+ and Ca2+ ion channels and the 
Na+/K+ ATPase pump. In addition to this, glutamate and DA signalling converging at 
DARPP-32 can dynamically stimulate changes in AMPA and NMDA currents, and also 
long-term changes in the electrophysiology of MSNs (e.g. LTD and LTP). DARPP-32 
also regulates the expression of a number of important neuronal proteins including c-fos, 
delta fosB, arc, enkephalin and dynorphin which we will discuss below. 
1.10 DARPP-32 a common striatal substrate for drugs of abuse: behavioural and 
molecular insights from acute and repeatedly administered drugs of abuse 
The striatum is a common neural pathway for drugs of abuse. Psychoactive substances 
increase striatal DA release and DARPP-32 is a well-studied post-synaptic integrator of 
drug-stimulated striatal neurotransmission (see Borgkvist & Fisone, 2007; Nairn et al., 
2004; & Svenningsson, Nairn & Greengard, 2005 for reviews). Acutely administered 
drugs of abuse, including amphetamine (Svenningsson et al., 2003), methamphetamine 
(Chen & Chen, 2005), cocaine (Nishi et al., 2000), morphine (Borgkvist, Usiello, 
Greengard & Fisone, 2007), cannabis (Borgkvist, Marcellino, Fuxe, Greengard, & 
Fisone, 2008) and nicotine (Hamada, Higashi, Nairn, Greengard & Nishi, 2004) increase 
Thr34-DARPP-32 phosphorylation. Acute amphetamine treatment also increases Ser130-
DARPP-32 phosphorylation (Svenningsson et al., 2003) and nicotine increases Ser97-
DARPP-32 phosphorylation and Ser130-DARPP-32 phosphorylation, whilst decreasing 
Thr75-DARPP-32 phosphorylation (Hamada et al., 2005). Caffeine increases Thr75-
DARPP-32 phosphorylation (Lindskog et al., 2002) whilst amphetamine (Svenningsson 
41 
 
 
et al., 2003) and cocaine (Nishi et al., 2000) cause a decrease in the phosphorylation of 
this residue. The effects of acute cocaine on DARPP-32 are sensitive to the activation of 
5-HT2C receptors in the NAcC. Co-administration of the 5-HT2c receptor antagonist Ro 
60-0175 attenuates Thr34-DARPP-32 phosphorylation in NAcC, suggesting that DARPP-
32 requires co-incident activation of 5-HT2c receptors to undergo D1 receptor-induced 
increases in Thr34-DARPP-32 phosphorylation (Cathala et al., 2014). Thus, DARPP-32 
is affected by acutely administered psychoactive drugs mainly via their ability to 
influence Thr34-DARPP-32 and/or Thr75-DARPP-32 phosphorylation. 
 Numerous well-studied behavioural and molecular effects of drugs of abuse involve 
DARPP-32, and systematic investigations recruiting mice with either global deletion of 
DARPP-32, or mice with non-phosphorylatable alanine knockin replacements at specific 
phosphorylation residues have characterised the pathways by which DARPP-32 mediates 
these effects. The locomotor activating effects of various psychoactive drugs is disturbed 
in DARPP-32 mutant mice. For instance, the locomotor activating effects of acutely 
administered cocaine (Fienberg et al, 1998), caffeine (Lindskog et al., 2002), 
amphetamine (as cited in Fienberg et al., 1998) and morphine (Borgkvist et al., 2007) are 
attenuated in DARPP-32 KO mice. In contrast, locomotor activity to an acute dose of 
ethanol is enhanced in DARPP-32 KO mice (Risinger, Freeman, Greengard & Fienberg, 
2001). Using mice with bacterial artificial chromosomes which selectively tag DARPP-
32 in the D1-expressing striatonigral vs D2-expressing striatopallidal pathways with 
distinct fluorescence proteins, Bateup and colleagues revealed that cocaine differentially 
alters the phosphorylation of DARPP-32 in striatonigral and striatopallidal neurons, 
promoting increases in Thr34-DARPP-32 and decreases in Thr75-DARPP-32 
phosphorylation in striatonigral MSNs, but promoting decreases in Thr34-DARPP-32 and 
increases in Thr75-DARPP-32 phosphorylation in striatopallidal MSNs. The D2 receptor 
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antagonist haloperidol selectively affects the phosphorylation of Thr34-DARPP-32 in the 
striatopallidal pathway but does not affect Thr75-DARPP-32 phosphorylation in either 
pathway. (Bateup et al., 2008). In a similar study, Bateup and colleagues showed that 
targeted genetic disruption of DARPP-32 in striatonigral MSNs reduced the acute 
locomotor activating effects of cocaine whilst targeted disruption of striatopallidal 
DARPP-32 reduced the cataleptic liability of haloperidol (Bateup et al., 2010). Thus 
striatonigral D1 and striatopallidal D2 receptors differentially modulate DARPP-32 and 
the motor effects of distinct DAergic compounds. 
1.10.1 DARPP-32 and psychomotor sensitisation 
In contrast to acutely administered drugs of abuse, cocaine or methamphetamine, when 
repeatedly administered, stimulate an inverse phosphorylation profile which involves 
reductions in Thr34-DARPP-32 and increases in Thr75-DARPP-32 (Chen & Chen, 2005; 
Scheggi et al., 2007). Repeated drug administration also induces a profound sensitisation 
of locomotor activity and this behaviour is disturbed in DARPP-32 KO mice or in knockin 
mutant mice with a targeted genetic interference of either the Thr34-DARPP-32 or Thr75-
DARPP-32 substrates. For example, DARPP-32 KO mice display increased psychomotor 
sensitisation to repeated cocaine administration (Hiroi et al., 1999) and this effect is 
mirrored in Thr34-DARPP-32 knockin mutants (Zachariou et al., 2006). In contrast to 
Thr34-DARPP-32 knockin mutants, Thr75-DARPP-32 knockin mutants do not acquire 
psychomotor sensitisation to cocaine (Zachariou et al., 2006). Unlike cocaine, however, 
psychomotor sensitisation is undisturbed to repeated morphine administration (Borgkvist 
et al., 2007). The injection protocol recruited in a given study might also be an important 
consideration when examining the acquisition of psychomotor sensitisation in DARPP-
32 mutant mice. When employing the so-called two-injection sensitisation protocol, 
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Valjent and colleagues reported that both cocaine (Valjent et al., 2005) and morphine 
sensitisation (Valjent et al., 2010) are blocked in Thr34-DARPP-32 mutant mice. 
1.10.2 DARPP-32 is a critical mediator of drug-induced gene transcription 
Drugs of abuse such as cocaine and amphetamine, and DA agonists which alter the 
phosphorylation of the aforementioned GluR1 and NR1 glutamate receptor subunits also 
stimulate the expression of genes and IEGs in striatal neurons. For example, the D1 
agonist SKF 82958 increases the expression of the opioid peptides substance P and 
prodynorphin, the IEG zif268 and the neuronal activity marker c-fos. The expression of 
these neuropeptides and IEGs is disturbed in DARPP-32 KO mice (Svenningsson et al., 
2000). Drugs of abuse like amphetamine and cocaine similarly stimulate the expression 
of genes and IEGs such as arc, c-fos and deltaFosB. Psychostimulant induced expression 
of these genes is severely diminished in DARPP-32 KO mice or in mice with a targeted 
interference of the Thr34-DARPP-32 substrate (Fienberg et al., 1998; Hiroi et al., 1999; 
Zachariou et al. 2006). Thus, DARPP-32 is an important effector of striatal gene 
expression, in addition to its role as an effector of striatal electrophysiology. 
1.10.3 DARPP-32 and drug reinforced learning 
The repeated pairing of a drug in a discrete context promotes conditioned contextual 
associations between the drug and its administration environment with subjects preferring 
to reside in a drug-paired context more than a non-drug paired context when tested under 
extinction; this behaviour is known as CPP. Cocaine CPP simultaneously increases 
accumbal Thr34-DARPP-32 and reduces Thr75-DARPP-32 (Tropea, Kosofsky & 
Rajadhyaksha, 2008). In addition to this, cocaine (Zachariou et al., 2002) and ethanol 
(Risinger et al., 2001) CPP are disturbed in DARPP-32 mutant mice. DARPP-32 also 
mediates the reinforcing properties of psychostimulant drugs. Drug self-administration 
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paradigms assess the abuse liability of a given substance by correlating its reinforcing 
properties with the number of drug infusions subjects earn. Mice with targeted 
interference of either the Thr34 or the Ser130 residue recorded significantly more cocaine 
infusions than WT controls (Zhang et al., 2006). In contrast, ethanol self-administration 
is significantly lower in DARPP-32 KO mice (Risinger et al., 2001).  
1.11 DARPP-32 and natural reward 
Although the vast majority of behavioural work relating to DARPP-32 has been 
published in the domain of drug reward, DARPP-32’s behavioural effects are not limited 
to psychoactive substances. In similar fashion to drugs of abuse, novel food reinforcers 
initially promote increases in Thr34-DARPP-32, reductions in Thr75-DARPP-32, and 
increases in GluR1 and NR1 phosphorylation (Rauggi et al., 2005). This effect was 
apparent between 30 & 45 min after receipt of the reinforcer but these values had returned 
to baseline after approximately 60 min. However, reduced Thr34-DARPP-32 and 
increased Thr75-DARPP-32 were observed 2-3 hrs post reinforcer receipt. The D1 receptor 
antagonist SCH 23390 blocked all of these effects whereas the delayed increase in Thr75-
DARPP-32 was prevented by the mGluR5 antagonist MPEP. The phosphorylation profile 
of DARPP-32 in the NAcSh, though not the NAcC, habituates in response to repeated 
palatable food exposure in non-food-deprived but not food-deprived subjects (Danielli et 
al., 2010; Scheggi, Secci, Marchese, De Montis & Gambarana, 2013). Nonnutritive 
sweeteners (e.g. saccharin) promote similar changes in DARPP-32 phosphorylation to 
palatable foods (Scheggi et al., 2013). However, DARPP-32 phosphorylation in the 
NAcSh of food-deprived subjects does habituate to nonnutritive sweetener, suggesting 
that caloric demand prevents the habituation of DARPP-32 phosphorylation in response 
to motivationally relevant goals.  Thus, as with drugs of abuse, food reinforcers promote 
changes in DARPP-32 phosphorylation that involve time-dependent shifts in 
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phosphorylation. However, subtle differences in the ability of food vs drug to modify 
DARPP-32 phosphorylation exist, with motivational state being of particular relevance 
to food reinforcers. 
1.11.1 DARPP-32: instrumental learning and behavioural flexibility 
Accumulating evidence has identified instrumentally induced changes in DARPP-32 
phosphorylation in the nucleus accumbens and CPu during high effort tasks. Thr34-
DARPP-32 phosphorylation in the nucleus accumbens core is associated with the 
magnitude of responding in a concurrent PR free-feeding choice task (Randall et al., 
2012) and the topographical profile of DARPP-32 phosphorylation undergoes the 
classical ventral-dorsal shift as a function of the duration of training in a fixed ratio-5 
(FR-5) schedule of reinforcement procedure (Segovia, Correa, Lennington, Conover & 
Salamone, 2012). DARPP-32’s role in mediating effortful behaviours does not appear to 
be a mere correlational phenomenon. For instance, evidence suggests that mice with a 
Ser97-DARPP-32 alanine knockin mutation are impaired during food reinforced 
progressive ratio schedules of reinforcement, though these results were limited to a single 
session test for PR (Stipanovich et al., 2008). In addition to the role of DARPP-32 in free 
operant responding, mice lacking the DARPP-32 gene display impairments during a 
simple instrumental reversal learning task (Heyser, Fienberg, Greengard & Gold, 2000). 
Finally, DARPP-32 KO mice lack novel object recognition, with KO mice exploring 
novel and familiar objects equally (Heyser, McNaughton, Vishnevetsky & Fienberg, 
2013). The authors of this study suggest that this impairment may reflect disturbances in 
behavioural flexibility such that the DARPP-32 KO mice may either be less responsive 
to environmental changes or have deficient attention. Novel object recognition was 
rescued in DARPP-32 KO mice in this study by administering methylphenidate (MPH) 
which suggests that behavioural disturbances might be rescued in these mice by 
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increasing DA transmission. Thus DARPP-32 has important consequences for 
instrumental learning processes and behavioural flexibility in rodents which require 
subjects to update/modify their behaviour. 
1.12 DARPP-32 and human reinforcement learning 
Perhaps in line with the above findings from preclinical (rodent) models, DARPP-32 
has been studied in a few human reward learning experiments. For example, performance 
during a probabilistic reinforcement learning task was predicted by the presence of a 
single nucleotide polymorphism (SNP) of the DARPP-32 gene with AA homozygote 
carriers of this rs907094 polymorphism faring better at the task (Frank, Moustafa, 
Haughey, Curran & Hutchison, 2007). This task requires subjects to learn about the 
probability that pairs of stimuli have of being correct and to modify their performance as 
they learn the probabilistic relations between the stimuli and their likelihood of being 
correct. It has also been suggested that DARPP-32 is involved in the updating of outcome-
expectancies in humans. In an electroencephalography (EEG) study, AA homozygote 
carriers of the same rs907094 SNP of the DARPP-32 gene displayed greater P200 
amplitudes whilst performing the same probabilistic reinforcement task utilised by Frank 
and co-workers (Hämmerer et al., 2013). The task provides subjects with feedback about 
their performance as they select one of 2 probabilistically constrained stimuli (e.g. 80% 
correct vs 20% correct, 60% correct vs 40% correct etc.), so as subjects progress through 
the task they are required to update outcome expectancies in order to maximise gains. It 
has been suggested that the amplitude of the P200 wave “reflects updating in changing 
environments” (Hämmerer et al., 2013). In addition to this, T carriers of the rs907094 
polymorphism display improved positive reinforcement learning during a task in which 
subjects were more likely to be rewarded with points if they responded quickly (Frank, 
Doll, Oas-Tepstra & Moreno, 2009). DARPP-32 therefore has important behavioural 
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consequences for reinforcement learning and decision-making processes in human 
subjects.  
1.13 The DARPP-32 knockout mouse 
The DARPP-32 knockout (KO) mouse is a fairly well-characterised mouse construct 
which has proved instructive for investigating incentive motivational processes. In these 
mutant mice, the DARPP-32 gene is disrupted by replacing a 400bp fragment of the 
DARPP-32 gene with a neomycin gene (Fienberg & Greengard, 2000). The DARPP-32 
KO mouse does not show any baseline deficits in locomotion or any abnormalities in gait 
(Fienberg & Greengard, 2000). As mentioned above, these mice show selective dose-
dependent behavioural deficits to acute and repeatedly administered drugs of abuse, 
disturbances in ethanol and cocaine self-administration, impairments in novel object 
recognition and in reversal learning. In addition to this, these mice display abnormalities 
in striatal synaptic plasticity, AMPA subunit phosphorylation, AMPA channel currents, 
NMDA subunit phosphorylation and NMDA channel currents, as well as disturbances in 
ion channel properties and also to drug-stimulated gene transcription. There are few, if 
any, published studies in existence which have examined the relationship between 
DARPP-32 and complex conditioned reward behaviours, such as PIT or CRf. There are, 
however, some existing unpublished data (Crombag et al., 2008) which suggest that, 
whilst DARPP-32 KO mice acquire conditioned approach and variable interval schedules 
of reinforcement, they are impaired during the general PIT test. In contrast, DARPP-32 
KO mice display CRf that is indistinguishable to WTs. 
In light of the existing data in animals indicating that DARPP-32 is an important 
component of instrumental processes and conditioned behaviours, and in light of the 
insights from human studies indicating that DARPP-32 contributes to cost-benefits 
computations, it was felt that this mouse represented an important and interesting tool for 
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addressing the role of DARPP-32 in mediating incentive motivational behaviours that 
directly involve reward-value relations.  
1.14 Thesis aims  
Whilst the above evidence exposes DARPP-32 as a major player in the effects of 
drugs, natural rewards and the ability of organisms to behaviourally adapt (i.e. learn) in 
their presence, many question remain as to the precise mechanisms by which DARPP-32 
does so. As noted at the beginning of this introduction, incentive learning involves 
complex mechanisms by which animals learn about the relations between rewards and 
their investments costs. Adaptive reward related behaviours also involve associative and 
instrumental mechanisms by which animals can learn about the relations between rewards 
and reward-predictive stimuli and the interaction such stimuli have with instrumentally 
focussed behaviour. To this end, the following specific aims were explored: 
1) Whilst DARPP-32 localisation in the mouse has been published, a more thorough 
anatomical analysis of DARPP-32 expression patterns was conducted in the 
circuitries involved in incentive learning, focussed on the accumbens and amygdala 
with the aim of more precisely elaborating the pattern of DARPP-32 in the mouse 
forebrain. 
 
2) Although DARPP-32 is expressed in brain regions (e.g. PFC and NAc) known to 
underpin delay-based instrumental cost-benefits computations and, even though such 
computations are sensitive to interference with the DA and glutamate systems, there 
are no existing studies to have directly addressed whether DARPP-32 is a molecular 
component of delay-based instrumental reinforcement. This question was addressed 
by comparing the performance of DARPP-32 knockout mice, DARPP-32 
heterozygous mice and wildtype mice during an intertemporal discounting task. Mice 
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were also exposed to 2 reinforcer devaluation manipulations. Because DARPP-32 is 
also expressed in regions associated with reinforcer devaluation (e.g. OFC & CPu) 
and habit formation (e.g. CeA and CPu) and, because DARPP-32 mutant mice 
exhibited impaired instrumental motivation during a progressive ratio of responding 
(Stipanovich et al., 2008), it was deemed necessary to establish whether differences 
in instrumental motivation might account for any potential between genotype 
differences that might arise during this task. 
 
3) In similar fashion, probabilistically constrained cost-benefits decisions are 
underpinned by brain regions associated with the expression of DARPP-32 (e.g. PFC, 
NAc) and, again, probabilistic reinforcement choices are sensitive to direct 
manipulation of either the DA or glutamate systems. In addition to this, human 
participants with an allelic variant of a DARPP-32 SNP performed more efficiently 
in a probabilistic task than participants who were carriers of a different allele (Frank 
et al., 2007). There are no existing studies to have established whether DARPP-32 is 
an important component of probabilistic cost-benefits decisions in rodents. To 
directly address whether DARPP-32 is an important molecular component of 
probabilistic reinforcement, performance was compared between DARPP-32 KO and 
WT mice during a probability discounting task. Mice were also subjected to 2 
reinforcer devaluation manipulations for the reasons outlined in the previous 
paragraph. 
 
4)  In addition to time and risk, effort costs are also incurred during instrumental 
reward-seeking. Furthermore, because Ser97-DARPP-32 knockin mice were impaired 
on a single session test of progressive ratio testing (Stipanovich et al., 2008), another 
aim was to establish whether DARPP-32 KO mice were similarly less willing than 
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wildtype controls to expend effort to achieve reinforcement. To this end, the 
performance of DARPP-32 KO mice was compared against the performance of WT 
mice during an extended food-reinforced progressive ratio experiment. Mice were 
tested during a variety of progressive ratio schedules, each associated with unique 
effort costs. Mice were also exposed to a number of reinforcer devaluation 
manipulations with the aim of establishing the sensitivity of the procedure to measure 
instrumental motivation and to also identify whether any differential sensitivity to 
shifts in motivational state were evident between genotypes.  
 
5) Prior research has suggested that DARPP-32 KO mice are unable to perform 
general PIT. In addition to this, certain behavioural disturbances in DARPP-32 KO 
mice (e.g. acute cocaine-induced hyperlocomotion) (Fienberg et al., 1998) and novel 
object recognition (Heyser et al., 2013) have been restored by increasing DA 
transmission. One further aim of this thesis was to establish whether the absence of 
general PIT in DARPP-32 KO mice could be rescued by increasing DA transmission 
prior to PIT test. To this end, DARPP-32 KO and WT mice were first provided with 
instrumental and Pavlovian training and then given 3 PIT tests, once with saline 
(SAL) on board, and with methylphenidate (2.5 mg/kg, 5 mg/kg) on board during 2 
further tests. 
 
6)  Whilst previous research has identified an important role for DARPP-32 in the 
locomotor response to acutely administered amphetamine and also the acquisition of 
cocaine psychomotor sensitisation, no data are known to exist which have addressed 
whether DARPP-32 is an important component of amphetamine psychomotor 
sensitisation. The final aim of this thesis was to address this question. DARPP-32 KO 
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and wildtype animals were repeatedly administered saline or amphetamine over 11 
sessions, before undergoing a 7 day washout period, which was followed by an 
escalating dose-response test to identify whether there were any between-genotype 
differences in the expression of amphetamine psychomotor sensitisation. 
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Chapter 2 
Fluorescence immunohistochemistry 
2.1 Introduction  
DARPP-32 has been extensively mapped and quantified in a host of phylogenetically 
related and unrelated species including frog (Hemmings & Greengard, 1986), cow 
(Hemmings & Greengard, 1986), turtle (Smeets, Lopez & Gonzalez, 2003), gecko 
(Smeets, Lopez & Gonzalez, 2001), rabbit (Hemmings & Greengard, 1986), rat 
(Hemmings & Greengard, 1986; Ouimet et al., 1984; Ouimet, Langley-Guillon & 
Greengard, 1998; Walaas & Greengard, 1984), mouse (Perez & Lewis, 1992), human 
(Brene et al., 1994) and non-human primates (Berger, Febvret, Greengard & Goldman-
Rakic, 1990; Ouimet, Lamantia, Goldman-Rakic, Rakic & Greengard, 1992). DARPP-
32 is most abundantly enriched in the mammalian brain in the striatum - in both its ventral 
and dorsal portions - the substantia nigra, the pallidum and the olfactory tubercle 
(Hemmings & Greengard, 1986). Striatal MSNs and their projections are highly enriched 
with DARPP-32, with immunolabelling occurring in approximately 96% of MSNs in the 
rat caudate putamen (Ouimet et al., 1998). DARPP-32 has additionally been observed in 
the frontal cortex, the amygdala, the ventral tegmental area, the cerebellum, the thalamus 
and the hippocampus, as well as the olfactory bulb and the septum of the rat and mouse 
(Ouimet et al., 1984; Perez & Lewis, 1992).  
DARPP-32 is expressed throughout the dendrites, spines, cytoplasm and the nucleus 
of striatal MSNs in the rat brain. (Ouimet et al., 1984; Ouimet & Greengard, 1990; Walaas 
& Greengard, 1984). In layer II of the rat brain, sparse DARPP-32 enrichment has been 
observed throughout the cytoplasm, nucleus and apical dendrites of pyramidal cells 
(Ouimet et al., 1984). Intense – moderate amygdaloid immunolabelling for DARPP-32 
has been observed in both the central and basolateral amygdala nuclei of the rat (Ouimet 
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et al., 1984) whereas DARPP-32 mRNA was highly expressed in the mouse CeA but 
absent in the BLA (Perez & Lewis, 1992). Pallidal labelling has been observed in axons, 
rather than the cell body or dendrites of pallidal neurons, presumably in the terminals of 
striatal MSN projection neurons forming synapses with pallidal cells (Ouimet et al., 
1984). In-situ hybridisation performed in mouse tissue has identified a considerable 
cellular and regional overlap between the expression of DARPP-32 mRNA in the mouse 
and the expression of the DARPP-32 protein in rats (Perez & Lewis, 1992).  
Immunofluorescence was first used to outline the topographical and cellular 
distribution of DARPP-32 in the rat brain approximately 30 years ago (Ouimet et al., 
1984). However, no such data are known to exist for the adult mouse. Therefore, the 
primary objective of this study was to use fluorescence immunohistochemical detection 
(fIHC) to more precisely delineate the topographical distribution of DARPP-32 in the 
mouse brain by focussing on 3 dopaminoceptive areas that are known to play a role in 
incentive motivational behaviours (e.g. PFC, striatum and amygdala). In particular, and 
in light of reported differences in the expression profile of DARPP-32 protein in the rat 
amygdala, and the DARPP-32 mRNA profile in the mouse amygdala (Ouimet et al., 1984; 
Perez & Lewis, 1992), a second specific aim was to delineate the precise anatomical 
distribution of DARPP-32 expression within the amygdala compartments (central versus 
basolateral compartments). To this end, slices were double labelled for DARPP-32 and 
the calcium binding protein calbindin D-28k which is expressed preferentially in the 
basolateral, but not the central nucleus of the rodent amygdala (McDonald, 1997). In light 
of previous anatomical evidence, as well as evidence from behavioural tasks (e.g. general 
PIT and CRf) recruiting distinct amygdala sub-divisions (Crombag et al., 2008), it was 
predicted that fIHC detection of DARPP-32 would be high in the central, but not in the 
basolateral compartment of the amygdala. Finally, other anatomical regions implicated in 
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incentive motivational tasks were also explored, including the NAc, CPu, ACC, mPFC 
and CPu.  
2.2 Methods 
2.2.1. Genotyping 
DARPP-32 status was identified by polymerase chain reaction (PCR) gel 
electrophoresis. Tissue was first collected from individual mouse ears and then immersed 
in a 20µl solution containing 1 mg/ml proteinase K (Roche Products LTD, UK) in lysis 
buffer solution consisting of 10mM EDTA (Sigma-Aldrich, Dorset, UK) and 20 mM Tris 
HCl (Sigma-Aldrich, Dorset, UK). Each sample was then overlaid with 2 drops of PCR 
grade mineral oil (Sigma-Aldrich, Dorset, UK) before being placed into a PCR machine 
to undergo tissue digestion.  
Once digested, each sample was diluted in 80µl of PCR grade water. The primers 
identifying the DARPP-32 gene were a forward (AGAGAACTGAATCTTCTTGCG) 
and a reverse primer (GCGGGATTTTCCTGG). A forward 
(GCAAGGTGAGATGACAGGAGATC) and a reverse primer 
(CGCTTGGGTGGAGAGGCTATTC) were used to identify the neomycin replacement 
gene which was substituted for DARPP-32 in KO mice. Two samples per mouse were 
analysed, 1 sample to identify the presence or absence of the DARPP-32 gene and 1 
sample to identify the presence or absence of the neomycin replacement gene. To do this, 
0.5 µl of each primer was placed into 23 µl of Mega Mix Blue (Microzone LTD, 
Haywards Heath, UK), along with 1µl of DNA. This mixture was then overlaid with 2 
drops of PCR grade mineral oil before being subjected to PCR.  
After completion of the PCR cycles, samples were subjected to gel electrophoresis. In 
preparation for this process, a 1.5% agarose gel consisting of 300ml 1 x TAE buffer and 
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4.5g agarose and containing 10 µl of ethidium bromide was made. The completed gel was 
then placed into an electrophoresis tank containing 1 X TAE running buffer, each sample 
was added to the gel and 120v was then applied to the gel for 30 min. DARPP-32 status 
was then identified by photographing the gel whilst it was exposed to ultraviolet light. 
2.2.2 Subjects 
 Six DARPP-32 KO mice and 6 WT littermates, aged 8-16 weeks old were used for 
this study. Mice were at least the 8th generation, backcrossed on a C57BL/6J strain and 
were bred at the University of Sussex through heterozygote parent mating to yield WT 
and KO offspring. Mice were sacrificed with a terminal dose (200 mg/kg) of sodium 
pentobarbital (Euthatal, Merial Animal Health LTD, Harlow, UK) delivered 
intraperitoneally (IP). Brains were fixed via transcardial perfusion performed with 4% 
paraformaldehyde (PFA). Following dissection, brains were post-fixed for between 2 to 
4 hr in 4% PFA and then suspended in a 30% sucrose in 0.1M PBS solution for up to 3 
days at 4°c before being stored at -80°c.  
2.2.3 Fluorescent immunohistochemical (fIHC) detection of DARPP-32 
Free-floating brain sections containing the PFC (containing ACC, OFC and mPFC), 
striatum (containing the dorsal and ventral striatum, including both the NAcC and NAcSh 
sub-divisions, and the OT), the ventral pallidum  and the amygdaloid complex (containing 
both CeA and BLA divisions) were identified with guidance from Paxinos and Franklin’s 
Brain Atlas (Academic Press, San Diego, CA, USA). Brain sections 30 microns in 
thickness were collected from these regions and stored in PBS (0.1M) containing 0.02% 
sodium Azide at 4°c. 
Briefly, the fIHC procedure was as follows: sections from regions of the prefrontal 
cortex, striatum and amygdala were exposed to 3 x 10 min washes in 1 x Tris-buffered 
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saline (TBS), followed by a 30 min dual incubation/blocking procedure consisting of 
bathing the sections in a 10% normal goat serum (NGS) solution in 0.2% TBS-TX to 
permeabilise the tissue. Sections were then incubated overnight for between 14-16 hrs in 
DARPP-32 anti-rabbit (1/10000, Cell Signalling Technologies) and Calbindin-D28k anti-
mouse (1/8000, Sigma-Aldrich, Dorset, UK) antibodies in a 3% NGS solution in 0.2% 
TBS-TX at 4°c. After incubation with the primary Ab, the sections were given 3 
additional 10 min washes in TBS followed by incubation with Alexa Fluor 488 anti-rabbit 
and 568 anti-mouse (1/200, Life Technologies, Paisley, UK) secondary Ab for 1 hr in 3% 
NGS in 0.2 TBS-TX. Slices were given 3 final 10 min washes and were then mounted 
onto either gelatin coated or Super Frost Plus (Fisher Scientific, Loughborough, UK) 
histology slides and air-dried prior to coverslipping. Coverslips were mounted to 
histology slides with PermaFluor mounting medium (Thermo Fisher Scientific, 
Loughborough, UK). 
2.2.4 Imaging 
All microscopy was performed using a BX53 Epifluorescent microscope (Olympus, 
Southend, UK) and all images were captured with a QI Click (Q Imaging, Surrey, BC, 
Canada) 12-bit fluorescent imaging camera controlled by iVision (Biovision 
Technologies, Exton, PA, USA) for Mac software. Multiple images taken at 4x 
magnification (mag) were captured to map an entire hemisphere of each target area for 
DARPP-32 expression patterns and joined using iVision to create a single composite 
image of the entire hemisphere. These composite images depicting DARPP-32 expression 
in an entire hemisphere are compared between WT and KO subjects in target regions in 
order to provide the reader with evidence of antibody specificity. For finer, within-region 
and cellular level qualitative analysis of DARPP-32 distribution, additional images were 
taken at 4x, 10x and 20x magnifications of brain slices from WT mice.  
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2.3 Results 
Table 2.1 Summary of DARPP-32 expression in the mouse forebrain 
Region DARPP-32 expression 
Anterior olfactory nucleus Weak-to-moderate-to-intense 
Basolateral nucleus of the amygdala Null 
Caudate-putamen Intense 
Central nucleus of the amygdala Moderate-to-intense 
Layers  II/III Weak 
Layer VI Weak 
Medial prefrontal cortex Null 
Nucleus accumbens core Intense 
Nucleus accumbens shell Intense 
Olfactory tubercle Intense 
Orbitofrontal cortex Weak 
Primary motor cortex Moderate 
Primary somatosensory cortex Moderate 
Ventral pallidum Intense 
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2.3.1 Telencephalon 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figs. 2.1A & 2.1B. Composite images representing rostral forebrain areas in a WT mouse (Fig. 2.1A) 
(approx. bregma 2.22mm – 2.34 mm) and a comparable section from a DARPP-32 KO mouse (Fig 2.1B) 
(approx. bregma 2.22mm – 2.34mm). Figs. 2.1C & 2.1D Comparatively caudal forebrain sections taken 
from a WT mouse (Fig. 2.1C) (approx. bregma 1.98mm - 2.10mm) and a DARPP-32 KO mouse (Fig. 
2.1D) (approx. bregma 1.98 – 2.10mm). 
 
 
 
KO WT 
2.1A 2.1B 
WT 
2.1D 2.1C 
KO 
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2.3.2 Prefrontal, motor and somatosensory cortices 
 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Immunoreactivity for DARPP-32 was mostly weak and only present in sparse 
populations of pyramidal neurons in layers II-III and VI of the cerebral cortex (Figs. 2.2A, 
2.2B, 2.2C, 2.2D & 2.2E). Weak pyramidal labelling was seen throughout the cell bodies 
and apical dendrites of a narrow band of neurons in layers II/III throughout most of these 
cortical layers (Figs. 2.2A & 2.2B). Layer VI pyramidal labelling was similarly seen in 
cell bodies and apical dendrites and although this expression was more intense than in 
2.2A 2.2B 
2.2C 2.2D 
2.2E 
SSp 
MOp 
ACC 
CPu 
Layer II/III 
Layer VI 
Fig. 2.2A 20x mag image of layer II/III 
pyramidal cells. Fig. 2.2B 4x mag image of 
layer VI ACC cells. Fig. 2.2C 4x mag image of 
primary somatosensory (SSp), primary motor 
(MOp) and anterior cingulate cortices. Fig. 
2.2D 10x mag image of pyramidal motor cortex 
cell bodies and apical dendrites. Fig. 2.2E 2 
joined 4x mag images of orbitofrontal cortex 
neurons. 
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layers II-III, it was restricted to sparse clusters of neurons in the forebrain resembling the 
profile seen in Fig. 2.2B. In layer VI, DARPP-32 expression was seen with greater 
intensity in comparatively caudal forebrain slices in the somatosensory, cingulate and 
motor cortices (Figs. 2.2C & 2.2D). However, this caudal labelling was still restricted to 
sparse networks of pyramidal cells. Sparse pyramidal labelling was also evident in the 
orbitofrontal cortex (Fig. 2.2E). The medial PFC (prelimbic and infralimbic cortices) 
appeared to be almost entirely devoid of DARPP-32 labelling (images not shown).  
2.3.3 Anterior olfactory nucleus (AON) 
 
 
 
 
 
 
 
 
 
 
 
 
Weak-to-moderate-to-intense labelling was present in AON cells. Visual comparison 
of immunoreactivity between rostral and caudal forebrain regions indicated a general 
rostral-caudal gradient in the intensity of DARPP-32 expression in these regions, with 
caudal forebrain sections fluorescing more intensely. For example, relatively sparse 
Figs. 2.3A (10x mag) & 2.3B (20x mag) 
DARPP-32 positive anterior olfactory nucleus 
neurons. Figs. 2.3C 20x mag image of 
comparatively caudal anterior olfactory 
nucleus neurons. 
2.3A 2.3B 
2.3C 
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populations of moderate labelling were seen in the nuclei, cytoplasm and dendrites of 
cells of rostral forebrain sections (Figs. 2.3A & 2.3B). In comparison, a comparatively 
dense network of intense DARPP-32 immunolabelling was evident in the nuclei, 
cytoplasm and dendrites of caudal AON neurons (Fig. 2.3C).  
2.3.4 Amygdala 
 
 
 
 
 
 
 
 
 
Fig. 2.4 Composite images of a full brain hemisphere taken from a WT mouse (Fig. 2.4A) (approx. bregma 
-1.46mm - -1.58mm) and a DARPP-32 KO mouse (Fig. 2.4B) (approx. bregma -1.22mm - -1.34mm) mice 
determined to contain the CeA and BLA. 
 
 
 
 
 
 
 
 
 
2.4A 2.4B 
2.4A 2.4B 
WT KO 
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Fig. 2.5 DARPP-32 positive CeA and DARPP-32 negative BLA (Fig. 2.5A), calbindin positive BLA and 
calbindin negative CeA (Fig. 2.5B), and Figs. 2.5A & 2.5B merged (Fig. 2.5C).  
 
CeA neurons were moderately-to-intensely immunoreactive for DARPP-32 (Fig. 
2.5A). In contrast, the basolateral portion of the amygdala was entirely devoid of DARPP-
32 labelling (Fig. 2.5A). This anatomical dissociation in the expression of DARPP-32 
between amygdala CeA and BLA sub-compartments was complemented by images of 
tissue double-labelled for DARPP-32 and calbindin-D28k taken at 10x magnification. 
Calbindin expression was seen only in the BLA (Fig. 2.5B) and no overlap in expression 
of DARPP-32 and calbindin-D28k is seen in Fig. 2.5C. Thus, DARPP-32 expression was 
restricted to the CeA and calbindin-D28K immunoreactivity was isolated to the BLA.  
 
BLA 
CeA 
DARPP-32 
100m 
BLA 
CeA 
Calbindin 
100m 
BLA 
CeA 
Merged 
100m 
2.5A 
2.5B 
2.5C 
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2.3.5 Basal ganglia 
 
 
 
 
  
 
 
 
 
Fig. 2.6 Images representing a full hemisphere of comparable striatal sections taken from DARPP-32 WT 
(Fig. 2.6A) (approx. bregma 1.44mm - 1.54 mm) and DARPP-32 KO (Fig. 2.6B) (approx. bregma 1.34mm 
- 1.42mm) mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
2.6A 2.6B 
WT KO 
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Fig. 2.7A 4x mag image of the dorsal and ventral striatum. Fig. 2.7B 10x mag image of the CPu. Fig. 2.7C 
20x mag image of the NAcC. Fig. 2.7D 20x mag image of the NAcSh. Fig. 2.7E 20x image of the VP and 
the islands of calleja (ICj). Fig. 2.7F 20x mag image of the olfactory tubercle. 
 
Consistent with earlier reports, intense DARPP-32 enrichment was observed in the 
CPu (Figs. 2.7A & 2.7B), the NAcC (Figs. 2.7A & 2.7C), the NacSh (Figs. 2.7A & 2.7D), 
the VP (Fig. 2.7E) and the olfactory tubercle (Fig 2.7F). Although intense patches of 
NAcSh 
NAcC 
CPu 
CPu 
NAcC NAcSh 
ICj 
VP 
VP 
2.7A 2.7B 
2.7C 2.7D 
2.7E 2.7F 
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immunolabelling were evident in the striatum - as shown in Fig. 2.6A - there was no (‘to-
the-eye’) obvious distinction in the levels of immunoreactivity seen between striatal 
regions. DARPP-32 enrichment was evident in CPu and NAcC and NAcSh MSN nuclei 
but its label was most intense in the cytosol and dendrites in these areas.  
Unlike the pattern of immunolabelling seen in the CPu and the NAc, DARPP-32 
expression in the VP was observed predominantly in areas outside of the cell body in a 
profile resembling the VP expression in the rat and monkey brain (Ouimet et al., 1984; 
Ouimet et al. 1994). For example, VP expression was observed in patches of unlabelled 
cells encircled by bundles of immunolabelled fibres, presumed to be the axons of striatal 
MSNs rather than the cell bodies of VP neurons (Ouimet et al., 1984) (Fig. 2.7E).  
DARPP-32 was highly enriched throughout the nucleus, cytosol and dendrites of 
olfactory tubercle neurons. Such was the extent of DARPP-32 labelling, DARPP-32 
positive OT cells appeared to be embedded in a fabric-like matrix of fluorescent dendritic 
fibres (Fig. 2.7F). Whilst there were examples of unlabelled nuclei in these neurons, 
DARPP-32 immunoreactivity was present in almost (to-the-eye) equal intensities in the 
cytosol and nucleus in the majority of these neurons.  
2.4 Discussion  
Unlike slices extracted from KO mice, which were entirely devoid of DARPP-32 
immunolabelling (Figs. 2.1B, 2.1D, 2.4B & 2.6B), slices extracted from WT mice 
displayed DARPP-32 immunolabelling in varying intensities in discrete regions of the 
forebrain. This absence of DARPP-32 immunoreactivity in KO mice and the regionally 
specific expression of DARPP-32 in WT mice establishes the specificity of the antibodies 
used in this experiment. Moreover, the findings presented in this chapter gathered using 
fIHC detection of DARPP-32 in the mouse closely, but not completely, resemble those 
of the rat (Ouimet et al., 1984) and demonstrate intense DARPP-32 labelling throughout 
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DA innervated brain regions that make up the basal forebrain and associated regions. 
Thus, in MSNs neurons of the striatum, immunoreactivity levels in the dorsal and ventral 
portions were largely indistinguishable and immunolabelling intensity was also 
indistinguishable within the ventral striatum between the shell and core subdivisions of 
the nucleus accumbens. Additional consilience between mice and other species (including 
rat) was evident elsewhere. For example, sparse populations of pyramidal cortical 
neurons were reportedly immunoreactive for DARPP-32 in layer III in the rat (Ouimet et 
al., 1984) and layer II-III in the rhesus monkey (Berger et al., 1990). A similar pattern of 
expression was seen in the mouse, with layers II-III exhibiting weak-moderate levels of 
fluorescence. Cortical layer II-III DARPP-32 mRNA has previously been identified in 
the mouse (Perez and Lewis, 1992). In addition, the observation that layer VI was 
moderately fluorescent in pyramidal cells and apical dendrites throughout the motor and 
somatosensory cortex resembled the fluorescence profile described in the rat (Ouimet et 
al., 1984), the mRNA distribution characterised in the mouse (Perez and Lewis, 1992) 
and immunohistochemistry findings captured from rhesus monkey tissue (Berger et al., 
1990). Layer VI immunoreactivity was evident in the ventral portion of the anterior 
cingulate cortex and in the caudal portion of the orbitofrontal cortex. DARPP-32 
expression was moderately expressed in sparse networks of pyramidal neurons in layer 
VI of the cingulate cortex. Intense DARPP-32 immunoreactivity was present in the 
ventral pallidum. Although this expression was seen predominantly outside of the cell 
body, it resembled the regional profile described in the rat and rhesus monkey VP 
(Ouimet et al., 1984; Ouimet et al., 1992). In addition, accumbal MSNs project to the 
ventral pallidum and it has previously been suggested that the pronounced level of 
DARPP-32 expression in the VP resides in the axons arriving from MSN projections, 
giving rise to the dark, unlabelled clusters of pallidal neurons seen in Fig. 2.7E (Ouimet 
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et al., 1984). As also shown in Fig. 2.7E, DARPP-32 immunoreactivity was absent in the 
islands of calleja. This observation is also consistent with earlier findings described in the 
rodent and non-human primate literature which have also noted the absence of DARPP-
32 immunolabelling and mRNA in the islands of calleja in the rat (Ouimet et al., 1984), 
mouse (Perez & Lewis, 1992) and rhesus monkey (Ouimet et al., 1992) respectively.  
Although pockets of DARPP-32 negative cells were observed in the CeA, the majority 
of CeA neurons displayed moderate to vivid fluorescence whereas BLA neurons appeared 
devoid of DARPP-32 labelling. These findings extend those reported by Perez and Lewis 
(1992) who identified pronounced DARPP-32 mRNA in the CeA but little to no DARPP-
32 mRNA in the BLA. DARPP-32 has been reported in other amygdala nuclei in the 
mouse; however, the analysis in this chapter did not extend to the caudal amygdala 
regions where this mRNA expression reportedly occurs. Taken together, the report in this 
chapter of the topographical profile of DARPP-32 protein expression in the mouse 
amygdala, and the DARPP-32 mRNA expression reported in the mouse amygdala (Perez 
& Lewis, 1992), provides substantive evidence of a subtle species difference in the 
regional expression of DARPP-32 in the subdivisions of the amygdala. Fluorescent 
labelling was evident in both the rat CeA and BLA (Ouimet et al. 1984). Despite earlier 
observations that DARPP-32 mRNA was devoid in the mouse BLA, fluorescence in-situ 
hybridisation solely detects nucleic messenger RNA. Perez & Lewis (1992) noted that 
DARPP-32 mRNA cannot be detected in areas such as the globus pallidus where DARPP-
32 expression has been identified solely in cellular compartments distal to the cell body 
such as axons. However, DARPP-32 was reportedly present in the cell bodies of BLA 
neurons in the rat, rather than axon terminals synapsing onto these neurons and, as such, 
it is unlikely that the different methods employed in these studies is a plausible 
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explanation for the observed differences in amygdaloid DARPP-32 expression between 
these sub-species of rodent (Ouimet et al., 1984).  
In addition to the regions that were inspected in the current study, DARPP-32 
immunolabelling or mRNA has been reported in the globus pallidus (Ouimet et al., 1984), 
hippocampus (Ouimet et al., 1984; Perez & Lewis, 1992), cerebellum (Ouimet et al., 
1984; Perez & Lewis, 1992), hypothalamus (Liedtke et al., 2011; Meister et al., 1988; 
Ouimet et al., 1984), the bed nucleus of the stria terminalis, and the piriform and 
entorhinal cortices (Ouimet et al., 1984 Perez & Lewis, 1992) in rodents. Furthermore, 
little, if any, DARPP-32 was observed in the prelimbic and infralimbic cortices in this 
study whereas others have identified sparse labelling in these regions (Trantham-
Davidson, Kroner & Seamans, 2008). Because the analysis in this chapter was cross-
sectional, it could be that DARPP-32 positive mPFC cells are present in different sections 
along the rostral-caudal plane to those examined in this study. For a fuller account of the 
rodent expression profile of DARPP-32, see Ouimet et al (1984) and Perez & Lewis 
(1992). In general, the expression profile of DARPP-32 in the mouse brain also resembles 
the profile reported in humans, where low-moderate labelling was reported in the cortex 
and intense labelling was reported throughout the divisions of the striatum (Brene et al., 
1994). Furthermore, DARPP-32 expression is also seen in the amygdala and the 
hippocampus in both humans (Brene et al., 1994), rats (Ouimet et al., 1984) and mice 
(Perez & Lewis, 1992) suggesting that there is a significant degree of translational 
relevance to studying DARPP-32 in rodents. Although we have briefly discussed some 
potential cross-species differences and their implications, for the most part, there is a 
considerable degree of cross-species consilience in the topographical, morphological and 
cellular expression of DARPP-32, highlighting the potential translation relevance of this 
complicated phosphoprotein.  
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DARPP-32 is expressed in regions associated with instrumental learning, instrumental 
cost-benefits computations, Pavlovian learning and incentive motivation. In light of this 
expression profile and the well-defined role this molecule has in mediating experience-
dependent changes (e.g. LTP and LTD), DARPP-32 might have important functional 
(behavioural) consequences for reward-related Pavlovian and instrumental processes. In 
considering this and the existing behavioural data, it was predicted that DARPP-32 KO 
mice would display impairments in complex reward-based decision-making tasks (e.g. 
intertemporal and probability discounting), as well as impairments in food-reinforced 
progressive ratio of reinforcement testing and incentive salience (e.g. general PIT).  
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Chapter 3 
Intertemporal discounting 
3.1 Introduction  
Time is a finite resource which must be flexibly and efficiently invested to promote 
survival and achieve effective social integration. Accordingly, choices concerning the 
temporal costs of positive and negative reinforcement are important investment decisions. 
Choosing to wait for an extended period could, in some instances, reduce the likelihood 
of reinforcement and of receiving alternative rewards. Conversely, electing for instant 
gratification could conceivably reduce one’s profitability by biasing one towards less 
profitable but immediately available rewards and to discounting propitious but delayed 
alternatives. Such decisions can have important consequences. For example, an enduring 
and impulsive preference for instant gratification is a neuropsychological hallmark of 
many psychiatric disorders, including addiction (Petry, 2001), pathological gambling 
(Alessi and Petry, 2003), attention deficit hyperactivity disorder (ADHD) (Scheres, Lee 
& Sumiya, 2008), bipolar disorder and schizophrenia (Ahn et al., 2011).  
The intertemporal/delay discounting task is routinely used in laboratory settings as a 
measure of choice impulsivity. During this task, subjects can choose between a small, 
immediately available reward and a large but delayed reward. When the delay associated 
with the large reward is brief, subjects will typically prefer to choose that reward. 
However, as the delay associated with the large reward is increased across blocks of trials, 
subjects come to choose the large reward less and less, instead opting for the small but 
immediately available alternative. Extending the delay to reinforcement, therefore, 
devalues the incentive value of the large reward.  
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Neurobiological investigations have established a necessary role for DA and glutamate 
innervated fronto-striatal-amygdala regions in the provision of intertemporal choices, 
many of which are associated with DARPP-32 expression. These intertemporal choice 
facilitating regions include the OFC (Mar, Walker, Theobald, Eagle & Robbins, 2011; 
Winstanley et al., 2004), mPFC (Churchwell, Morris, Heurtelou & Kesner, 2009) BLA 
(Winstanley et al., 2004), ventral hippocampus (Abela & Chudasama, 2013) and NAc 
(Acheson et al., 2006; Cardinal et al., 2001). 
Findings from pharmacological studies have been mixed but broadly support a 
DAergic, glutamatergic and serotonergic influence in the facilitation of delayed 
reinforcement choices. For example, in some studies, amphetamine reduced impulsive 
choices (Cardinal et al., 2000; Floresco et al., 2008; Winstanley, 2003) but enhanced them 
in others (Cardinal et al., 2000; Helms, Reeves & Mitchell, 2006). Amphetamine has also 
been shown to bi-directionally modify intertemporal choices, enhancing the preference 
for delayed gratification in a group of subjects where a cue bridged the delay to 
reinforcement but conversely increasing instant gratification in a group trained without a 
cue (Cardinal et al., 2000).  
Despite these DAergic effects, reducing NAc DA levels by 70%-75%, by performing 
NAc 6-hydroxydopamine (6-OHDA) lesions, does not impair amphetamine’s ability to 
alter discounting. For example, when amphetamine was administered to 6-OHDA 
lesioned rats, it modestly but temporarily enhanced the delay tolerating effects of 
amphetamine. Yet when amphetamine was co-administered with the 5-HT1A agonist 8-
OH-DPAT, its capacity to affect intertemporal choices was blocked in sham-lesioned but 
only attenuated in 6-OHDA lesioned animals, indicating that the DA and 5-HT systems 
interact in the nucleus accumbens to mediate intertemporal choices (Winstanley, 
Theobald, Dalley & Robbins, 2005).  
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A variety of other compounds with an affinity for the DA and 5-HT systems have been 
shown to affect intertemporal choices: these include the D2 receptor antagonist 
haloperidol (Denk et al., 2005), the D1 receptor antagonist SCH 23390 (Koffarnus et al., 
2011), the mixed D1-D2 antagonist alpha-flupenthixol (Cardinal et al., 2000), the selective 
DA reuptake inhibitor GBR 12909 (Baarendse & Vanderschuren, 2012), and the mixed 
5-HT2A/C agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) (Wischhof, Hollensteiner, & 
Koch, 2011). 
In addition to DA and 5-HT, glutamate transmission has also been identified as a 
significant effector of intertemporal choices. For example, the NMDA receptor antagonist 
ketamine was shown to increase delay discounting (Floresco et al., 2008). In contrast to 
this report, Yates et al (2014) reported that ketamine altered baseline preference for the 
large but delayed reward (i.e. when there was no delay associated with the large reward) 
but had no effect on choices during blocks where a delay to reinforcement was associated 
with the delayed reward lever. This group did, however, report that the NMDA receptor 
antagonist MK 801 significantly reduced impulsive choices.  
Despite the pharmacological basis of impulsive choice being fairly well elaborated, 
little is known about the molecular mechanisms residing downstream from receptors in 
brain regions implicated in the provision of such choices. Therefore, the purpose of the 
current experiment was to investigate whether DARPP-32, a target of DA, 5-HT and 
glutamate signal transduction in mPFC, OFC & NAc makes a significant contribution to 
the facilitation of intertemporal choices.  
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3.2 Methods 
3.2.1 Subjects 
Eight DARPP-32 knockout mice (mean weight = 22.14 g), 8 heterozygous (HET) 
DARPP-32 mice (mean weight = 21.68 g) and 8 wildtype littermates (mean weight = 
23.40 g) aged 7-8 to 14 weeks old were used for this study. DARPP-32 status was 
identified prior to study commencement using the genotyping protocol described in 
chapter 2. Each group consisted of 5 male and 3 female mice. Subjects were at least the 
5th generation of backcrossed mice bred from heterozygous mating pairs to yield WT, 
HET & KO pups at the University of Sussex from a C57BL/6J background. Mice were 
housed in the conditions listed previously. Mice were food restricted to approximately 
85% of their free-feeding weight and provided with ad libitum access to tap water in their 
home cages. Mice were handled for 5 min per day for 3 consecutive days prior to study 
commencement to limit handling stress.  
3.2.2 Apparatus 
All testing was conducted in 8 identical conditioning chambers (22.5 x 18 x 13 cm) 
(Med Associates, Georgia, VT, USA), each housed in a sound-attenuating cabinet. The 
front and rear walls of the chambers were constructed from removable steel plates and 
the lateral walls consisted of transparent acrylic panels. Each cabinet was fitted with an 
extractor fan to conceal extraneous environmental noise and provide continuous 
ventilation. Each conditioning chamber contained 2 highly sensitive operant levers, 
positioned equidistant from a centrally located reward delivery magazine. Reward 
magazines were fitted with an infrared head entry detector configured to detect the 
number of beam breaks. The operant chambers were also fitted with a houselight. A 10% 
liquid sucrose solution, contained in a 20ml Plastipak syringe and delivered by a single 
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speed syringe pump (Med Associates, Georgia, VT, USA), served as the reinforcer in all 
operant chamber components of the experiment. 
3.2.3 Procedure 
3.2.3.1 Magazine training 
 Mice were first provided with 3 sessions, 1 per day, of magazine training during which 
sucrose reward was delivered on average of 60 s (range 30 s - 90 s) using a random 
interval schedule (RI-60) to familiarise them with the location of reward receipt. A 
session commenced when the mouse made its first magazine head entry and continued 
until it had received 20 reinforcements; each reinforcement consisted of a 1.5 s pump 
activation, calculated to deliver 46.4 µl of sucrose.  
3.2.3.2 Lever training 
Mice were next given daily sessions, 1 lever per day for 6 days in total, of fixed ratio-
1 (FR-1) lever training to encourage reliable and comparable responding on both 
operanda. Thus each lever response was reinforced on an FR-1 schedule with 46.4 µl of 
sucrose. 
3.2.3.3 Trial initiation training 
Subjects were then given 8 sessions of trial initiation training. These sessions consisted 
of 5 blocks of 12 trials with each trial lasting 80 s. All trials were forced choice trials, 
thus only 1 lever was present per trial and each lever was presented 6 times per block (i.e. 
a total of 12 trials per block). Trials began in darkness and their start was indicated by the 
illumination of the houselight. Mice were given 20 s to make a head entry into the reward 
delivery receptacle following the illumination of the houselight. Failure to respond within 
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this period resulted in the houselight being extinguished, the trial being recorded as an 
omission and the subject being forced into a timeout period for the remaining duration of 
the trial. If mice made a magazine response within 20 s from the start of the trial, 1 lever, 
selected pseudorandomly with respect to position, was extended into the chamber. Failure 
to respond on the lever within 20 s of its introduction resulted in the lever being retracted, 
the houselight extinguishing, the trial being recorded as an omission, and the subject 
being forced into a timeout period for the remainder of the trial. Lever responses during 
the 20 s period resulted in the immediate delivery of 46.4 µl of sucrose and the 
simultaneous extinguishing of the light and the lever being retracted into the chamber 
wall. Trial length was held constant regardless of whether the animal achieved 
reinforcement or recorded a lever or magazine omission.  
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3.2.3.4 Delay discounting 
 
Fig. 3.1 Simplified schematic diagram of the delay discounting procedure 
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Table 3.1 Delay discounting session parameters 
 
Sessions 
 
Delays (s) 
 
Trial length (s) 
 
Delay pattern 
 
1-7 0, 4, 8, 16, 32 
 
90 Ascending 
8-12 0, 8, 16, 32 90 Ascending 
13-37 0, 8, 16, 32 90 Descending 
38-51 0, 16, 32, 48 
105 
Descending 
52-68 0, 16, 32, 48 105 Ascending 
69-70 0, 16, 32, 64 125 Ascending 
71-94 0, 25, 50, 75 135 Ascending 
 
Discounting sessions consisted of either 5 blocks of 12 trials or 4 blocks of 12 trials 
(see Table 3.1). The first 4 trials of each block were always forced choice trials to ensure 
that subjects experienced the programmed consequences of each lever at the start of each 
‘delay block’. The remaining 8 trials were choice trials during which mice were freely 
able to select which of the 2 levers to press. As before, discounting sessions began with 
the illumination of the houselight. If mice made an entry into the reward magazine within 
20 s of the trial start, either 1 lever during forced choice trials, selected pseudorandomly 
with regards to lever position, was inserted into the chamber, or both levers were inserted 
during choice trials. As before, failure to make a head entry into the reward delivery 
magazine or to respond on the lever within 20 s of the trial start or lever insertion, 
respectively, resulted in the houselight being extinguished and mice entering a timeout 
period for the remainder of the trial. The 2 levers were designated as either the delayed-
large/larger later (LLR) or immediate-small/smaller sooner (SSR): counterbalanced 
across genotypes with respect to the physical position of the lever. LLR responses resulted 
in the delivery of 69.6 µl of sucrose solution delivered in 3 consecutive 0.75 s activations 
of the syringe pump (23.2 µl per activation) after a progressively increasing (by block) 
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delay (See Table 3.1 for delays associated with the LLR lever at each block). SSR 
responses always immediately delivered 23.2 µl of sucrose in a single 0.75 s activation 
of the syringe pump. Responses on either lever resulted in the immediate retraction of 
both levers and the houselight being extinguished. Trial length was held constant 
irrespective of whether subjects completed the trial successfully or entered an omission 
period (see Table 3.1). Mice were exposed to a variety of delays presented in an ascending 
and/or descending pattern (see Table 3.1). 
3.2.3.5 Reinforcer devaluation  
To assess the potential relationship between motivational state and DARPP-32 in the 
attribution of intertemporal choices, subjects undertook the following 2 types of 
reinforcer devaluation manipulations: a sensory-specific and a general satiety (pre-
feeding) manipulation were conducted to validate whether within-session shifts in LLR 
choices could alternatively be explained by a) either satiation of a sucrose appetite or b) 
a significant shift in the general motivational state of the mice.  
The first reinforcer devaluation manipulation, a sensory-specific intervention, 
involved pre-feeding half of all animals with 10% sucrose for 2 hrs on day 1. During these 
pre-feeding sessions, home cage water bottles were replaced with bottles containing 10% 
sucrose. Pre-feeding was counterbalanced with respect to genotype and lever position. 
All animals, including those that were not sucrose pre-fed, were then immediately 
subjected to a temporal discounting test session. On day 2, the remaining half of animals 
that had not undergone sucrose pre-feeding were given a 2 hr sucrose pre-feeding session 
which was followed with all animals conducting a temporal discounting session.  
The second reinforcer devaluation procedure was a general motivation intervention. 
These sessions, conducted over 2 days, were procedurally similar to the sucrose pre-
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feeding sessions, except animals were pre-fed with their dietary maintenance chow for 2 
hrs prior to the discounting sessions. 
3.2.4 Data analysis  
Lever response rates for WT, HET & KO mice during the final session of lever training 
were compared by conducting a genotype (WT vs HET vs KO) by lever (l vs 2) repeated 
measures analysis of variance (ANOVA) to ensure that performance was equal on both 
levers within- and between genotypes. 
A mixed genotype (WT vs HET vs KO) by lever (1 vs 2) by block (1 vs 2 vs 3 vs 4 vs 
5) ANOVA of the final trial initiation training session was conducted to ensure that 
performance was not biased between genotypes, levers or blocks. 
Magazine and lever omissions recorded during the final trial initiation training session 
were each analysed separately and compared between genotypes by conducting one-way 
ANOVAs.  
The percentage of total choices in each block that were LLR choices was the dependent 
variable. This was calculated by dividing total LLR responses by the total number of lever 
responses for each block and multiplying by 100 (i.e., (LLR choices/(SSR choices + LLR 
choices)*100). Responses from each delay block were averaged over 5 sessions and these 
values were used to calculate the rate of discounting as a function of delay, except during 
the devaluation sessions (79-80 & 93-94), which were analysed separately, and those 
sessions containing a maximum delay of 75 s which were averaged over 20 sessions. The 
values were compared between genotypes at each stage of the experiment by subjecting 
% LLR choices to a genotype (WT vs HET vs KO) by delay (4 levels) repeated measures 
ANOVA. The area under the discounting curve (AUC) was also calculated for each 
subject using the method reported by Myerson and colleagues (Myerson, Green & 
Warusawitharana, 2001). AUC provides an atheoretical approach to analysing 
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discounting data by avoiding many of the problems associated with hyperbolic or 
exponential discounting models. AUCs were compared between groups with one-way 
ANOVA except when stated otherwise. 
The percent LLR choices during devaluation sessions were analysed with genotype 
(WT vs HET vs KO) by motivational state (food-deprived vs pre-fed) by delay (0 s vs 25 
s vs 50 s vs 75 s) mixed model ANOVA. 
AUCs corresponding to the devaluation sessions were analysed by conducting 
genotype (WT vs HET vs KO) by motivational state (food-deprived vs pre-fed) repeated 
measures ANOVA.  
Trial initiation and choice latencies were analysed separately by conducting genotype 
(WT vs HET vs KO) by delay (4 levels) repeated measures ANOVA except during the 
devaluation sessions which were analysed with genotype (WT vs HET vs KO) by 
motivational state (food-deprived vs pre-fed) by delay (0 s vs 25 s vs 50 s vs 75 s) mixed 
model ANOVAs.  
Forced choice latencies were analysed by conducting lever (SSR vs LLR) by genotype 
(WT vs HET vs KO) by delay (4 levels) mixed model ANOVAs.  
Although choice latencies were inspected by collapsing latencies across levers, lever 
was included as a within-subjects factor for forced choice latencies to identify whether 
there were any between-genotype differences in the time taken to respond when only 
presented with one lever.  
Total magazine (i.e. trial initiation) and total lever omissions were analysed separately 
for each stage of the experiment and compared between genotypes using one-way 
ANOVA, except during the devaluation sessions where these values were treated to a 
genotype (WT vs HET vs KO) by motivational state (food-deprived vs pre-fed) repeated 
measures ANOVA.  
81 
 
 
Mice failing to discount their LLR preference in the final block by less than 10% of 
the maximum objective value relative to their % LLR choice value at baseline were 
excluded from statistical analysis on the basis that these mice were considered to be delay 
insensitive (e.g. a mouse recording a % LLR choice of 90 in block one and 81 in the final 
block would be excluded). This criteria was based on Johnson and Bickel’s (2008) 
algorithm for identifying non-systematic data in discounting studies.  
 Mice with AUC scores more than 2 standard deviations from their group mean were 
also excluded from the analysis.  
Data were not presented from a significant number of sessions. These data were 
omitted from the analysis because, having adjusted the task parameters, it took subjects a 
significant number of sessions to respond appropriately to the changes and significant 
numbers of mice were producing delay insensitive/inflexible response patterns.  
3.3 Results 
3.3.1 Lever training 
Response rates during the final lever training session were equal as a function of lever 
designation (would-be) and genotype, either in main or interaction effect (Fs = < .76, Ps 
= > .48).  
3.3.2 Trial initiation training  
Trial initiation training performance was consistent across levers, genotypes and 
blocks, either as main effects or interaction effects during the final trial initiation training 
session (Fs = < 2.38, Ps = > .07). Magazine and lever omissions were also consistent 
between genotypes (Fs = < 1.46, Ps = > .26).  
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3.3.3 Delay discounting 
Data from the first 7 sessions were not analysed on the basis that mice had not yet 
exhibited block-dependent discounting for 5 consecutive sessions.  
3.3.3.1 Sessions 8-12 (ascending delays of 0 s, 8 s, 16 s & 32 s)  
 
 
 
 
 
 
 
 
 
 
 
At this stage of the experiment, 8 WT, 7 HET and 6 KO mice met the inclusion criteria. 
There was a significant main effect of delay (F(1.92, 34.46) = 78.27, p = .001) (Fig. 3.2A), 
with subjects recording a smaller percentage of LLR choices as the delay increased. 
However, the prediction that differential discounting would emerge between DARPP-32 
KO mice and their WT and HET littermates was not supported during discounting 
sessions constrained by the parameters listed above; the main effect of genotype and the 
delay by genotype interaction were not significant (Fs = < .47, Ps = > .75). Similarly, 
there were no between genotype differences in AUCs (F(2,18) = .02, p = .98) (Fig 3.2B). 
Thus, DARPP-32 deletion had no effect on both measures of intertemporal discounting 
at this point in the experiment. Both magazine and lever omissions were not significantly 
Fig. 3.2 WT vs HET vs KO % LLR 
choices at each block (A), grand mean 
WT vs HET vs KO AUCs for sessions 8-
12 (B), & mean  WT vs HET vs KO 
AUCs for individual sessions 8-12 (C). 
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different between genotypes (Fs = < .70, Ps = > .51). Although trial initiation (F(1.56, 28.08) 
= 47.11, p = .001) and choice (F(1.26, 22.63) = 13.30, p = .001) latencies were significantly 
slower as the delay to reinforcement increased, there were no significant main effects of 
genotype or significant delay by genotype interactions for either of these performance 
measures (Fs = < 2.09, Ps = > .12). Mice made significantly faster forced choices when 
presented with the LLR lever (main effect of lever (F(1, 18) = 34.24, p = .001). There were, 
however, no other significant main or interaction effects when inspecting forced choice 
latencies (Fs = < 2.10, Ps = > .10). 
3.3.3.2 Sessions 33-37 (descending delays of 32 s, 16 s, 8 s & 0 s)  
 
 
 
 
 
 
 
 
 
Because subjects took a significant number of sessions to adjust to the reversal of the 
delay order, data captured during the intervening sessions (i.e. sessions 13-32) were not 
analysed. Only 3 knockout subjects, compared to 6 WT and 5 HET subjects met the 
inclusion criteria which suggests that KO mice were impaired in reconfiguring 
intertemporal choices in response to changes in the task parameters. Mice made a smaller 
Fig. 3.3 WT vs HET vs KO % LLR 
choices at each block (A), grand mean 
WT vs HET vs KO AUCs for sessions 
33-37 (B), & mean  WT vs HET vs KO 
AUCs for individual sessions 33-37 (C). 
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percentage of LLR choices as the delay to reinforcement increased (F(2.0, 21.97) = 34.58, p 
= .001) Fig. 3.3A). However, the prediction that DARPP-32 deletion would differentially 
alter intertemporal discounting performance was again unsupported at this stage of the 
experiment, as the main effect of genotype and the delay by genotype interaction were 
not significant (Fs = < 1.42, Ps = > .27). Likewise, AUCs were not significantly different 
between genotypes (F(2, 11) = 1.53, p = .26) Fig. 3.3B). Magazine and lever omissions 
were also not significantly different between genotypes (Fs = < 1.08, Ps = > .37) and there 
was also no significant main effect of delay and no significant delay by genotype 
interactions for either trial initiation or choice latencies (Fs = < 2.11, Ps = > .16). Mice 
continued to execute significantly faster forced choices when presented with the LLR 
lever (F(1, 11) = 13.63, p = .004) but there were no significant main effects of genotype or 
delay in this measure (Fs = < .72, Ps = > .55). Whilst there was a significant lever by 
delay interaction (F(3, 33) = 4.59, p = .009), there were no other significant interaction 
effects when inspecting forced choice latencies (Fs = < 1.91, Ps = > .20).  
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3.3.3.3 Sessions 47-51 (descending delays of 48 s, 32 s, 16 s and 0 s)  
 
 
 
 
 
 
 
 
 
 
 
Eight KO, 8 WT & 7 HET mice met the inclusion criteria at this stage of the 
experiment. Mice recorded a smaller percentage of LLR choices as the delay to 
reinforcement increased (F(1.67, 33.45) = 146.96, p = .001) (Fig. 3.4A). Whilst there was no 
significant main effect of genotype (F(2, 20) = 1.10, p = .35), there was a significant delay 
by genotype interaction (F(3.35, 33.45) = 5.72, p = .002) and post hoc one-way ANOVAs 
revealed that KO mice recorded a significantly smaller percentage of LLR choices than 
WT or HET mice during the 0 s delay block (F(2, 20) = 5.77, p = .01) (Bonferroni post hoc 
tests Ps = < .05) but not at any other delays (Fs = < 3.12 Ps = > .07). Despite the 
abovementioned effects, there were no significant differences in AUCs between 
genotypes (F(2, 20) = 1.10, p = .35) (Fig. 3.4B). Overall, then, DARPP-32 deletion 
modestly altered baseline choices at this stage of the experiment but did not appear to 
have any overall effect on the rate of intertemporal discounting. Thus, the experimental 
predictions continued to be unsupported. Magazine and lever omissions were also not 
different between genotypes (Fs = < 1.88, Ps = > .18). Trial initiation latencies were 
Fig. 3.4 WT vs HET vs KO % LLR 
choices at each block (A), grand mean 
WT vs HET vs KO AUCs for sessions 
47-51 (B), & mean  WT vs HET vs KO 
AUCs for individual sessions 47-51 (C) 
* p = <.05. 
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significantly different across blocks (F(1.52, 30.41) = 3.82, p = .04) with mice taking longer 
to initiate trials as the sessions progressed. KO mice also took significantly longer than 
WT but not HET mice to initiate trials (F(2, 20) = 4.41, p = .03) (Bonferroni post hoc tests 
Ps = .03 & .11 respectively). The delay by genotype interaction was not significant (F(3.04, 
30.41) = .74, p = .54). Choice latencies were not significantly different across delay blocks 
(F(3, 60) = 2.41, p = .08) but there was a significant main effect of genotype (F(2, 20) = 5.53, 
p = .01), with KO mice taking significantly longer than HET (p = .02) but not WT (p = 
.06) mice to execute choices. The delay by genotype interaction was not significant (F(6, 
60) = .20, p = .98). Mice recorded similar forced choice latencies for both levers (F(1, 20) = 
1.79, p = .20). There was a significant main effect of genotype (F(2, 20) = 7.82, p = .003) 
with HET mice making faster forced choices than WT and KO mice (Ps = < .03). Forced 
choice latencies were similar between WT and KO subjects. There was a significant main 
effect of delay (F(2.21, 44.16) = 3.48, p = .04) and a significant lever by delay interaction 
(F(2.29, 45.89) = 7.30, p = .001). None of the other interactions were significant, however (Fs 
= < 1.39, Ps = > .24). 
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3.3.3.4 Sessions 64-68 (ascending delays of 0 s, 16 s, 32 s 48 s)  
 
 
 
 
 
 
 
 
 
Once again, after reversing the delays, only 3 KO mice, compared to 5 WT & 7 HET 
mice met the inclusion criteria at this stage of the experiment. Whilst mice continued to 
discount the LLR lever in a delay sensitive fashion (F(3, 36) = 60.19, p = .001) (Fig. 3.5A), 
there was no significant main effect of genotype and no significant delay by genotype 
interaction (Fs = < 1.95, Ps = > .18). There were also no differences between genotypes 
in AUCs (F(2, 12) = 1.88, p = .20) (Fig. 3.5B).  Magazine (F(2, 12) = 2.37, p = .14) and lever 
omissions (F(2, 12) = 2.69, p = .11) were also similar between genotypes. Trial initiation 
latencies slowed as sessions progressed (F(1.09, 13.03) = 14.04, p = .002) and whilst the 
significant main effect of delay indicated that choice latencies also differed across delay 
blocks (F(1.66, 19.94) = 3.63, p = .05) none of the Bonferroni post hoc tests were significant 
(p = > .14). There were no significant main effects of genotype or significant delay by 
genotypes interactions in either of these performance measures (Fs = < 3.11, Ps = >.08). 
Mice made significantly faster forced choices when presented with the LLR lever (F(1, 12) 
Fig. 3.5 WT vs HET vs KO % LLR 
choices at each block (A), grand mean 
WT vs HET vs KO AUCs for sessions 
64-68 (B), & mean  WT vs HET vs KO 
AUCs for individual sessions 64-68 (C). 
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= 10.91, p = .006) but there were no significant main effects of genotype or delay (Fs = 
< 1.88, Ps = > .19). The lever by delay interaction (F(3, 36) = 3.32, p = .06) approached 
significance. However, none of the other interaction effects were significant (Fs = < 1.62, 
Ps = > .20).  
3.3.3.5 Sessions 69-70 (ascending delays of 0 s, 16 s, 32 s, 64 s)  
 
 
 
 
 
 
 
 
 
 
 Five KO, 7 WT and 7 HET mice were eligible for inclusion. Whilst mice recorded a 
significantly smaller percentage of LLR choices as the delay to reinforcement increased 
(F(1.70, 27.24) = 42.87, p = .001) (Fig. 3.6A), there were no between genotype differences, 
either as a main effect or as an interaction between delay and genotype (Fs = < 2.20, Ps 
= > .14). AUCs were also not significantly different between genotypes (F(2, 16) = 2.02, p 
= .17) (Fig. 3.6B). Likewise, magazine and lever omissions were similar between 
genotypes (Fs = < .11, Ps = > .90). Whilst trial initiation latencies slowed as sessions 
progressed (F(1.76, 28.09) = 27.33, p = .001), there were no between genotype differences or 
significant interactions in this measure and there were no significant effects or 
Fig. 3.6 WT vs HET vs KO % LLR 
choices at each block (A), grand mean 
WT vs HET vs KO AUCs for sessions 
69-70 (B), & mean  WT vs HET vs KO 
AUCs for individual sessions 69-70 (C). 
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interactions involving choice latencies (Fs = < 2.01, Ps = > .13). LLR forced choices were 
executed significantly faster than SSR forced choices (F(1, 16) = 5.42, p = .03), however, 
there were no other significant main or interaction effects (Fs = < 2.64, Ps = > .09).  
3.3.3.6 Sessions 71-78 and 81-92 (ascending delays 0 s, 25 s, 50 s, 75 s) 
 
 
 
 
 
 
 
 
 
 
 
Six KO, 6 WT and 7 HET mice met the inclusion criteria at this stage of the 
experiment. Mice made a smaller percentage of LLR choices as the delay to 
reinforcement increased (F(1.61, 25.68) = 230.54, p = .001) (Fig. 3.7A). Notably, there was a 
significant main effect of genotype (F(2, 16) = 15.09, p = .001) with KO mice recording a 
higher percentage of LLR choices than WT and HET mice (Bonferroni post hoc tests Ps 
= < .01). There was also a significant delay by genotype interaction (F(3.21, 25.68) = 4.80, p 
= .008) with post hoc one-way ANOVAs revealing that KO mice recorded a higher 
percentage of LLR choices than both WTs and HETs at the 25 s, 50 s and 75 s blocks (Fs 
Fig. 3.7 WT vs HET vs KO % LLR 
choices at each block (A), grand 
mean WT vs HET vs KO AUCs for 
sessions 71-78 & 81-92 (B), & mean  
WT vs HET vs KO AUCs for 
individual sessions 71-78 & 81-92 
(C) * p = < .05. 
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= > 7.09, Ps = < .006) but not the zero s delay block (F(2, 16) = .86, p = .44). AUCs were 
also significantly different between genotypes (F(2, 16) = 14.75, p = .001) (Fig. 3.7B) with 
DARPP-32 KO mice producing significantly larger AUCs than WT and HET mice 
(Bonferroni post hoc tests Ps = < .001). There were no significant differences between 
WT and HET animals in AUCs. Magazine and lever omissions were not significantly 
different between genotypes (Fs = < .04, Ps = > .96).Trial initiation latencies slowed as 
sessions progressed (F(1.57, 25.05) = 37.55, p = .001) but they were not significantly different 
in any way between genotypes, and choice latencies were not different between delay 
blocks, genotypes or when these variables were analysed in interaction (Fs = < 2.32, Ps 
= > .13). Forced choices were significantly different between levers (F(1, 16) = 12.56, p = 
.003), however, unlike previous phases of the experiment, latencies were faster when 
mice were presented with the SSR lever (F(1, 16) = 12.56, p = .003). The main effect of 
genotype was not significant (F(2, 16) = .31, p = .74). There was a significant main effect 
of delay (F(3, 48) = 21.04, p = .001) with mice tending to make slower forced choices as 
the session progressed (i.e. at the longest delays). There was also a significant lever by 
delay interaction (F(1.89, 30.23) = 44.78, p = .001). Post hoc tests examining the effect of 
delay separately for each lever revealed that SSR forced choices were executed 
significantly faster as the delay to reinforcement increased (F(3, 54) = 11.10, p = .001) 
whereas LLR choices were executed significantly slower as the delay increased (F(3, 54) = 
38.88, p = .001). There were no other significant interaction effects (Fs = < 2.89, Ps = > 
.09).  
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3.3.3.7 Sessions 71-75 vs sessions 88-92 stability analysis 
 
 
 
 
 
 
 
 
In light of the aforementioned transient effects during sessions 47-51 and the relatively 
inflexible profile of DARPP-32 KO mice in response to changes in task parameters, 
AUCs captured during the first 5 sessions with a maximum 75 s delay (i.e. sessions 71-
75) were compared with AUCs captured during the final 5 (non-feeding) sessions with a 
maximum 75 s delay (i.e. sessions 88-92). There was a significant main effect of session 
(F(1, 16) = 26.36, p = .001) (Fig. 3.8C) with mice producing smaller AUCs in sessions 88-
92 compared to sessions 71-75. A significant session by genotype interaction (F(2, 16) = 
11.12, p = .001) followed up with post hoc paired t-tests indicated that KO mice produced 
significantly smaller AUCs during the final 5 sessions of testing with a maximum delay 
of 75 s compared to the first 5 sessions at these delays (t(5) = 5.51, p = .003) whereas WT 
(t(5) = 1.61, p = .17) & HET (t(6) = .71, p = .51) mice both produced similar AUCs between 
sessions 71-75 and sessions 88-92. When comparing AUCs between genotypes in the 
first sessions with a maximum delay of 75 s and the final 5 session at these parameters 
separately, AUCs were only significantly different between genotypes in the first 5 
Fig. 3.8. Mean WT vs HET vs KO % 
LLR choices at each block sessions 71-
75 (A) vs 88-92 (B) and mean WT vs 
HET vs KO AUCs sessions 71-75 vs 
sessions 81-92 (C) *p = <.05. 
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sessions (F(2, 16) = 32.48, p = .001) but not the final 5 sessions (F(2, 16) = 3.01, p = .08), 
indicating that by the end of the experiment, discounting performance was equivalent 
between genotypes. These findings suggest that with extended training, DARPP-32 KO 
mice achieved comparable performance to their WT and HT counterparts.  
3.3.3.8 Sensory-specific reinforcer devaluation (sessions 79-80)  
 
 
 
 
 
 
 
Fig. 3.9 Non-devalued vs devalued % LLR choices for WT (A), HET (B) & KO (C) mice and non-devalued 
vs devalued AUCs for WT, HET & KO mice (D).  
Table 3.2 Mean (±SEM) magazine omissions during the sucrose pre-feeding devaluation 
Session WT  HET  KO  
Non-devalued .50 (.22) 2.43 (1.81) .33 (.21) 
Devalued 3.17 (1.51) 4.14 (2.06) 5.33 (2.45) 
Table 3.3 Mean (±SEM) lever omissions during the sucrose pre-feeding devaluation  
Session WT HET KO 
Non-devalued 1.00 (.63) .29 (.18) 1.67 (.92) 
Devalued .83 (.65) .29 (.29) .17 (.17) 
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Pre-feeding mice with sucrose generally had no effect on % LLR scores. The main 
effect of motivational state and all associated interaction terms were not significant (Fs = 
< 2.02, Ps = > .08) (Figs. 3.9A, 3.9B & 3.9C). There was a significant main effect of 
delay (F(1.81, 28.96) = 147.50, p = .001), with mice continuing to discount the LLR lever as 
the delay to reinforcement increased, and a significant main effect of genotype (F(2, 16) = 
7.12, p = .006), with KO mice recording a significantly higher percentage of LLR choices 
than WT and HET mice (Bonferroni post hoc comparisons Ps = < .018). There was also 
a significant delay by genotype interaction (F(3.62, 28.96) = 7.29, p = .001). Pre-feeding 
subjects with sucrose similarly had no effect on AUCs when inspected as either a main 
effect of motivational state or as a motivational state by genotype interaction (Fs = < 1.21, 
Ps = > .30) (Fig. 3.9D). However, AUCs were significantly different between genotypes, 
collapsing across motivational state (F(2, 16) = 9.28, p = .002), with KO subjects producing 
significantly larger AUCs than both WT and HET subjects (Ps = .005). Pre-feeding 
increased the number of magazine omissions (F(1, 16) = 12.08, p = .003) but did not 
increase lever omissions (F(1, 16) = 3.08, p = .10) (Tabs. 3.2 & 3.3). However, there were 
no significant main effects of genotype and no significant interactions between genotype 
and motivational state in either of these measures (Fs = < 2.22, Ps = > .14). Whilst pre-
feeding slowed trial initiation latencies (F(1, 16) = 18.64, p = .001) and initiation latencies 
also slowed as sessions progressed (F(1.85, 29.60) = 10.62, p = .001), choice latencies were 
not affected by pre-feeding and nor did they change across delay blocks (Fs = < 1.04, Ps 
= > .32). There were no between genotype differences or any significant interactions 
between genotype, delay and motivational state in any combination in either of these 
response measures (Fs = < 2.48, Ps = > .12). Forced choice latencies were similarly not 
affected by pre-feeding (F(1, 16) = .21, p = .65). The main effect of genotype was not 
significant (F(2, 16) = .13, p = .88). There was a significant main effect of lever (F(1, 16) = 
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24.23, p = .001) with mice continuing to record faster response latencies on the SSR lever 
and a significant main effect of delay (F(3, 48) = 7.83, p = .001) with mice recording 
significantly slower latencies as the session progressed. There was also a significant lever 
by delay interaction (F(3, 48) = 17.78, p = .001). None of the other interaction terms were 
significant (Fs = < 2.86, Ps = > .09). 
3.3.3.9 General motivational reinforcer devaluation 
 
 
 
 
 
 
 
 
 
 
Fig. 3.10. Non-devalued vs devalued % LLR choices for WT (A), HET (B) & KO (C) mice and non-
devalued vs devalued AUCs for WT, HET & KO mice (D).  
Table 3.4 Mean (±SEM) magazine omissions during the chow pre-feeding devaluation  
Session WT HET KO 
Non-devalued 1.17 (.65) 1.43 (1.27) .17 (.17) 
Devalued 7.17 (1.49) 3.71 (1.80) 4.17 (1.19) 
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Table 3.5 Mean (±SEM) lever omissions during the chow pre-feeding manipulation 
Session WT HET KO 
Non-devalued .83 (.54) .14 (.14) .50 (.34) 
Devalued .83 (.40) .14 (.14) .83 (.48) 
Pre-feeding mice with their maintenance diet produced a trend toward a significant 
main effect of motivational state, with mice tending to record a smaller percentage of 
LLR choices in the devalued vs non-devalued session (F(1, 16) = 3.75, p = .07) (Figs. 3.10A, 
3.10B & 3.10C). There was a significant motivational state by delay interaction (F(1.85, 
28.54) = 5.18, p = .01). Post hoc paired t-tests revealed that the percentage of LLR choices 
recorded during the 0 s block of the devalued session was significantly smaller than the 
percentage of LLR choices recorded during the non-devalued session (t(18) = 2.97, p = 
.008). However, % LLR choices were not different during any other delay blocks (Ps = > 
.48). There were no significant interactions between motivational state and genotype or 
between motivational state, delay and genotype (Fs = < .49, Ps = > .67). There was a 
significant main effect of delay (F(2.00, 31.97) = 224.63, p = .001), with mice discounting 
the LLR lever as the delay to reinforcement increased. KO mice made a significantly 
higher percentage of LLR choices than HET but not WT subjects when collapsing across 
motivational state (F(2, 16) = 4.59, p =.03) (Bonferroni post hoc tests p = .03 and p = .16 
respectively). Finally, there was also a significant delay by genotype (F(4.00, 31.97) = 4.64, 
p =.005) interaction. Pre-feeding mice with chow produced no significant main effect of 
motivational state and no significant genotype by motivational state interaction when 
analysing AUCs (Fs = < 1.86, Ps = > .19) (Fig. 3.10D). However, a significant main effect 
of genotype (F(2, 16) = 5.50, p = .02) revealed that KO mice produced significantly larger 
AUCs than HET (p = .02) but not WT (p = .09) mice. Pre-feeding increased the number 
of magazine omissions (F(1, 16) = 13.16, p = .002) but not the number of lever omissions 
(F(1, 16) = .19, p = .67) (Tabs. 3.3 & 3.4). However, there was no significant main effect 
96 
 
 
of genotype or any significant genotype by motivational state interactions for either of 
these measures (Fs = < 1.71 Ps = > .21). In comparison to the non-devalued session, both 
trial initiation (F(1, 16) = 42.90, p = .001) and choice latencies (F(1, 16) = 22.30, p = .001) 
were slower during the devalued sessions. Whilst initiation latencies slowed as sessions 
progressed (F(3, 48) = 12.12, p = .001), choice latencies were indifferent across delay blocks 
(F(2.08, 33.33) = .45, p = .65). There were no other significant main or interaction effects in 
the time taken to initiate trials (p = > .34). There was a significant main effect of genotype 
for choice latencies (F(2, 16) = 4.12, p = .04), however Bonferroni post hoc tests were not 
significant (p = > .07). A significant motivational state by genotype interaction (F(2, 16) = 
4.61, p = .03), followed up with one-way ANOVA comparing choice latencies between 
genotypes separately for each session revealed that KO mice produced significantly 
slower choice latencies than HET but not WT mice during the devalued session (F(2, 16) = 
4.91, p = .02) (Bonferroni post hoc tests Ps = .03 and .07 respectively) but not during the 
non-devalued session (F(2, 16) = .84, p = .45). The motivational state by delay by genotype 
interaction was not significant (F(6, 48) = .85, p = .54). Forced choice latencies were also 
significantly slower during the pre-fed session (F(1, 16) = 10.12, p = .006), however, forced 
choice latencies were not significantly different between genotypes (F(2, 16) = .25, p = .78). 
There was a significant main effect of lever (F(1, 16) = 6.76, p = .02) with mice continuing 
to execute faster choices when presented with the SSR lever and a significant main effect 
of delay (F(3, 48) = 3.48, p = .02), with mice recording slower latencies as the session 
progressed. There was also a significant lever by delay interaction (F(3, 48) = 11.61, p = 
.001. However, none of the other interaction terms were significant (Fs = < 2.26, Ps = > 
.14).  
 
 
97 
 
 
3.4 Discussion 
KO mice recorded a significantly greater proportion of LLR choices than both WT and 
HET mice at the 25 s, 50 s and 75 s blocks during the final 20 sessions of training. At first 
sight, these results imply that DARPP-32 KOs are significantly less sensitive to the effects 
of delay to reinforcement than their DARPP-32 positive counterparts when delays to 
reinforcement are relatively long but not when the delays to reinforcement are 
comparatively short. Such a proposal that DARPP-32 KO mice are less sensitive to the 
effects of delay to reinforcement than their DARPP-32 carrying counterparts would be 
commensurate with our predictions. However, insofar that signalling via DARPP-32 
transduction has a simple direct relationship with choice under delay discounting 
conditions, the finding that the genotype effect only appeared after extensive training 
seems unexpected. That is, relative to both WT and HET mice, KO mice diverged to 
become more myopic only after approximately 70 training sessions. Moreover, there was 
a ‘to-the-eye’ relatively higher level of delay insensitivity/inflexibility in DARPP-32 KO 
mice when inspecting the discounting curves for individual mice (data not shown). 
Percent LLR choices for individual KO mice were often characterised by block 
insensitive choice patterns. And, on the basis of the inclusion criteria, DARPP-32 KO 
mice also exhibited relatively higher levels of delay insensitivity compared to their WT 
and HET counterparts with fewer KO mice reaching the inclusion criteria during most 
stages of the experiment. In addition to this, KO mice appeared to take longer than both 
WT and HET mice to modify their LLR choices following changes in task parameters, 
especially after the delays were reversed from an ascending to a descending profile and 
vice versa. For example, only 3 KO mice were eligible for inclusion compared to 6 WT 
& 5 HET mice during sessions 33-37. There was also comparatively inflexible responding 
in DARPP-32 KO mice during sessions 64-68 with only 3 KOs, compared to 5 WTs & 7 
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HETs meeting the eligibility criteria. Again, this was approximately 13-18 sessions after 
the delays had been reversed from a descending to an ascending profile. By session 71, 
however, 6 KO mice met the eligibility criteria. KO mice then discounted less steeply 
than WT and HET mice during sessions (non-feeding sessions only) conducted with a 
maximum delay of 75 s. However, when these sessions were broken down statistically 
and discounting performance was compared between the first 5 and final 5 sessions, 
performance was only significantly different between genotypes during the first 5 
sessions after the maximum delay was increased to 75 s. This suggests that, after extended 
experience at these parameters, DARPP-32 KO mice achieved comparable performance 
with their DARPP-32 carrying littermates.  
When analysing data from delay discounting tasks, especially in studies recruiting 
non-human subjects where the contingencies between responses and outcomes are 
unknown by subjects at the outset of the study, it is crucial that one dissociates differences 
in the initial learning of the task from differences in performance once the task is fully 
learned (Cardinal, et al., 2003). It is also crucial, one assumes, to dissociate learning to 
update action/response-outcome contingencies following adjustment in the task 
parameters from the performance of the task once those parameters are fully learned. In 
accordance with this idea, care must be taken when analysing data captured in the 
intervening sessions following changes in task parameters. Animals must first learn that 
the contingencies have changed. Thus, any between-group differences which emerge in 
sessions following changes in the task parameters could reflect either an impairment in 
detecting such changes and/or a corresponding slowness to accordingly update choices 
(i.e. learning) or these group differences might reflect a genuine and enduring group 
difference in intertemporal choices. It is only through extended training following such 
changes that one can be sure of the underlying nature of these differences. On this basis, 
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it is possible that the between genotype differences which were observed during sessions 
with a max 75 s delay reflected difficulties in rapidly modifying choices following 
alterations in the task parameters.  
DARPP-32 is densely enriched in the NAc and lesions to this region impairs both 
delay-based action-outcome instrumental learning and performance of already learned 
contingencies of the same nature (Cardinal & Cheung, 2005). Additionally, whilst NAc 
lesions promote delay aversion when delays are predictable (Cardinal et al., 2001), such 
lesions also increase delay tolerance when the delays are unpredictable (Acheson et al., 
2006). When delays are suddenly increased, as was the case in the current experiment, 
subjects are clearly incapable of having pre-empted this change, so it is possible that 
owing to the unpredictable nature of these adjustments, that any subsequent group 
differences which occurred after the delays were extended might have reflected a relative 
slowness to detect and/or respond to changes in the delays rather than a true performance 
difference between genotypes. Again, it is only following extended training that one is 
able to discern the underlying nature of such differences, and by the completion of the 
experiment, the between-group differences had disappeared. Even though evidence 
suggests that the NAc is broadly involved in time-based action-outcome learning and 
intertemporal discounting, the mPFC (Churchwell et al., 2009) and OFC (Mar et al., 
2011) also contribute to intertemporal choices so, of course, one cannot exclude the 
contribution that the loss of OFC or mPFC DARPP-32 might have had in producing the 
effects reported above.  
At first sight, it appears somewhat peculiar that between groups differences were 
observed to delays of 25 s and 50 s in the final arrangement of delays (i.e 0 s, 25 s, 50 s 
70 s) but not to delays of 32 s or 48 s in earlier delay arrangements. However, an important 
point warrants discussion when considering performance during within-session 
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discounting procedures. LLR choices in any given block may be affected by the delay 
associated with reinforcement in previous blocks within and between sessions. That is, 
the experience which subjects have with a reinforcement contingency within a delay 
block is believed to carryover into subsequent blocks and subsequent sessions, such that 
it impacts intertemporal choices during blocks of trials which are constrained by different 
temporal contingencies. It has been suggested that these carryover effects might be the 
underlying reason behind groups of subjects rarely achieving 100% LLR choice in the 0 
s delay block, even though LLR choices are reliably reinforced in this block (Madden & 
Johnson, 2010). It is believed that the encounters subjects have with delayed 
reinforcement choices in previous sessions carryover into subsequent sessions and 
devalue the LLR in the no delay block, as well as in other blocks. When seen in this light, 
it is advisable not to consider delays in sequential within-session discounting paradigms 
as wholly discrete phenomena which can be compared with similar delays in different 
portions of a study, or between different studies, when other delays are present in one 
arrangement but not the other. That is, even though group differences were observed to 
the 25 s and 50 s delays, but not the 32 s or 48 s delays, one cannot reliably compare 
performance between these delays because the maximum delay in the arrangement 
containing the 25 s and 50 s delays was 75 s, whereas the maximum delay subjects 
experienced during any arrangement containing the 32 s or 48 s delays was 48 s or 64 s 
respectively. Moreover, aside from the 0 s delay block, subjects encountered a minimum 
delay of 25 s in the arrangement containing a maximum delay of 75 s. In comparison, 
subjects experienced a minimum delay of either 8 s or 16 s in the arrangements containing 
32 s or 48 s delays. Put simply, delays of 0 s, 25 s, 50 s and 75 s (average delay of 37.5 
s) are more stringent than delays of 0 s, 8 s, 16 s and 32 s (average delay of 14 s), or 0 s 
16 s 32 s and 48 s (average delay of 26 s), or delays of 0 s, 16 s, 32 s and 64 s (average 
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delay of 28 s). Therefore one might expect carryover effects to exert a more pronounced 
influence upon the LLR choices of animals in the 0 s, 25 s, 50 s and 75 s arrangement 
compared to their influence during less stringent delay arrangements. Whilst this point in 
isolation cannot provide an adequate explanation for the presence of group differences to 
delays of 25 s and 50 s but not to comparable delays of 32 s or 48 s, when it is considered 
in conjunction with the proposal that the impairment might reflect either an insensitivity 
to detect changes in the task and/or a failure to efficiently reorganise behavioural output 
following such changes, it might have been that KO animals were initially less sensitive 
to detect and/or respond to the introduction of  3 novel delays (25 s , 50 s, 75 s) and 
initially less sensitive to the carryover effects one might expect from these much more 
stringent delays. For example, 3 unfamiliar delays (25 s, 50 s & 75 s) were introduced 
into the experiment during the period where group differences emerged.  In comparison, 
when delays were extended to include either a 48 s or a 64 s delay, only one delay was 
changed in the arrangement, and in earlier arrangements containing a maximum delay of 
32 s, no changes in delay length were introduced.  Indeed, subjects conducted 70 sessions 
of testing which included a 32 s delay. Thus, the group differences might have been 
present during the 25 s and 50 s blocks, but not the 32 s and 48 s blocks, because subjects 
were required to assimilate much more information following the introduction of 3 novel 
delays (e.g. 25 s, 50 s, 75 s) and also because the delay arrangement differentially 
impacted the subjective value of the LLR across blocks and sessions (i.e. carryover 
effects).    
 Nevertheless, the precise nature of the disturbances that were observed in DARPP-32 
KO mice during intertemporal discounting are difficult to disentangle on the basis of the 
data presented in this chapter. There were 2 general disturbances in DARPP-32 KO mice 
related to changes in the task parameters. First, and as noted above, DARPP-32 mice took 
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longer to modify/devalue LLR choices when the delays were extended. Second, DARPP-
32 KO mice displayed a relatively inflexible choice pattern following the reversal of the 
delay order. These 2 disturbances might reflect a disturbance in a single process or they 
could be distinct. For instance, when the delay order is reversed, mice must learn to 
reverse their choices in relation to the block order. To elaborate this point, mice had 
initially experienced the shortest delay in the first block but, following delay order 
reversal, mice experienced the longest delay in the first block. Mice therefore must learn 
to no longer select the LLR lever most frequently in the first block and to select the SSR 
lever most frequently instead. This adaptation requires animals to overcome the 
previously learned response and to replace it with a novel response strategy. In contrast, 
when the delays were extended, the 0 s delay block maintained its sequential position as 
the first block subjects experienced, and mice merely had to detect that the length of the 
delay had increased within single blocks, as opposed to the delay order having been 
reversed between blocks. Although the NAc has a role in mediating learning about delays 
to reinforcement and intertemporal choice, there is reason to believe that the NAc is 
involved in specific kinds of behavioural flexibility. For example, in a study examining 
the effects of NAc lesions on behavioural flexibility, lesioned animals were impaired in 
learning the Morris Water Maze task (Annett, McGregor & Robbins, 1989). However, 
subjects were eventually able to achieve comparable performance with controls. In the 
same study, NAc lesions impaired spatial discrimination and reversal learning in a T-
maze task. However, rather than simply displaying perseverative responding, the authors 
deemed that the lesioned animals were slow in learning the new position of the reward 
following its relocation. In another study, NAc inactivation also impaired set-shifting, not 
by increasing preservation but by hindering the learning and performance of a novel 
strategy (Floresco, Ghods-Sharifi, Vexelman & Magyar, 2006). In exploring the 
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pharmacological basis of strategy shifting, Haluk & Floresco (2009) reported that NAcC 
injections of D1 antagonist SCH 23390 impaired strategy switching not by inducing 
perseverative errors but by increasing regressive errors which are indicative of difficulties 
in sustaining novel strategies. In contrast, the D2 receptor agonist quinpirole increased 
perseverative errors in the same task and also reversal learning. This is not to suggest that 
the abovementioned tasks are analogous to the changes introduced in this experiment. 
Merely I am suggesting that the nucleus accumbens assists in both time-based 
instrumental learning and in flexible responding to changes in tasks that require subjects 
to update a previously learned strategy by acquiring a new one and, as noted above, 
diminished transmission through accumbal D1 receptors impairs this kind of flexibility 
whilst accumbal D2 receptors also contribute to behavioural flexibility (Haluk & Floresco, 
2009). Of course, one cannot exclude the role of DA in dorsal striatal (O’Neill & Brown, 
2007) or PFC (Floresco, 2013; Winter et al., 2009) regions in mediating behavioural 
flexibility. Furthermore, DARPP-32 is distributed in regions more intimately associated 
with behavioural flexibility than the NAc, such as the DMS (Castañé et al., 2010), OFC 
(Kim & Ragozzino, 2005) and mPFC (Winter et al., 2009). OFC lesions, for example, 
impair learning when the positions of the SSR and LLR levers are reversed (Mar et al., 
2011). 
Whilst the precise nature of the disturbances reported in this chapter are unknown, 
there is reason to believe that DARPP-32 assists in the flexible updating of behaviour. In 
a human study, subjects with an SNP of the DARPP-32 gene had higher P200 event 
related potentials during a task which explicitly requires subjects to update outcome-
expectancies (Hämmerer et al., 2013). And as noted elsewhere, DARPP-32 KO mice are 
also generally less flexible/responsive to changes in instrumental contingencies, as 
determined by instrumental reversal learning (Heyser et al., 2000) and to alterations in 
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environmental stimuli (e.g. novel object recognition) (Heyser et al., 2013). This evidence, 
as well as that presented in this chapter, suggests that DARPP-32 assists in adapting to 
changes in task parameters. 
Finally, while selective or general devaluation produced an effect on consummatory 
magazine approach, it failed to markedly alter responding under delay discounting 
conditions irrespective of genotype. Although the general motivation devaluation 
significantly reduced baseline preference for the LLR lever, it did not alter the % LLR 
choices in any blocks during which a delay was ascribed to the LLR lever and nor did 
pre-feeding significantly alter AUCs. Importantly, there were no significant interaction 
effects between motivational state and genotype nor a main effect of genotype during pre-
feeding sessions. On this basis, it is unlikely that the between genotype differences in 
LLR choices can be alternatively accounted for by motivational differences. Whilst there 
were some small transient differences between KO and HET mice in initiation latencies, 
there were no clear or enduring differences in the time taken between DARPP-32 KO 
mice and HET or WT mice to initiate trials or to execute choices during this experiment, 
thus there does not appear to be any slowing or speeding of responses as a result of 
deleting DARPP-32.  
In summary, there were no differences between KO, HET and WT mice at the 
beginning of the experiment. However, once the parameters were reversed from an 
ascending to a descending profile, DARPP-32 KO mice exhibited a relatively inflexible 
profile with the majority failing to meet the inclusion criteria during sessions 33-37. Then, 
when the parameters were reversed from a descending to an ascending profile, KO mice 
again exhibited a relatively inflexible profile. Thus, there were comparatively higher 
levels of inflexibility in DARPP-32 KO mice following changes in the task parameters. 
Moreover, there were no clear differences in performance between mice with or without 
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the DARPP-32 gene for the overwhelming majority of sessions and only when the delays 
were changed toward the end of the experiment did a genotype difference appear, and 
only then was it a transient effect. This suggests that rather than being inherently different 
from DARPP-32 carrying littermates in their performance during intertemporal 
discounting tasks, that DARPP-32 KO mice are impaired in the ability to flexibly adapt 
to task changes and/or at updating outcome-expectancies following changes in the task 
parameters. These were unexpected findings, though given the role of this signalling 
molecule in facilitating flexible responding in rodents and decision-making processes in 
humans, it is not altogether unsurprising that DARPP-32 KO mice were comparatively 
inflexible in this task. 
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Chapter 4 
Probability discounting 
4.1 Introduction 
In the previous chapter, we examined the relationship between global DARPP-32 
deletion and its effects on intertemporal choices. In addition to dimensions of time, 
reinforcement choices can be isolated along dimensions of uncertainty/risk and the 
procedures which capture risky choices are important tools for identifying the biological 
basis of risk proneness. An exaggerated preference for risky outcomes is associated with 
life-limiting pathologies such as addiction (Bornovalova, Daughters, Hernandez, 
Richards & Lejuez, 2005; Brand, Roth-Bauer, Driessen & Markowitsch, 2008), ADHD 
(Groen, Gaastra, Lewis-Evans & Tucha, 2013), pathological gambling (Kräplin et al., 
2014), and also with the side effects of antiparkinson medications (Weintraub et al., 
2006). On the other hand, maintaining a normative level of risk is often necessary for the 
exploitation of ecologically relevant reinforcers and an excessively risk averse 
predisposition might limit opportune reinforcement.  
Research conducted with the probability discounting task has shown that when the 
probabilities of reinforcement for a small or a large reinforcer are equal and certain (p = 
1), subjects will preferentially choose the large reinforcer. However, as uncertainty - or 
risk - is systematically and unevenly introduced (i.e. when the probability of 
reinforcement associated with the large reinforcer decreases and the probability of 
reinforcement for the small reinforcer remains constant), subjects will begin to direct their 
preference away from the large uncertain reinforcer towards the small certain reinforcer 
(Cardinal & Howes, 2005; Ghods-Sharifi, St Onge & Floresco, 2009; Rachlin, Ranieri & 
Cross, 1991; Richards, Zhang, Mitchell & de Wit 1999; St Onge & Floresco, 2009; St 
Onge & Floresco, 2010; Stopper et al., 2013; Stopper, Green & Floresco, 2012). Thus, in 
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such tasks, risk-prone subjects are identified as those who execute risky decisions in the 
face of a probabilistically diminishing positive outcome or, conversely, a probabilistically 
increasing likelihood of a less desirable outcome.  
Neurobiological studies have elucidated many structures involved in the provision of 
probabilistically constrained reinforcement choices. Some of these regions include the 
mPFC (St Onge & Floresco, 2010), the OFC (Abela & Chudasama, 2013; Stopper et al., 
2012), the BLA (Ghods-Sharifi et al., 2009), and the NAcC (Cardinal & Howes, 2005). 
However, temporary inactivation of the NAcSh but not the NAcC affected probability 
discounting (Stopper & Floresco, 2011), suggesting that the NAcSh but not the NAcC 
has a role in mediating probabilistic reinforcement choices. As noted by Stopper & 
Floresco (2011), the lesions in the Cardinal & Howes (2005) study also damaged parts of 
the NAcSh. Many of these regions but particularly the NAc are associated with the 
enrichment of DARPP-32 and studies examining the pharmacological underpinnings of 
probabilistic reinforcement have identified a role for transmitter systems (e.g. DA & 
glutamate) that regulate the phosphorylation of DARPP-32. 
There is a growing empirical literature exploring how different DA receptor subtypes 
contribute to probabilistic positive reinforcement choices. For instance, systemic 
administration of the D1 receptor agonist SKF 82197 increases risky probability 
discounting choices at a low (0.3mg/kg) dose. At a higher dose (1.0 mg/kg), the effects 
on choice were bi-directional, reducing risky choices in a low-risk block (p = 0.5) but 
increasing risky choices in a high-risk block (p = 0.25) (St Onge & Floresco, 2009). 
Conversely, amphetamine or the D2 receptor agonist bromocriptine also increased risky 
choices and systemic administration of the D1 receptor antagonist SCH 23390 or the D2 
receptor antagonist eticlopride both reduced risky choices. Co-administration of 
amphetamine with either of these latter 2 compounds attenuated the risk promoting effects 
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of amphetamine, although this effect was most pronounced when amphetamine was co-
administered with SCH 23390. The D3 receptor antagonist nafadotride was inefficacious 
in affecting choices, however, when it was co-administered with amphetamine, it 
potentiated the risky-choice enhancing effects of amphetamine. The D3 receptor agonist 
PD 128907 sub-optimally reduced choices of a large but uncertain reward by driving 
down choices in high probability of reinforcement trials.  
Intra-mPFC SCH 23390 significantly decreased risky probabilistic choices whereas 
the D2 receptor antagonist eticlopride increased risky decisions (St Onge et al., 2011). In 
a similar study, Stopper, Khayambashi & Floresco (2013) showed by directly targeting 
NAc DA receptors that NAc D1 & D3, but not D2, receptors are important determinants 
of probabilistic positive reinforcement choices. In summary, DA is a significant mediator 
of probabilistic choices but the specific DA receptor sub-types that mediate uncertain 
reinforcement choices vary on a regional basis, with D1 receptors being of relevance in 
the mPFC and NAc, whereas D2 receptors appear to have relevance to probability 
discounting in the mPFC but not NAc.  
It was recently shown that glutamate transmission is involved in the facilitation of 
uncertain reinforcement choices, especially via the NMDA receptor. The NMDA receptor 
antagonist, MK801, but not the AMPA receptor antagonist CNQX, reduces probability 
discounting (Yates et al., 2014). MK801 abolishes the ability of glutamate to increase 
Thr34-DARPP-32 phosphorylation in striatal slices (Nishi et al., 2005). To the best of 
one’s knowledge, whilst there are no published studies providing evidence of the precise 
neural locus of the glutamatergic mediation of probabilistic reinforcement choices it is 
likely that, given the tightly interwoven relationship between DA and glutamate in 
regions of the brain that mediate incentive motivational processes and reinforcement 
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choices, these 2 transmitter systems converge in the striatum to modify probability 
discounting.  
As noted earlier, probabilistic choice procedures recruit DA innervated brain regions, 
some of which are associated with the profound expression of DARPP-32, in particular 
the NAc where the D1 receptor exerts a prominent influence on probabilistic 
reinforcement choices. As an integrator of accumbal DA and glutamate (originating from 
e.g. amygdala and prefrontal cortex) transmission, DARPP-32 is well positioned as a 
credible molecular candidate for the targeted investigation of intracellular mediators of 
probabilistic choices. Perhaps to date, the most direct evidence implicating DARPP-32 in 
probabilistic reinforcement is provided by Michael Frank and colleagues who showed 
that an allelic variant of a DARPP-32 SNP was associated with improved performance 
during a probabilistic reinforcement learning task in humans (Frank et al., 2007). On the 
basis of these studies, it was proposed that DARPP-32 deletion would significantly 
increase probability discounting in knockout mice relative to a cohort of DARPP-32 
possessing WT littermates. To test this prediction, a probability discounting paradigm 
which was a modified version of the procedure described by Cardinal and Howes (2005) 
was implemented. The effects of reinforcer devaluation on probabilistic choices were 
examined as such manipulations have been shown to induce risk aversion (St Onge & 
Floresco, 2009). In light of these reports, and of the expression of DARPP-32 in regions 
identified as mediating reinforcer devaluation (CPu, OFC,) and habit formation (CPu, 
CeA, OFC), it was deemed important to establish whether DARPP-32 KO mice are 
differentially sensitive to the effects of pre-feeding on risky choices compared to WT 
mice. In addition to this, pre-feeding provides a degree of control for establishing whether 
differences in motivational state might differentially contribute to instrumental choices 
between genotypes.  
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4.2 Methods 
4.2.1 Subjects 
 Eight DARPP-32 KO mice (mean weight = 24.30 g), aged 14 to 24 weeks old and 8 
WT littermates (mean weight = 25.60 g), aged 15 to 24 weeks at study commencement 
were used for this study. Subjects were at least the 7th generation of backcrossed mice 
bred at the University of Sussex on a C57BL/6J background in the manner described 
previously. Genotyping was conducted prior to study commencement using the protocol 
described in chapter 2. Equal numbers of male and female mice were present in each 
group. Animals were food restricted to 85% of their free-feeding weight for the duration 
of the experiment, except when stated otherwise, and provided with ad libitum access to 
tap water in their home cages. Mice were housed in the conditions described earlier. Each 
mouse was handled for 5 min per day on 3 consecutive occasions prior to study 
commencement to reduce handling stress. 
4.2.2 Apparatus 
All testing was conducted in the operant chambers described in chapter 3. A 10% 
liquid sucrose solution was used as the reinforcer in all operant box sessions.  
4.2.3 Procedure 
4.2.3.1 Magazine training 
Mice were first given 2 magazine training sessions, 1 per day, to develop an 
association with the location of reward receipt. These sessions commenced when subjects 
made their first magazine entry and continued until a total of 20 rewards had been 
dispensed. Reinforcements consisted of 46.4 µl of sucrose which were dispensed on a RI-
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60 schedule. One mouse responded markedly lower after 2 sessions and was therefore 
given an additional magazine training session.  
4.2.3.2 Lever training 
 Mice were then given 6 daily sessions of fixed ratio-1 (FR-1) instrumental training, 1 
lever per session, to establish reliable and equivalent responding on both operanda. Both 
levers, when activated, were reinforced with 46.4 µl of sucrose. Lever training sessions 
terminated after 60 min and were conducted daily until mice had acquired 50 
reinforcements on each lever during 2 consecutive sessions. One poorly performing 
mouse was given 2 additional lever training sessions to overcome a side bias.  
4.2.3.3 Trial initiation training 
 Subjects were next provided with up to 11 sessions of trial initiation training. These 
sessions consisted of 4 blocks of 22 trials with each trial lasting 70 s. All trials were forced 
choice trials, such that only 1 lever was presented per trial but each lever was presented 
an equal number of times per block. Trials began in darkness and their commencement 
was indicated by the illumination of the houselight. Mice were given 20 s to nosepoke 
into the reward magazine following the illumination of the houselight. Failure to respond 
within this period resulted in the houselight being extinguished, the trial being recorded 
as an omission, and being forced into a timeout period that lasted the duration of the trial. 
If mice made a magazine response within 20 s of the light illuminating, 1 lever, selected 
pseudorandomly with respect to position, was extended into the chamber. In turn, failure 
to respond on the lever within 20 s of its presentation resulted in the lever being retracted, 
the houselight being extinguished, the trial being recorded as an omission and the subject 
experiencing a timeout period for the duration of the trial. Responding on the lever prior 
to the 20 s timeout period resulted in the immediate delivery of 24.7 µl of sucrose and the 
112 
 
 
simultaneous extinguishing of the light and retraction of the lever. Trial length was held 
constant at 70 s regardless of whether the animal achieved reinforcement or recorded 
omissions.  
4.2.3.4 Probability discounting 
 
Fig. 4.1 Simplified schematic diagram of the probability discounting procedure. 
The probability discounting procedure was similar in many ways to the one described 
in the delay discounting chapter. Between sessions 1 and 14, the first 10 trials of each 
block were forced choice trials, involving the extension of only 1 lever per trial, and the 
remaining 12 were choice trials involving the presentation of both levers. Discounting 
sessions began with the illumination of the houselight. If mice made a head entry into the 
reward magazine within 20 s of the trial start, either 1 lever, selected pseudorandomly 
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with regards to lever position, was inserted into the chamber during forced choice trials, 
or both levers were inserted during choice trials. Failure to make a head entry into the 
reward delivery magazine or to respond on the lever within 20 s of the trial start or lever 
insertion, respectively, resulted in the houselight being extinguished and mice entering a 
timeout period for the remainder of the trial. Levers were presented an equal number of 
times during the forced choice component of each block of trials to ensure that mice 
experienced the programmed consequences of both levers at the start of each ‘probability 
block’. Lever responses were reinforced on a probabilistic basis in relation to the lever 
selected, with 1 lever designated as the small certain (SC) lever and the other lever 
designated as the large uncertain (LU) lever: counterbalanced across genotypes with 
respect to the physical position of the lever. During the first 14 sessions, responses on the 
SC lever were always reinforced with 23.2 µl of sucrose following a single 0.75 s reward 
pump activation and LU lever responses were reinforced with 3 deliveries of 23.2 µl of 
sucrose (i.e. 69.9 µl of sucrose) dispensed over 3 consecutive 0.75 s activations of the 
reward pump. LU rewards were delivered on a probabilistic basis which progressively 
diminished across consecutive blocks (e.g. 1.0, 0.75, 0.5, and 0.25). Therefore, during 
choice trials mice were provided with the opportunity to select either a small certain 
reinforcer or a large uncertain reinforcer.  
Because neither WT nor KO groups were discounting by session 14, the procedure 
was altered as follows: first, by increasing the number of blocks to 5, with each consisting 
of 20 trials, 10 of which were forced choice trials. Second, the probabilities of delivery 
of the large reward were adjusted so that p = 1.0, 0.5, 0.25, 0.125, or 0.0625, depending 
on the block to accelerate the acquisition of block-dependent discounting. Third, the 
reward magnitude was reduced to compensate for the increased number of trials, so that 
114 
 
 
responses on the SC lever yielded 18.6 µl of sucrose and responses on the LU lever 
yielded 3 deliveries of 18.6 µl of sucrose dispensed via consecutive 0.75 s activations of 
the reward pump.  
4.2.3.5 Reinforcer devaluation 
Mice were subjected to 2 different reinforcer devaluation procedures on 2 separate 
occasions. The first reinforcer devaluation procedure was a sensory-specific intervention 
which involved pre-feeding half of all animals with 10% sucrose for 2 hrs on day 1. 
During these pre-feeding sessions, home cage water bottles were replaced with bottles 
containing 10% sucrose. Pre-feeding was counterbalanced with respect to genotype and 
lever position. All animals, including those that were not sucrose pre-fed, were then 
immediately subjected to a probability discounting session. On day 2, the remaining half 
of animals that had not undergone sucrose pre-feeding were given a 2 hr sucrose pre-
feeding session which was followed with all animals conducting a probability discounting 
session.  
The second reinforcer devaluation procedure was a general motivation intervention. 
These sessions, conducted over 2 days, were identical to the sensory-specific devaluation 
session except that during the 2 hr pre-feeding sessions, mice were pre-fed with regular 
laboratory chow prior to the discounting sessions.  
4.2.4 Data analysis 
The response rates of WT & KO mice on each lever during the final session of lever 
training were compared by conducting a genotype (WT vs KO) by lever (l vs 2) repeated 
measures ANOVA to ensure that performance was equal on both levers within and 
between genotypes. 
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 A mixed genotype (WT vs KO) by lever (1 vs 2) by block (1 vs 2 vs 3 vs 4) ANOVA 
of the final trial initiation training session was conducted to ensure that performance was 
equivalent between genotypes, levers or blocks. 
Magazine and lever omissions recorded during the final trial initiation training session 
were each analysed separately and compared between genotypes by conducting 
independent t-tests. 
The percentage of total choices made in each block that were LU choices during 
discounting sessions was the dependent variable (i.e. LU choices/(SC choices + LU 
choices)*100). Responses from each block (e.g. p = 1.0, p = 0.5, p = 0.25, p = 0.125, p = 
0.0625) for each animal were averaged over 5 sessions. These values were then used to 
calculate the overall rate of discounting as determined by AUC (see chapter 3 for details). 
To this end, the probability of reinforcement was converted to the odds against 
reinforcement using the formula (1 - p)/p and then normalised as a proportion of the 
largest odds against reinforcement (see Myerson et al., 2001 for a more detailed 
description). Figures report the probabilities of reinforcement rather than the odds against. 
To compare discounting performance between genotypes, a genotype (WT vs KO) by 
probability (p = 1.0 vs p = 0.5 vs p = 0.25 vs p = 0.125 vs p = 0.0625) repeated measures 
ANOVA of % LU choices at each block corresponding to the 5 session average was 
conducted except when stated otherwise. Independent t-tests were conducted to compare 
AUCs between genotypes except when stated otherwise. 
% LU choices during the devaluation sessions were compared by conducting genotype 
(WT vs KO) by motivational state (food-deprived vs pre-fed) by probability (p = 1 vs p 
= 0.5 vs p = 0.25 vs p = 0.125 vs p = 0.0625) mixed model ANOVAs. 
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AUCs from the 2 reinforcer devaluation manipulations were subjected to genotype 
(WT vs KO) by motivational state (food-deprived vs pre-fed) repeated measures 
ANOVAs.  
Magazine and lever omissions were similarly averaged over the corresponding 5 
sessions. Each omission type was analysed separately and compared between genotypes 
by independent t-test. 
Magazine and lever omissions recorded during the devaluation manipulation sessions 
were analysed separately by conducting genotype (WT vs KO) by motivational state 
(food-deprived vs pre-fed) repeated measures ANOVAs for each variable of interest.  
A post hoc stability analysis was conducted by comparing the AUCs from sessions 30-
34 with the AUCs from sessions 40-44 by conducting a genotype (WT vs HET vs KO) 
by session (30-34 vs 40-44) repeated measures ANOVA.  
Trial initiation and choice latencies were analysed separately by conducting genotype 
(WT vs KO) by probability (p = 1 vs p = 0.5 vs p = 0.25 vs p = 0.125 vs p = 0.0625) 
repeated measures ANOVA except during the devaluation sessions which were analysed 
with genotype (WT vs KO) by motivational state (food-deprived vs pre-fed) by 
probability (p = 1 vs p = 0.5 vs p = 0.25 vs p = 0.125 vs p = 0.0625) mixed model 
ANOVAs.  
Forced choice latencies were analysed by conducting lever (SC vs LU) by genotype 
(WT vs KO) by probability (p = 1 vs p = 0.5 vs p = 0.25 vs p = 0.125 vs p = 0.0625) 
mixed model ANOVAs except during the devaluation manipulations when an additional 
within-subjects variable of motivational state (food-deprived vs pre-fed) was introduced 
to the ANOVA. 
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4.3 Results 
4.3.1 Lever training 
Response rates on both levers were similar for both genotypes during the final session 
of lever training (Fs = < 2.94, Ps = > .11).  
4.3.2 Trial initiation training  
Trial initiation training performance was consistent between levers, probability blocks 
and genotypes (Fs = < 2.95, Ps = > .11). Magazine (t(14) = -.36, p = .73) and lever (t(14) = 
.86, p = .41) omissions were not significantly different between genotypes.  
4.3.3 Probability discounting 
No data are presented from the first 14 sessions because animals were persistently 
selecting the LU lever in a block-insensitive fashion (i.e. the discounting curves were flat 
in both groups). 
Table 4.1 Mean (±SEM) magazine omissions 
Session WT omissions KO omissions 
30-34 1.16 (.32) 1.03 (.33) 
35-39 .90 (.18) 1.80 (.93) 
40-44 1.35 (.82) 1.35 (.33) 
Sucrose non-devalued 1.25 (.62) 2.00 (1.12) 
Sucrose devalued 7.13 (2.22) 5.50 (3.00) 
Chow non-devalued 13.63 (4.43) 10.88 (7.00) 
Chow devalued 36.88 (5.36) 23.63 (5.27) 
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Fig. 4.2 WT vs KO % LU choices at each 
block (A), grand mean WT vs KO AUCs 
for sessions 30-34 (B), & mean  WT vs 
KO AUCs for individual sessions 30-34 
(C). 
Table 4.2 Mean (±SEM) lever omissions 
 
 
4.3.3.1 Sessions 30-34 
 
 
 
 
 
  
 
 
Mice discounted the LU lever as the probability of reinforcement decreased across 
blocks (F(1.52, 21.34) = 42.26, p = .001) but there was no significant main effect of genotype 
and no significant probability by genotype interaction (Fs = < .76, Ps > .45) (Fig. 4.2A). 
Average AUCs were also similar between genotypes during sessions 30-34 (t(14) = .46, p 
= .65) (Fig. 4.2B). Likewise, magazine (t(14) = .30, p = .77) and lever omissions (t(14) = 
Session WT KO 
30-34 1.45 (.78) 1.05 (.35) 
35-39 .65 (.46) 1.19 (.59) 
40-44 .20 (.17) .40 (.15) 
Sucrose non-devalued .25 (.25) .00 (.00) 
Sucrose devalued 1.50 (1.22) .63 (.50) 
Chow non-devalued .88 (.61) .13 (.13) 
Chow devalued 1.38 (.84) .63 (.18) 
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.47, p = .65) were not significantly different between genotypes (Tabs. 4.1 & 4.2). Trial 
initiation latencies slowed as sessions progressed (F(2.11, 29.57) = 5.55, p = .008). However, 
there were no differences between genotypes in this measure, either as a main effect or 
genotype by probability interaction and there were no significant main effects or 
interactions relating to choice latencies (Fs = < 3.22, Ps = > .10). Mice were quicker to 
press the LU lever during forced choice trials when collapsing across genotypes (F(1, 14) = 
58.99, p = .001). KO mice were significantly slower to respond during forced choice trials 
than WT mice (F(1, 14) = 5.88, p = .03). KO mice were also significantly slower at 
depressing the SC lever but not the LU lever than WT mice during forced choice trials 
(lever by genotype interaction (F(1, 14) = 10.08, p = .007); post hoc independent t-tests 
comparing SU lever latencies (t(10.39) = -3.14, p = .01) and LU lever latencies (t(14) = -1.03, 
p = .32) for each lever between genotypes). There was also a significant lever by 
probability interaction (F(2.33, 32.55) = 7.05, p =.002). There were no other significant effects 
involving forced choice latencies (Fs = < 1.17, Ps = > .33). 
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Fig. 4.3 WT vs KO % LU choices at each 
block (A), grand mean WT vs KO AUCs 
for sessions 35-39 (B), & mean  WT vs 
KO AUCs for individual sessions 35-39 
(C). 
4.3.3.2 Sessions 35-39 
 
 
 
 
 
  
 
 
As training progressed beyond session 33, a distinct genotype difference emerged. 
Whilst all mice significantly reduced the proportion of LU choices they made across 
probability blocks (F(2.24, 31.37) = 85.17, p = .001) (Fig. 4.3A) - i.e. discounted the larger 
but progressively uncertain reward option - DARPP-32 KO mice made a significantly 
smaller percentage of LU choices than WT mice (F(1, 14) = 7.74, p = .02). The probability 
by genotype interaction was not significant (F(2.24, 31.37) = 1.46, p = .25). AUCs were also 
significantly different between genotypes (t(14) = 2.58, p = .02), with KO mice producing 
significantly smaller AUCs than WT mice (Fig. 4.3B). Neither magazine omissions (t(7.53) 
= -.95, p = .37) or lever omissions were significantly different between genotypes (t(14) = 
-.73, p = .48) (Tabs 4.1 & 4.2). Although trial initiation latencies continued to slow as 
sessions progressed (F(1.79, 25.08) = 7.81, p = .001), there were no significant differences 
between genotypes in the time taken to initiate trials either as main effects or as an 
interaction between probability and genotype (Fs = < 1.26, Ps = > .28). Although choice 
latencies were similar across blocks (F(4, 56) = .51, p = .73), KO mice took significantly 
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Fig. 4.4 WT vs KO % LU choices at each 
block (A), grand mean WT vs KO AUCs 
for sessions 40-44 (B), & mean  WT vs 
KO AUCs for individual sessions 40-44 
(C). 
longer than WT mice (F(1, 14) = 6.66, p = .02) to execute their choices. The probability by 
genotype interaction was not significant (F(4, 56) = .35, p = .84). Forced choice latencies 
were similar between levers (F(1, 14) = .04, p = .86) and across probability blocks (F(2.58, 
36.10) = .81, p = .48). However, KO mice continued to record significantly slower forced 
choice latencies than WT mice (F(1, 14) = 5.13, p = .04). There was a significant lever by 
probability interaction (F (4, 56) = 6.45, p = .001). However, there were no other significant 
interaction effects relating to forced choice latencies (Fs = < 2.06, Ps = > .10).  
4.3.3.3 Sessions 40-44 
 
 
 
 
 
 
 
 
With additional sessions, mice dramatically reduced the proportion of LU choices they 
made as the probability of reinforcement decreased across blocks (F(1.71, 23.89) = 148.04, p 
= .001) (Fig. 4.4A). LU choice patterns were significantly different between genotypes 
(F(1, 14) = 12.41, p = .003) and there was also a significant probability by genotype 
interaction (F(1.71, 23.89) = 6.60, p = .007), suggesting that DARPP-32 KO mice were 
discounting the LU lever significantly more steeply than WT mice. Post hoc independent 
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t-tests revealed that KO mice recorded a significantly smaller percentage of LU choices 
during the p = 0.5 (t(14) = 3.97, p = .001), the p = 0.25 (t(14) = 4.89, p = .001) and the p = 
0.125 (t(14) = 2.96, p = .01) blocks, but not the p = 1 or p = 0.0625 blocks when correcting 
the significance value for multiple comparisons (Ps = > .04, sig = .01). These results 
suggest that DARPP-32 KO mice executed sub-optimal choices during the 0.5 probability 
block, where selecting the LU lever is the most efficient path to reinforcement but, as the 
probability of reinforcement diminished, they executed choice patterns that were better 
optimised than WT mice. The AUC analysis also showed that KO mice continued to 
discount more steeply than WT mice (t(14) = 3.37, p = .005) (Fig. 4.4B). Both magazine 
(t(14) = .001, p = .99) and (t(14) = -.88, p = .39) lever omissions were similar between 
genotypes (Tabs 4.1 & 4.2). Trial initiation latencies slowed as trials progressed (F(4, 56) 
=  9.50, p = .001) but there were no significant differences between genotypes in this 
measure, either as a main effect or an interaction between probability and genotype (Fs = 
< 2.08, Ps = > .15). In contrast, choice (F(2.36, 32.97) = .36, p = .73) latencies did not slow 
as sessions progressed. KO choice latencies, however, were significantly slower than WT 
choice latencies (F(1, 14) = 10.23, p = .006). The probability by genotype interaction for 
choice latencies was not significant (F(2.36, 32.97) = .88, p = .44). KO mice also continued 
to make significantly slower forced choices than WT mice (F(1, 14) = 10.02, p = .007). 
There was also a significant lever by probability interaction (F(2.45, 34.30) = 5.61, p = .005) 
and whilst the main effect of probability (F(4, 56) 2.37, p = .06) and the probability by 
genotype interaction approached significance (F(4, 56) = 2.40, p = .06), there were no other 
significant effects for forced choice latencies (Fs = < 1.32, Ps = > .27).  
 
 
123 
 
 
4.3.3.4 Stability analysis 
 
The between genotype difference emerged slowly and only after a significant amount 
of training had occurred. To further examine this, a stability analysis was performed to 
establish whether differences arose due to diminishing AUCs in KO mice and also to 
establish whether discounting performance was comparatively stable in WT mice. To do 
this, AUC stability was assessed within and between genotypes by comparing AUCs from 
sessions 30-34 with those from sessions 40-44 by performing a genotype (WT vs KO) by 
session (30-34 vs 40-44) two-way ANOVA. There was a significant main effect of 
session (F(1, 14) = 34.72, p = .001) and also a significant genotype by session interaction 
(F(1, 14) = 9.83, p = .007), suggesting that the AUCs of one group were changing more 
significantly between sessions than the other. Post hoc paired t-tests revealed that mean 
AUCs produced by KO animals during sessions 40-44 (Fig. 4.4B) were significantly 
smaller than their mean AUCs during sessions 30-34 (t(7) = 5.90, p = .001) (Fig. 4.2B). In 
contrast, there was only a trend toward significantly different AUCs in WT subjects 
between sessions 30-34 and 40-44 (t(7) = 2.14, p = .07) which suggests that, in comparison 
to WT mice, KO mice were developing an increasingly risk sensitive pattern of responses 
between sessions 30-34 and 40-44. Thus KO mice adjusted their LU choices in an 
experience-dependent fashion more dramatically than WT mice between these sessions.  
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4.3.3.5 Sensory specific devaluation  
 
 
 
 
Fig. 4.5 Non-devalued vs devalued % LU choices for WT & KO mice (A) and non-devalued vs devalued 
AUCs for WT & KO (B) mice.  
 
Sucrose pre-feeding had no clear effects on discounting (F(1, 14) = .27, p = .62) (Fig. 
4.5A). There were, however, significant main effects of probability (F(2.38, 33.38) = 58.54, 
p = .001) and genotype (F(1, 14) = 7.92, p = .01), with KO mice continuing to record a 
smaller proportion of LU choices than WT mice. None of the interaction terms were 
significant (Fs = < 2.46, Ps = > .06). Sucrose pre-feeding similarly did not affect AUCs 
(main effect of motivational state (F(1, 14) = .90, p = .36)); genotype by motivational state 
interaction (F(1, 14) = .23, p = .64) (Fig 4.5B). The main effect of genotype approached 
significance with KO mice tending to produce smaller AUCs than WT mice (F(1, 14) = 
4.33, p = .060). By contrast, mice made significantly more magazine omissions during 
the pre-fed session compared to the food-deprived session (F( 1, 14) = 12.66, p = .003). 
However, there were no differences between genotypes and the genotype by motivational 
state interaction was also non-significant (Fs = < .81, Ps = > .38). In contrast, lever 
omissions did not differ in any way between motivational states, genotypes or either of 
these variables in interaction (Fs = < 2.92, Ps = > .11) (Tabs 4.1 & 4.2). Trial initiation 
latencies were slower during the devalued session in comparison to the non-devalued 
session (F(1, 14) = 15.17, p = .002). Whilst there was no significant main effect of genotype 
(F(1, 14) = .07, p = .80), there was a significant motivational state by probability interaction 
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(F(4, 56) = 4.10, p = .006) and a significant motivational state by probability by genotype 
interaction (F(4, 56) = 3.28, p = .02). This latter interaction term was followed up with 
independent samples t-tests to compare performance between genotypes at each 
probability block separately for each motivational state. None of these tests were 
significant (Ps = > .20). There were no other significant effects for trial initiation latencies 
(Fs = < .94, Ps = > .45). Choice latencies were not significantly affected in any way by 
pre-feeding and nor were there any significant differences between genotypes in choice 
latencies either as main effects or interactions (Fs = < 2.53, Ps = > .13). There were no 
significant main effects of motivational state, lever or probability when inspecting forced 
choice latencies (Fs = < 2.77, Ps = > .12). There was, however, a significant main effect 
of genotype (F(1, 14) = 4.78, p = .05) with KO mice continuing to execute slower forced 
choices than WT mice. The lever by genotype interaction was also significant (F(1, 14) = 
4.46, p = .05) but the post hoc tests were not significant when controlling for multiple 
comparisons (Ps = > .04, sig = .025). Whilst there was also a significant lever by 
probability interaction (F(4, 56) = 7.78, p = .001), there were no other significant interaction 
effects (Fs = < 2.08, Ps = > .10).  
 
 
 
 
 
 
 
126 
 
 
4.3.3.6 General motivational devaluation 
 
 
 
 
 
 
 
Fig. 4.6 Non-devalued vs devalued % LU choices for WT & KO mice (A) and non-devalued vs devalued 
AUCs for WT & KO (B) mice.  
Chow pre-feeding similarly had no clear effect on % LU choices (F(1, 14) =  1.35, p = 
.27,) (Fig. 4.6A). There were, however, significant main effects of probability (F(2.20, 30.86) 
= 27.35, p = .001) and genotype (F(1, 14) = 9.72, p = .008), with KO mice continuing to 
record a smaller percentage of LU choices than WT mice. There were no other significant 
interaction effects (Fs = <. 94, Ps = > .45). Pre-feeding mice with their maintenance diet 
similarly did not affect AUCs (main effect of motivational state (F(1, 14) = 2.88, p = .11); 
genotype by motivational state interaction (F(1, 14) = .23, p = .64) (Fig. 4.6B). KO mice 
did, however, continue to produce smaller AUCs than their WT counterparts (F(1, 14) = 
7.65, p = .02). Pre-feeding mice again significantly increased the number of magazine 
(F(1, 14) = 28.47, p = .001), as well as the number of lever omissions (F(1, 14) = 5.60, p = 
.03). However, neither of these measures differed between genotypes, either as main 
effects or interactions (Fs = < 2.42 p = > .14) (Tabs 4.1 & 4.2). Magazine latencies were 
significantly slower during the devalued session (F(1, 14) = 16.73, p = .001). However, 
there were no other significant main or interaction effects (Fs = < 2.09, Ps = > .09). Choice 
latencies were not affected by pre-feeding and there were no significant differences 
between genotypes either as main or interaction effects (Fs = < 2.80, Ps = > .12). Aside 
from a significant lever by probability interaction (F(4, 56) = 3.21, p = .02), all main effects 
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and interaction terms relating to forced choice trials during the general motivational 
devaluation were not significant (Fs = < 2.72, Ps = > .12).  
4.4 Discussion 
By the completion of the experiment, mice lacking the DARPP-32 gene appeared to 
be less tolerant of uncertainty than WT mice. For example, the significant interaction 
recorded during sessions 40-44 indicated that DARPP-32 KO mice were executing sub-
optimal choices during the p = 0.5 block, selecting the LU lever on significantly fewer 
occasions than WT mice, and also selecting the LU lever on significantly fewer occasions 
than WT mice during the p = 0.25 and p = 0.125 blocks, when to do so was the more 
optimal strategy. It is interesting to note that these 3 blocks are the blocks where LU 
reinforcement is the most uncertain. The likelihood of LU reinforcement is a certainty in 
the p = 1 block, whereas the likelihood of not being reinforced following an LU choice 
in the p = 0.0625 is close to certain. Overall, DARPP-32 KO mice executed a choice 
strategy that appeared to involve selecting the LU lever significantly less than WT mice 
did during these sessions. 
Nonetheless, significant differences in baseline responding, (see figs. 4.3 & 4.4, and 
particularly figs. 4.5 & 4.6) when KO mice biased away from the LU lever even when 
the larger reward was certain, may hint at an issue with reward magnitude discrimination 
(St Onge & Floresco, 2009). Indeed, such explanations may well account for findings 
from studies examining the effects of acute drug treatment on probabilistic choices in 
previously well-discriminating subjects over comparatively few sessions. Thus, the 
effects of the drug are said to disrupt the subject’s ability to discriminate the large reward 
from the small reward. However, it is more difficult to imagine such an effect in the case 
of a constitutive genetic manipulation like the one reported here, as subjects in both the 
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experimental and control group had achieved comparable discrimination of the large 
reinforcer at baseline early in the experiment but, as the experiment progressed, 
experimental group subjects gradually began to select the LU lever less at baseline. 
Nevertheless, it is possible reinforcer magnitude discrimination might have partly 
contributed to the observations reported in this chapter. Indeed, inactivation of the NAcSh 
has been shown to minimally but significantly impair reinforcer magnitude 
discrimination (Stopper & Floresco, 2011).  
One possible explanation for the between groups discounting performance is that KO 
mice might differ from WT mice in their ability to overcome the impact of non-rewarded 
choices in previous sessions; in a sense, a reward-uncertainty carryover effect. For 
example, it is possible that KO mice might cumulatively degrade the subjective value of 
the LU reward following consistent experience with non-reward in low probability blocks 
which is registered and incorporated into the subjective value of the LU lever and 
manifests as a continuing adjustment of reward choices. Consistent with this 
interpretation, the results of the additional stability analysis indicate that there was a 
greater degree of instability in KO LU choices which diminished more consistently over 
sessions than WT LU choices.  
A similar interpretation of the role of D1 receptor activation was offered by Floresco 
and colleagues as being responsible for “keeping the eye on the prize” in the face of non-
rewarded choices to ensure that subjects maximise long-term gains when faced with 
reinforcement uncertainty by limiting the impact of negative-feedback (St Onge et al., 
2011). For instance, SCH 23390-induced antagonism of either mPFC (St Onge et al., 
2011) or accumbal (Stopper et al., 2013) D1 receptors reduces risky decisions by 
increasing the likelihood that subjects shift their subsequent choice to the SC lever after 
a non-rewarded LU choice. Taken together with the present findings then, it is possible 
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that in addition to maintaining optimal LU choices within sessions by mitigating the 
impact of non-rewarded choices, accumbal D1 receptors via DARPP-32 may also mitigate 
the impact of non-rewarded choices in previous sessions to maintain between-session 
response stability in low risk blocks in subsequent sessions by ‘returning the eye to the 
prize’.  
To some extent, these findings are consistent with our predictions and marry with those 
by Floresco and colleagues who have consistently reported that dampened DA 
transmission through D1 receptors increases probability discounting (Stopper et al., 2013; 
St Onge et al., 2011; St Onge & Floresco, 2009). They are also consistent with work in 
humans showing that an allelic variant of DARPP-32 predicted improved performance 
on a probabilistic choice task (Frank et al., 2007). Targeted nucleus accumbens injections 
of SCH 23390 have been shown to induce risk aversion (Stopper et al., 2013) and 
accumbal lesions (Cardinal & Howes, 2005) or temporary inactivation of the NAcSh also 
induced a risk-averse pattern of choices (Stopper & Floresco, 2011). On the other hand, 
Cardinal & Howes (2005) reported risk aversion following lesions of the NAcC in a 
probability discounting task. However, significant portions of the NAcSh were also 
damaged which makes interpretation of their findings difficult. A recent study showed 
that temporary inactivation of the NAcSh but not NAcC also impaired performance on a 
probabilistic reversal task indicating that NAcSh function is also critical for the flexible 
adjustment of behaviour during instrumental tasks constrained by probabilistic 
contingencies (Dalton et al., 2014). Taken together, these studies indicate that the absence 
of DARPP-32 in the NAcSh is the most plausible explanation for the differential 
performance between genotypes. Despite this proposal, however, DARPP-32 is also 
distributed in PFC regions associated with the mediation of probabilistic choices, albeit 
relatively sparsely, so one cannot exclude the possibility that the absence of DARPP-32 
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in PFC regions shown to influence probabilistic reinforcement choices, such as the OFC 
and mPFC, did not contribute to our findings.  
 In conjunction with these reports and those outlined in the introduction to this chapter, 
it was hypothesised that DA transmission, presumably in the nucleus accumbens shell, 
stimulates the D1-PKA-DARPP-32 pathway to flexibly alter behaviour during 
probabilistic tasks. The present experiment found some support for this hypothesis, 
though the results may suggest that the mechanism(s) is not straight forward. For 
example, differential discounting between WT & KO subjects was late onset, but when it 
did occur it persisted until the completion of the experiment. Cardinal & Howes (2005) 
initially reported no significant differences between lesioned and sham lesioned subjects 
in the first 3 discounting sessions post-surgery. However, lesioned subjects became 
significantly more risk averse than sham lesioned subjects between 10 & 12 sessions post-
surgery. Given that one can reasonably expect a greater and possibly more rapid effect 
on choice behaviour following the introduction of a lesion compared to a subtler 
manipulation like deletion of an intracellular signalling molecule, it is perhaps not 
surprising that it took approximately 20 sessions of training following the introduction of 
more ‘punitive’ probabilities for differences in probabilistic choices to emerge. Indeed, 
some other studies have subjected rodents to approximately 25 sessions before achieving 
stable responses (St Onge & Floresco, 2009) suggesting that rodents often require a 
significant number of sessions to assimilate the probabilistic contingencies and to 
efficiently organise their behavioural output under conditions of instrumental uncertainty.  
In addition to the significant differences in LU choices, KO mice also executed 
significantly slower choice and forced choice latencies than their WT littermates. These 
slower forced choice latencies were apparent prior to the emergence of between 
genotypes discounting. However, the emergence of significantly slower choice latencies 
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coincided with the significantly different discounting. In general, these data suggest that 
DARPP-32 deletion increases choice latencies during probability discounting. This is in 
contrast to intertemporal discounting, where no between genotype differences in either 
choice or forced choice latencies were apparent. It is unlikely that these effects can be 
accounted for by discrepancies in motivational state between genotypes because trial 
initiation latencies, and magazine and lever omissions were similar between genotypes 
throughout these sessions. 
The results from the reinforcer devaluation sessions suggested that pre-feeding with 
either sucrose or chow had no effect on the overall pattern of discounting and that these 
manipulations did not produce distinct differences between genotypes in either the 
number of omissions recorded or choice of the larger but uncertain reward option. 
However, the results from the general motivational devaluation were complicated by the 
high level of omissions during the non-devalued session of the chow pre-feeding 
devaluation. Whilst the mean number of magazine omissions during the food-deprived 
session from the sucrose devaluation were relatively low for both WT and KO subjects, 
mean omissions during the food-deprived (non-devalued) session of the chow pre-feeding 
manipulation were high for both KO and WT mice (Tabs. 4.1 & 4.2). On this basis, and 
also on the basis that prior research has shown that pre-feeding can increase probability 
discounting (St Onge & Floresco, 2009), it is difficult to completely exclude the 
possibility that between-group differences in the sensitivity to motivational shifts were 
responsible for the low baseline preference for the LU lever in KO mice during the 
general motivation devaluation. For example, because the mean number of magazine 
omissions were high during the non-devalued session, it is possible that mice were already 
in a relatively dampened state of motivation during the non-devalued session. With this 
is mind, it is difficult to exclude the possibility that motivational floor effects might have 
132 
 
 
prevented the manipulation from identifying between-group differences in the sensitivity 
to general motivational devaluation. Thus it is possible that LU choices were actually 
already devalued in the non-devalued session and, whilst pre-feeding increased magazine 
omissions, it might have been ineffective at devaluing % LU choices owing to a floor 
effect.  
Despite this interpretational difficulty concerning the chow pre-feeding devaluation, it 
is unlikely that a shift in motivational state can explain the between-group differences 
that emerged between sessions 35-39 because magazine and lever omissions were 
relatively low in both genotypes and nor were there any significant differences between 
genotypes in omissions (Tabs. 4.1 & 4.2). Moreover, magazine and lever omissions 
remained low in both KO and WT throughout most of the experiment, including the 
sucrose devaluation manipulation. Therefore, it is unlikely that any potential differences 
in the sensitivity to motivational shifts contributed to the between genotype discounting 
that emerged during sessions 35-39.  
Finally, even though task parameters were altered before the commencement of 
session 15 and, even though DARPP-32 KO mice appear to be impaired at integrating 
changes in task parameters - as reported in the previous chapter - there is reason to believe 
that changes in task parameters were not the cause of the findings in this study. In the 
previous chapter, DARPP-32 KO mice performance was different to WT animals 
following changes in the task parameters but, with experience, performance was 
comparable between genotypes. In this experiment, however, DARPP-32 KO mice 
increasingly diverged in their % LU choices from their WT littermates. This is more 
indicative of a persistent deficit in probabilistic reinforcement choices as opposed to a 
transient deficit in integrating changes in the task.  
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In summary, the findings presented in this chapter provide some evidence which 
suggests that DARPP-32 is a mediator of probabilistic reinforcement choices. Under 
ongoing conditions of reward uncertainty, it appears that DARPP-32 is involved in the 
flexible integration of probabilistic information which allows subjects to direct 
probabilistic reinforcement choices efficiently. In the absence of DARPP-32, KO subjects 
were impaired in their ability to sustain optimal reinforcement choices in high probability 
blocks but significantly better at executing optimal choices in low probability blocks. It 
is possible that DARPP-32 contributes to overcoming negative feedback in uncertain 
situations, thus allowing subjects to flexibly alter their choices in the face of changing 
reinforcement costs.  
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Chapter 5 
Progressive ratio 
5.1 Introduction  
In the previous chapters, the relationship between DARPP-32 deletion and 
intertemporal and probabilistic choices was examined. Although pre-feeding had no clear 
effects on choice patterns during both of these experiments, and on the basis that mice 
with targeted interference of the Ser97-DARPP-32 phosphorylation residue display 
impairments in progressive ratio responding (Stipanovich et al., 2008), it was deemed 
important to establish whether DARPP-32 KO mice similarly display motivational 
impairments during progressive ratio testing. It was felt that doing so would provide 
additional insight into whether any behavioural disturbances present in these mice might 
arise from motivational disturbances or from a learning deficit. Or, indeed, a combination 
of these factors. Finally, intertemporal and probabilistic choice paradigms assess 
investment costs along dimensions of time and risk respectively so, by assessing 
progressive ratio, it provided a platform to identify whether global deletion of DARPP-
32 impacted the willingness to invest effort. 
 DA has a well elucidated role in the provision of instrumental motivation. For 
example, responding on a food-reinforced FR-5 schedule, but not free-feeding, is 
associated with increases in extracellular accumbal DA in a pattern that is related to the 
magnitude of responding (Salamone, Cousins, McCullough, Carriero & Berkowitz, 
1994). Interference with accumbal DA transmission by 6-OHDA depletion significantly 
reduces responding during high but not low-effort instrumental schedules (Aberman & 
Salamone, 1999; Salamone, Wisniecki, Carlson & Correa, 2001). In addition to this, D1 
& D2 receptor antagonism reduces the breaking point of responding for food rewards in 
progressively escalating schedules of reinforcement (Aberman et al., 1998; Barbano, Le 
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Saux & Cador, 2009) and intra-NAcSh injections of amphetamine significantly enhances 
the number of active lever responses during a food reinforced PR-2 schedule (Zhang et 
al., 2003). Furthermore, the DA transporter (DAT) inhibitor MRZ-9547 was recently 
shown to significantly increase instrumental responding during both a PR task and a 
PR/chow concurrent choice task in which subjects can opt to exert effort for a highly 
palatable food reward reinforced under a progressive ratio schedule or to consume freely 
available but less valued chow (Sommer et al., 2014). Therefore, whilst DA antagonism 
or depletion reduce the motivation to expend effort during high-effort food-reinforced 
tasks, increasing DA transmission conversely increases motivation in such tasks. 
The postsynaptic effects of DA during progressive ratio responding most likely induce 
changes in the phosphorylation of DARPP-32. For example, significantly higher levels 
of Thr34-DARPP-32 labelling in NAcC MSNs were reported in the most vigorously 
responding subjects during the concurrent choice PR/chow task described briefly above 
(Randall et al., 2012). DA, however, is not the only effector of DARPP-32 that contributes 
to the allocation of effort during instrumental tasks. The adenosine and glutamate systems 
make important contributions to the allocation of instrumental motivation. For example, 
discrete injections of the adenosine A2A agonist CGS 21680 into the NAc significantly 
reduces FR-5 responding and increases chow consumption in the concurrent choice 
procedure described earlier (Font et al., 2008). Systemic administration of MSX-3, an 
adenosine A2A receptor antagonist, blocks the effort-dampening effects of haloperidol in 
a T-maze effort-based choice task (Mott et al., 2009) and A2A receptor null mice are less 
sensitive to the effects of haloperidol in the same procedure (Pardo et al., 2012). The 
mGluR5 receptor antagonist MPEP reduces the breaking point of responding in 
instrumental procedures reinforced with either cocaine, nicotine or food (Paterson & 
Markou, 2005). As discussed previously, both adenosine A2A and mGluR5 receptors 
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contribute to the phosphorylation of DARPP-32 in co-dependent fashion. Whilst 
additional work is required to directly establish whether mGluR5 & A2A receptors 
contribute to the exertion of effort by influencing the phosphorylation of DARPP-32, 
these findings do suggest that DA, adenosine and glutamate, all of which influence 
DARPP-32 phosphorylation, significantly impact the motivation to expend effort.  
Because Thr34-DARPP-32 phosphorylation increases in response to the magnitude of 
effort subjects produce and, as mentioned briefly above, because mice with targeted 
interference of the Ser97-DARPP-32 phosphorylation residue were impaired during a 
single session test of progressive ratio responding (Stipanovich et al., 2008), this 
experiment had 2 main purposes. Firstly, the previously reported disturbance in 
progressive ratio responding in Ser97-DARPP-32 mutant mice suggests that DARPP-32 
KOs might also possess motivational disturbances. Therefore, the first aim of this study 
was to establish whether DARPP-32 KO mice similarly display impairments in 
instrumental motivation. However, whilst PR schedules of reinforcement are routinely 
referred to as measures of instrumental motivation, it is important to establish the 
sensitivity of the procedure to measure motivation by directly manipulating motivational 
state (e.g. pre-feeding devaluation). As well as providing a mechanism to establish the 
sensitivity of the procedure to measure instrumental motivation, it was hoped that 
reinforcer devaluation sessions might also provide insight into whether DARPP-32 KO 
mice are more sensitive than WT mice to direct manipulations of motivational state. In 
accordance with this aim, mice were exposed to 3 reinforcer devaluation manipulations 
at various times throughout testing. The second aim of this study relates to the 
Stipanovich et al (2008) study which adopted a single session of progressive ratio testing 
but, because of this, it is not possible to interpret the precise nature of the deficits they 
reported (i.e. whether interference with DARPP-32 induces a transient, acquisitive deficit 
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or a persistent impairment in instrumental performance during tasks that directly measure 
incentive motivation). For example, mice with a non-phosphorylatable knockin Thr34-
DARRP-32 alanine residue were impaired in the acquisition of instrumental responding 
for cocaine, however, once these mice acquired stable performance, they eventually 
responded significantly more vigorously than controls (Zhang et al., 2006).  
Mice were subjected to an extended testing protocol which examined a number of 
progressive ratio schedules of reinforcement to establish whether any potential 
impairments or enhancements in food-reinforced instrumental responding varied as a 
function of the schedule (e.g. high effort vs low effort requirements). Mice were also 
provided with training on different instrumental devices associated with unique response 
components (levers and nosepokes) in separate phases of the experiment. This was done 
to establish whether responses associated with different effort requirements might 
uncover between genotype differences in PR responding. Previous research has revealed 
different breaking points of responding as a function of the effort required to produce a 
response (e.g. lever height) (Skjoldager, Pierre & Mittleman, 1993). Additionally, 
Clemens, Caillé & Cador (2010) found that nosepokes supported higher levels of FR-5 
instrumental responding than levers. Session length was also adjusted at various times 
throughout the experiment to establish whether short vs long sessions would uncover 
differences in instrumental motivation between genotypes.  
5.2 Methods 
5.2.1 Subjects  
Eight DARPP-32 KO mice aged 15 to 35 weeks (mean age = 24 weeks; mean weight 
= 28.95 g) and 8 WT counterparts aged 13 to 38 weeks (mean age = 25 weeks; mean 
weight = 27.19 g) were used for this study. Each group was composed of 5 males and 3 
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females. Genotyping was performed prior to study commencement using the procedure 
outlined in chapter 2. Subjects were at least the 6th generation of backcrossed mice bred 
at the University of Sussex from a C57BL/6J background in the way previously described. 
Mice were food restricted to 85% of their free-feeding weight for the duration of the 
experiment (except when explicitly noted). Mice were granted ad libitum access to tap 
water in their home cages and housed under the same conditions as those listed 
previously. Each mouse was handled for 5 min during 3 consecutive once a day sessions 
to reduce handling stress at the time of training and testing.  
5.2.2 Apparatus 
All testing was conducted in the conditioning chambers described in chapter 3. For the 
first phase of the experiment, ultra-sensitive levers were used as the instrumental 
manipulanda and, for the second phase of the experiment, these were replaced with 
nosepokes. 
5.2.3 Procedure  
5.2.3.1 Magazine training 
Mice were first provided with 3 sessions of magazine training which were identical to 
those listed previously except mice were given boluses of 17.7 µl of 10% sucrose.  
5.2.3.2 Phase one: PR responding for sucrose 
5.2.3.2.1 Continuous reinforcement  
Mice were trained for 4 sessions under a continuous reinforcement (FR-1) schedule to 
encourage reliable and similar responding in both genotype groups. Sessions ended after 
60 min had passed or when mice achieved 50 reinforcements. One KO mouse failed to 
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show appreciable lever responding (i.e. it failed to achieve in excess of 10 responses) and 
was omitted from the experiment. Genotypes were counterbalanced with respect to the 
position of the ‘reinforced’ active lever or nosepoke port (left vs right) for all portions of 
the experiment. 
5.2.3.2.2 Fixed ratio training 
 Mice were next provided with 7 sessions of fixed ratio-5 (FR-5) training. Sessions 
were terminated after 60 min or before if mice acquired 50 reinforcements. FR-5 training 
continued until all subjects in each group had acquired at least 20 reinforcements for 3 
consecutive sessions.  
5.2.3.2.3 Progressive ratio training 
The number of responses required to achieve reinforcement was progressively 
increased after each preceding reinforcement event throughout these sessions. Mice were 
first tested under a schedule calculated by Richardson and Roberts (1996) using the 
following formula (5e (reinforcement number * j) - 5) where j = 0.2. Response requirements for 
this schedule were as follows: 1, 2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95, 118, 145, 
178, 219, 268, 328. Mice received a total of 16 sessions of testing under this schedule. 
The first 12 sessions were terminated after 240 min or before that if mice failed to 
complete a schedule within 30 min. The final 4 sessions of testing conducted at this 
schedule were 60 min in length and had no timeout.  
In order to examine the sensitivity of the PR schedule to changes in motivation, and 
potential interactions with genotype, mice undertook a ‘general motivational’ reinforcer 
devaluation manipulation during the final 6 sessions of the j = 0.2 PR sessions. These 
reinforcer devaluation manipulations were near identical to those previously described 
with the exception that mice were granted ad libitum chow access for an extended period 
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(minimum of 16 hr). That is, for the first 3 sessions, half of the mice, counterbalanced 
with respect to genotype and active lever position, underwent PR training whilst being 
granted ad libitum access to their maintenance chow diet in their home cages, beginning 
the evening before their first devaluation session. The other half of the mice remained 
food-deprived whilst conducting PR training during these 3 sessions. After these 3 
sessions, the mice that were food-deprived were granted ad libitum home cage access to 
chow and were then exposed to 3 sessions of PR training whilst pre-fed. The other half 
of the mice that were previously fed ad libitum conducted the final 3 of these 6 sessions 
in a state of food deprivation.  A period of 5 days was allocated to return those mice 
granted ad libitum access during the first 3 sessions to a state of food deprivation before 
the final 3 sessions of the devaluation manipulation were conducted. 
After again returning mice to a state of food deprivation, a single 60 min session of 
testing was conducted with all mice food restricted under this same PR schedule and that 
included a stringent 10 min timeout (TO) period to examine whether including a relatively 
short timeout period would differentially affect responding between genotypes. A final 4 
sessions of testing under this same schedule were also 60 min in duration but contained 
no timeout period. Mice were finally given 4 sessions of testing during which the response 
requirements were doubled (PR x 2) after each reinforcement (e.g.1, 2, 4, 8, 16, etc.). 
These sessions were terminated after 240 min or when mice failed to complete a schedule 
within 30 min. The breaking point was designated as the last completed schedule for all 
schedules used in both phases of the experiment.  
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5.2.3.3 Phase two: PR responding for milk 
To establish whether using manipulanda associated with unique effort requirements 
would uncover differences between genotypes in progressive ratio performance mice 
were trained to make nosepoke responses to receive a 10% condensed milk solution.  
5.2.3.3.1 Continuous reinforcement 
 Mice were again first trained under continuous reinforcement (FR-1) for 3 sessions 
using novel instrumental manipulanda (nosepokes) and a novel reinforcer (10% 
condensed milk). These sessions were identical to FR-1 lever training sessions except 
levers were replaced with nosepokes.  
5.2.3.3.2 Fixed ratio training  
Mice were then provided with FR-5 training using the same parameters as those listed 
in the FR-5 lever training protocol.  
5.2.3.3.3 Progressive ratio training 
Mice were first tested for 6 sessions using the Richardson and Roberts (1996) schedule 
described before (i.e. j = 0.2). These sessions were 60 min long and contained no timeout 
period. Mice were then tested for 6 sessions on a variant of the abovementioned schedule; 
this schedule was also first calculated by Richardson and Roberts (1996) and used the 
following equation (5e (reinforcement number * j) - 5), where j = 0.12. This calculation generated 
the following schedule of reinforcement (1, 1, 2, 3, 4, 5, 7, 8, 10, 12, 14, 16, 19, 22, 25, 
29, 33, 38, 44, 50, 57, 65, 74, 84, 95, 108, 123, 139, 157, 178, 201, 228). Four of these 
sessions were reinforcer devaluation sessions (2 ad libitum, 2 food-deprived) which were 
implemented in the same way described previously. Sessions were 60 min long and 
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contained no timeout. Two additional sessions were conducted at this schedule which 
were 120 min long and contained a 30 min timeout. Finally, mice were tested for 8 
sessions on a shallow PR-1 schedule of reinforcement which increased the response 
requirements by 1 response after each reinforcement. PR-1 sessions were 90 min long 
and contained a 30 min TO period. The final 4 sessions were reinforcer devaluation 
manipulation sessions (i.e. 2 ad libitum, 2 food-deprived) which were implemented in the 
way previously listed.  
5.2.4 Data analysis 
In order to confirm that lever performance was equivalent between genotypes during 
the final FR-5 training session, independent t-tests were conducted to compare 
performance for each lever/nosepoke separately.  
Progressive ratio performance was compared by conducting genotype (WT vs KO) by 
session repeated measures ANOVA separately for breaking point, active responses, and 
inactive responses. Because in all instances, analyses of active lever/nosepoke responses 
and breaking point provided identical information, and because inactive lever/nosepoke 
responses did not yield any significant effects, the results of the statistical analyses of 
active and inactive lever/nosepoke responses are not presented and are graphically 
presented only.  
The effects of pre-feeding were analysed by conducting genotype (WT vs KO) by 
session (e.g. test day) by motivational state (food-deprived vs pre-fed) mixed model 
ANOVAs separately for each variable of interest.  
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5.3 Results  
5.3.1 Phase one  
5.3.1.1 Instrumental training 
Neither responses on the active or inactive lever were significantly different between 
genotypes during the final session of FR-5 lever training (active lever (t(8.42) = .85, p = 
.42); inactive lever (t(13) = .93, p = .37)).  
5.3.1.2 j = 0.2 schedule (240 min sessions 30 min TO) 
 
 
 
 
 
 
 
 
 
 
Fig. 5.1 Mean WT vs KO breaking points (A) and mean WT vs KO active & inactive lever responses (B).  
Breaking points were not significantly different across sessions or between genotypes, 
either as main effects or interactions, when mice were provided with 6 sessions of 240 
min (j = 0.2, 30 min TO) progressive ratio testing (Fs = < 1.92, Ps = > .15) (Fig. 5.1A). 
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5.3.1.3 j = 0.2 schedule (240 min sessions 30 min TO) pre-feeding manipulation 
 
 
 
 
 
 
Fig. 5.2 Collapsed mean WT vs KO breaking points during the 3 food-deprived (FD) & 3 ad libitum (AL) 
feeding sessions. 
In comparison to 3 sessions of 240 min (j = 0.2, 30 min TO) progressive ratio testing 
conducted when food-deprived, 3 days ad libitum access to maintenance chow 
significantly reduced the breaking point of responding during the corresponding sessions 
(F(1, 12) = 25.17, p = .001) (Fig. 5.2). However, breaking points did not significantly differ 
between genotypes or sessions and nor were there any significant interaction effects (Fs 
= < 2.01, Ps = > .16). 
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5.3.1.4 PR x 2 (240 min sessions 30 min TO) 
 
 
 
 
 
 
 
 
 
 
Fig. 5.3 Mean WT vs KO breaking points (A) and mean WT vs KO active & inactive lever responses (B).  
Mean breaking points recorded during 4 sessions of 240 min (PR x 2, 30 min TO) 
progressive ratio testing were not significantly different between genotypes when 
collapsing across session (F(1, 13) = .02, p = .89) (Fig. 5.3A). There was, however, a 
significant genotype by session interaction (F(3, 39) = 2.86, p = .05). Despite this significant 
interaction, post hoc independent t-tests comparing breaking points between genotypes 
for each session separately revealed no significant differences during any of these 
sessions (Ps = > .19). There was also a significant main effect of session (F(3 , 39) = 4.4, p 
= .01). However, none of the Bonferroni post hoc tests were significant (Ps = > .11).  
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5.3.1.5 j = 0.2 schedule (60 min sessions 10 min TO) 
 
 
 
 
 
 
 
 
 
 
Fig. 5.4 Mean WT vs KO breaking points (A) and mean WT vs KO active & inactive lever responses (B).  
Exposing mice to a comparatively brief 10 min timeout did not differentially alter the 
breaking point of responding between genotypes during a single 60 min (j = 0.2) session 
of progressive ratio testing (t(12) -.35, p = .74) (Fig. 5.4A).  
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5.3.1.6 j = 0.2 schedule (60 min sessions no TO) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.5 Mean WT vs KO breaking points (A) and mean WT vs KO active & inactive lever responses (B). 
Breaking points were not significantly different in any way across sessions or between 
genotypes when mice were provided with 4 sessions of 60 min (j = 0.2, no TO) 
progressive ratio testing (Fs = < 1.12, Ps = > .36) (Fig. 5.5A).  
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5.3.2 Phase 2: Nosepokes 
5.3.2.1 Instrumental training 
The mean number of active or inactive nosepoke responses were not significantly 
different between genotypes during the final stage of FR-5 training (active nosepokes 
(t(9.30) = .25, p = .81); inactive nosepokes (t(10.76) = 1.56, p = .15). 
5.3.2.2 j = 0.2 schedule (60 min sessions no TO) 
 
 
 
 
 
 
 
 
Fig. 5.6 Mean WT vs KO breaking points (A) and mean WT vs KO active & inactive nosepoke responses 
(B). 
Breaking points were not significantly different between genotypes either as a main 
effect of genotype or as an interaction between session and genotype when mice were 
provided with 6 sessions of 60 min (j = 0.2, 60 min TO) progressive ratio testing (Fs = < 
1.28, Ps = > .3) (Fig. 5.6A). There was, however, a significant main effect of session 
(F(2.97, 35.67) = 9.96, p = .001) with mice recording significantly higher breaking points 
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during session 1 than during all other sessions at these parameters (Bonferroni post hoc 
tests, Ps = < .05).  
5.3.2.3 j = 0.12 schedule (60 min sessions no TO) pre-feeding manipulation 
 
 
 
 
 
 
 
Fig. 5.7 Mean WT vs KO breaking points during the 2 food-deprived (FD) & 2 ad libitum (AL) feeding 
sessions. 
The breaking points recorded when mice were provided with 2 sessions of progressive 
ratio (j = 0.12, 60 min TO) testing in a pre-fed (ad libitum chow access) state were 
significantly lower than breaking points recorded during the corresponding 2 sessions 
conducted in a food-deprived state (F(1, 12) = 49.68, p = .001) (Fig. 5.7). There were, 
however, no significant main effects of session or genotype nor any significant interaction 
terms (Fs = < 1.71, Ps = > .22).  
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5.3.2.4 j = 0.12 (120 min sessions 30 min TO) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.8 Mean WT vs KO breaking points (A) and mean WT vs KO active & inactive nosepoke responses 
(B). 
 
Breaking points were not significantly different between genotypes during 2 sessions 
of 120 min (j = 0.12, 30 min TO) progressive ratio testing when collapsing across session 
(F(1, 12) = .57, p = .46) (Fig 5.8A). There was, however, a significant session by genotype 
interaction (F(1, 12) = 9.99, p = .01) but post hoc independent t-tests comparing breaking 
points between genotypes for each session revealed no significant differences (Ps = > 
.10). There was also a main effect of session (F(1, 12) = 7.08, p = .02) with Bonferroni post 
hoc tests revealing that breaking points were significantly higher during session 2 (p = 
.02).  
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5.3.2.5 PR-1 (90 min sessions no TO) 
 
 
 
 
 
 
 
 
 
Fig. 5.9 Mean WT vs KO breaking points (A) and mean WT vs KO active & inactive nosepoke responses 
(B). 
 
Breaking points recorded during 4 sessions of 90 min (PR-1, no TO) progressive ratio 
testing constrained by a shallow schedule were not significantly different between 
genotypes either as a main effect or as an interaction between session and genotype (Fs = 
< 1.90, Ps > .19) (Fig. 5.9A). The main effect of session was significant but the Bonferroni 
post hoc tests did not approach significance (F(3, 36) = 3.19, p = .04) (Bonferroni post hoc 
p = > .31). 
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5.3.2.6 PR-1 (90 min sessions no TO) pre-feeding manipulation 
 
 
 
 
 
 
 
Fig. 5.10 Collapsed mean WT vs KO breaking points for the 2 food-deprived (FD) & 2 ad libitum (AL) 
feeding sessions. 
Breaking points recorded when mice were in a pre-fed state (ad libitum chow access) 
during 2 sessions of 90 min (PR-1, no TO) testing were significantly lower than breaking 
points recorded during the corresponding food-deprived sessions (F(1, 12) = 129.37, p = 
.001) (Fig. 5.10). There were, however, no significant main effects of genotype and 
session and there were no significant interaction terms (Fs = < 1.20, Ps = > .29). 
5.4 Discussion 
The performance of mice without the DARPP-32 gene during a food reinforced 
progressive ratio task was indistinguishable from DARPP-32 WT mice. Both the 
breaking point of responding and active response measures were indistinguishable 
between WT and KO mice during all of the schedules that were employed. Nor were there 
any performance differences as a function of the response format (i.e. levers or 
nosepokes). These findings contrast with those reported by Stipanovich et al (2008) who 
identified significantly reduced nosepoke responding during a single session of food-
reinforced progressive ratio testing in mice with a targeted mutation to the Ser97-DARPP-
32 phosphorylation residue. At the outset, we can conclude then that global deletion of 
the DARPP-32 gene can produce differential effects to interference with selected 
phosphorylation residues of this protein. 
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As noted, DARPP-32 regulates the integration of at least 3 neurotransmitter systems 
implicated in the motivation to press for food reward reinforced under demanding 
schedules. Activation of the DA system enhances motivation to press for food (Zhang et 
al., 2003), whereas activation of the adenosine system dampens the motivation to exert 
effort to receive food reward (Font et al., 2008). Moreover, inhibition of the glutamate 
system similarly reduces the motivation to press for reward, suggesting that the glutamate 
system promotes incentive motivation (Paterson & Markou, 2005). Because DARPP-32 
moderates the integration of these transmitter systems within brain regions that facilitate 
incentive motivation, it is possible that selective interference with one phosphorylation 
residue upsets the equilibrium that exists between these neurotransmitter systems and 
promotes behavioural disturbances to a greater extent than globally deleting the entire 
DARPP-32 protein does. 
Two major aims of this experiment were to establish the sensitivity of the procedure 
to measure instrumental motivation by implementing reinforcer devaluation 
manipulations, and in doing so, to identify whether there were any between-group 
differences in the sensitivity to direct manipulations of motivational state. However, 
whilst all reinforcer devaluation manipulations were effective at significantly reducing 
the breaking point of responding, there were no significant main effects of genotype or 
any significant genotype by motivational state interactions. It is therefore unlikely that 
the lack of genotype effects were due to a relative insensitivity of the PR procedures to 
measure changes in motivation since both genotypes showed significant and equivalent 
reductions in breaking points and active responses following ad libitum chow access 
during all of the reinforcer devaluation manipulations. 
Furthermore, and perhaps more importantly, the findings from the reinforcer 
devaluation manipulations presented in this chapter, in conjunction with those presented 
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in earlier chapters, indicate that DARPP-32 KO mice do not possess significant 
impairments in instrumental motivation. These manipulations ranged from comparatively 
brief (e.g. 2 hours pre-feeding) in previous chapters, up to 3 days ab libitum access to 
maintenance chow in the current experiment. Said simply, these manipulations were 
effective at reducing motivation but not at delineating a role of DARPP-32 in motivated 
performance. 
It is also unlikely that the different observations reported here and those reported by 
Stipanovich and colleagues (2008) can be explained by the difference in the schedules 
recruited by the respective studies. Subjects were exposed to a variety of schedules in this 
study, 1 of which (PR x 2) was more demanding than the schedule employed by 
Stipanovich et al (2008) whilst others were similar in their requirements, and other 
schedules less arduous (PR-1).  
Instrumental performance was also indistinguishable between genotypes across 2 
distinct manipulanda each associated with different responses. Although it was not 
always possible to directly compare nosepoke performance of mice with lever 
performance, it was possible to compare performance across devices for some sessions at 
least. The final 4 sessions of PR lever training and the first 6 sessions of PR nosepoke 
training were conducted under identical task parameters (i.e. j = 0.2, 60 min duration, no 
timeout). Visual inspection of the figures from these sessions (Figs. 5.5B & 5.6B) shows 
that mice made markedly fewer active and inactive nosepokes than the corresponding 
lever responses which suggests that mice found nosepoking more arduous than lever 
pressing. These results contrast with a previous report which identified increased 
responding in nosepoke versus levers (Clemens et al., 2010). 
One simple explanation for the different levels of responding between levers and 
nosepokes concerns the different reinforcers that were associated with either response 
155 
 
 
device. For example, sucrose might preferentially sustain higher levels of instrumental 
responding than condensed milk. What makes this less likely is testing conducted in our 
laboratory has found that 10% condensed milk typically sustains higher levels of lever 
responding in C57BL/6J mice than 10% sucrose when these animals have been exposed 
to both the sucrose and condensed milk reinforcers during instrumental training. This 
does not account for other differences, of course, including that the custom developed 
levers in our lab have a significantly greater surface area than levers typically used in 
commercial designs.  
In summary, and in contrast to selective interference with the Ser97-DARPP-32 gene, 
deletion of the DARPP-32 gene has no significant effects on the willingness of mice to 
work for food reward. These data also suggest that the DARPP-32 KO mouse does not 
possess impaired motivation for food reward. Given that evidence in this thesis has 
identified that DARPP-32 KO mice perform differently to WT mice during food 
reinforced intertemporal and probabilistic choice tasks, these data additionally suggest 
that dampened motivation for food reward does not alternatively explain such differences. 
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Chapter 6 
Pavlovian-to-instrumental transfer 
6.1 Introduction  
Data presented in the previous chapters identified differential performance between 
DARPP-32 KO mice and their WT littermates in 2 distinguishable forms of instrumental 
choice but no such role in the motivation to work for food rewards. These 3 assays 
measured the extent to which incentive value decays as a function of time, risk and effort 
independently. The purpose of the current chapter, however, was to establish whether the 
previously identified absence of incentive salience in DARPP-32 KO mice (Crombag et 
al., 2008), as determined by general PIT, could be rescued.  
Neurobiologically, PIT is underpinned by a circuit comprising of the OFC (Ostlund & 
Balleine, 2007), the nucleus accumbens (Corbit & Balleine, 2011; Hall, Parkinson, 
Connor, Dickinson & Everitt, 2001), the amygdala (Corbit & Balleine, 2005; Hall et al., 
2001) and the VTA (Corbit et al., 2007). The anatomical subdivisions where PIT effects 
are mediated in the nucleus accumbens and the amygdala depends entirely on the precise 
experimental arrangement of conditioned cues, instrumental devices and USs/reinforcers. 
For instance, different amygdala and accumbal subregions are recruited when a solitary 
reward predictive stimulus (CS1) is superimposed over an instrumental device that 
delivered a single reward (R1) than compared to when multiple reward associated cues 
(e.g. CS1, CS2) that predict unique USs (US1, US2) are superimposed over multiple 
instrumental devices (e.g. R1, R2) that delivered these reward outcomes independently 
(O1, O2). The former of these 2 arrangements is referred to as general PIT; CS1 enhances 
R1 but this cue-potentiated effect does not require the subject to discriminate the 
reinforcer on the basis of its sensory properties. It is a purely motivation driven 
157 
 
 
phenomenon. The latter of these 2 arrangements is referred to as selective outcome PIT 
because CS1 selectively enhances responding on R1 whereas CS2 enhances responding 
on R2. Unlike the general form of PIT, this selective arrangement requires subjects to 
discriminate CSs and responses on the basis of the sensory features of the rewards that 
are encoded within the memorial representations of the stimuli and devices that predicted 
these rewards. Lesions to either the NAcC (Corbit & Balleine, 2011; Hall et al., 2001) or 
CeA (Corbit & Balleine, 2005; Hall et al., 2001) abolish the general form of PIT but leave 
the selective form intact, whereas lesions to either the NAcSh (Corbit & Balleine, 2011) 
or BLA (Corbit & Balleine, 2005) abolish the selective form of PIT but leave the general 
form of PIT intact. In contrast to the nucleus accumbens and the amygdala, reversible 
VTA inactivation does not distinguish between the selective and general forms of PIT. 
Both kinds of PIT are abolished following discrete reversible VTA inactivation with a 
baclofen/muscimol cocktail, which is consistent with a major DAergic influence over the 
attribution of this form of incentive salience (Corbit et al., 2007).  
DA and glutamate transmission converge in DARPP-32 expressing regions known to 
mediate PIT effects. Microinjections of amphetamine into the nucleus accumbens core or 
shell enhance cue-potentiated instrumental responding (Peciña, & Berridge, 2013; 
Wyvell & Berridge, 2000) whilst systemic administration of DA antagonists attenuate 
PIT (Dickinson, Smith & Mirenowicz, 2000). Direct NAcC or NAcSh injections of either 
the D1 receptor antagonist SCH 23390 or the D2 receptor antagonist raclopride abolish 
the PIT effect, although this effect is most pronounced in response to SCH 23390 (Lex & 
Hauber, 2008).  
Much of what is known about the glutamatergic influence on PIT has been derived 
from molecular studies targeting post-synaptic glutamate substrates. For instance, whilst 
global deletion of the AMPA GluR1 subunit did not disrupt general PIT (Mead & 
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Stephens, 2003), Crombag and colleagues identified a necessary role for this AMPA 
subunit in the general PIT assay by isolating the precise phosphorylation residues of the 
AMPA GluR1 receptor subunit that are required for the performance of general PIT 
(Crombag, Sutton, Takamiya, Holland, et al., 2008). Simultaneous genetic interference 
of the Ser845 and Ser831 phosphorylation residues of the AMPA GluR1 subunit, but not 
single mutations of either of these residues, abolishes the PIT effect. In the absence of the 
entire AMPA GluR1 subunit, compensatory mechanisms appear to rescue the 
instrumental enhancing effects of Pavlovian stimuli whereas interference with selected 
components of this receptor subunit critically disturbs the ability of conditioned 
associations to potentiate instrumental responding.  
Whilst simultaneous interference with the Ser831 and Ser845 GluR1 phosphorylation 
residues was required to abolish PIT, interference with components associated with only 
1 of those pathways similarly suppresses the PIT effect. For example, Ser831 GluR1 
phosphorylation is stimulated by calcium and calmodulin dependent protein kinase 
(CaMKII) and striatal interference with this protein abolishes PIT (Wiltgen, Law, 
Ostlund, Mayford & Balleine, 2007). Disturbing selected components in the Ser845 GluR1 
pathway also abolishes PIT. Crombag & collaborators (2008) have previously identified 
an absence of PIT in DARPP-32 KO mice. In light of this disturbance in DARPP-32 KO 
mice, the purpose of the present study was to establish whether acute treatment with 
methylphenidate prior to the PIT test could rescue this behaviour. Interestingly, certain 
behaviours which are disturbed in the DARPP-32 KO mouse, such as acute locomotor 
activity to cocaine and novel object recognition, have been rescued by increasing DA 
transmission with cocaine (Fienberg et al., 1998) and methylphenidate respectively 
(Heyser et al., 2013). On the basis of previous work by Crombag and colleagues, it is 
predicted that DARPP-32 KO mice will display indistinguishable instrumental 
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performance during variable interval instrumental training for a food reward, normal 
conditioned approach behaviour but crucially, will exhibit selective impairments in the 
ability of conditioned stimuli to potentiate instrumental responding when administered 
saline 20 min prior to test. It is not yet known whether the absence of PIT in DARPP-32 
KO mice reflects a disturbance in the acquisition or expression of incentive salience. 
Should the acute administration of methylphenidate prior to the PIT test rescue PIT in 
DARPP-32 KO mice, one can reasonably speculate that the impairment reflects a deficit 
in the expression of incentive salience rather than a disturbance in the acquisition of 
incentive salience. Should methylphenidate have no effect, however, it would be not be 
reasonable to suggest that this impairment reflects a disturbance in the acquisition of 
incentive salience since this effect could represent a general failure of the drug to 
influence responding.  
6.2 Methods  
6.2.1 Subjects  
Twelve DARPP-32 KO mice aged 7 to 18 weeks old, consisting of 9 males and 3 
females, (mean weight 22.3 g) and 12 WT littermates aged 6 to 20 weeks (mean weight 
27.3 g), consisting of 7 females and 5 males, were used for this study. Genotyping was 
conducted prior to study commencement using the method described earlier. Mice were 
at least the 8th generation of backcrossed mice bred from a C57BL/6J background at the 
University of Sussex in the manner previously described. Mice were granted ad libitum 
access to tap water in their home cages but were food restricted to 90% of their free-
feeding weight for the duration of the experiment. Subjects were housed in the same 
conditions as those previously reported. To reduce handling stress, each mouse was 
handled for 5 min per day on 3 consecutive occasions prior to study commencement.  
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6.2.2 Drug  
Methylphenidate hydrochloride (Sigma Aldrich, Dorset, UK) (MPH), at 2.5mg/kg or 
5 mg/kg doses was dissolved in 0.9% saline (SAL) and administered prior to PIT testing. 
SAL was administered as a control. See below for procedural details.  
6.2.3 Apparatus 
 All testing was conducted in the conditioning chambers described previously. A 
sonalert tone (4500 Hz, Med Associates, Georgia, VT, USA) approximately 8 dB above 
background and a solenoid clicker approximately 6 dB above background were both 
located on the ceiling of the sound-attenuating cabinet and these functioned as 
conditioned stimuli. Two ultra-sensitive levers were the instrumental devices for the 
instrumental training and PIT test sessions. A 10% liquid sucrose solution served as the 
reinforcer in all phases of the experiment.  
6.2.4 Procedure 
6.2.4.1 Magazine training  
Mice were provided with a single session of magazine training using the exact 
procedure described in the progressive ratio chapter. 
6.2.4.2 Pavlovian training 
Mice were provided with a total of 14 sessions of Pavlovian conditioning. For half of 
the mice, the CS+ was the sonalert tone and the CS- was the clicker and, for the remaining 
half of the mice, the CS+ was the clicker and the CS- was the tone. For the first 3 sessions, 
the CS+ and CS- were each presented on 5 occasions, with each stimulus presentation 
lasting 120 s. For all remaining sessions, both stimuli were presented on 4 occasions per 
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session. CS+ presentations were reinforced with 13.3 µl of sucrose dispensed on an RI-
30 schedule. ITI length was 180 s on average but never less than 120 s or more than 240 
s. Conditioned stimuli were counterbalanced with regards to genotype and lever position. 
Two consecutive sessions of Pavlovian training, 1 session per day, were followed by 2 
consecutive sessions of instrumental training, 1 session of training per day. This pattern 
continued for the duration of the experiment. 
6.2.4.3 Instrumental training  
For all instrumental sessions, 1 lever, counterbalanced with respect to position, 
functioned as the active lever so that presses delivered 13.3 µl of sucrose on a schedule 
dependent basis. The other lever was designated as the inactive lever and its activation 
had no programmed consequences. Mice were first given 2 60 min sessions, 1 session per 
day, of instrumental training reinforced on a continuous (FR-1) reinforcement schedule. 
All subsequent sessions were 30 min long and the schedule of reinforcement was a 
progressively increasing variable interval (VI) schedule such that the interval between 
reinforcements was extended across sessions. Mice received 2 sessions of VI-15 training, 
1 session of VI-20 training, 2 sessions of VI-30 training, 1 session of VI-45 training and 
4 sessions of VI-60 training prior to the first PIT test. 
6.2.4.4 Pavlovian-to-instrumental transfer test 
Each mouse was provided with 3 PIT tests under extinction conditions on separate 
days. Mice were given 1 session of instrumental training (VI-60) and 1 Pavlovian training 
session between each PIT test to mitigate the impact of repeated testing under extinction 
conditions. Mice were administered intraperitoneally either SAL, 2.5 mg/kg MPH or 5 
mg/kg MPH dissolved in SAL 20 min before each test. This time was selected on the 
basis of previous findings describing the time course of MPH (Gerasimov et al., 2000), 
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as suggested by Heyser et al (2013), and on the basis that MPH rescued novel object 
recognition in DARPP-32 KO mice (Heyser et al., 2013) when administered at this time 
point. Drug was administered according to a Latin square design. PIT test sessions began 
with the illumination of the houselight and the presentation of both levers. The first 2 min 
of each test were designated as an extinction period during which responses were 
recorded but were not included in the statistical analysis. After this extinction period came 
a 120 s ITI period. This period was followed by the presentation of the first conditioned 
stimulus which was presented for 120 s. The selection of the first stimulus (tone vs click) 
occurred pseudorandomly but all subsequent stimulus presentations occurred on an 
alternating stimulus basis (e.g. tone ITI click or click ITI tone). The number of lever 
responses that occurred during the presentation of the CS+, the CS- and the ITI periods 
were recorded to establish the effects of conditioned reward associations on instrumental 
responding. Magazine entries and time spent in the magazine during each period (ITI, 
CS+ & CS-) were also recorded.  
6.2.5 Data analysis 
Instrumental performance during training was compared between genotypes by 
conducting a genotype (WT vs KO) by session (14 levels) repeated measures ANOVA 
of lever response rates for each lever separately.  
Pavlovian training performance was compared between genotypes by conducting a 
genotype (WT vs KO) by session (14 levels) repeated measures ANOVA of a magazine 
entry discrimination index (i.e. % of the total magazine entries that were attributable to 
the CS+ period).  The magazine entry discrimination index was calculated by dividing 
the number of entries which occurred during the CS+ period by the total number of 
entries. This was then multiplied by 100 to provide the percentage of the total number of 
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magazine entries which occurred during the CS+ period (i.e. CS+ entries/(CS+ entries + 
CS- entries + ITI entries)*100). 
Pavlovian training performance was similarly compared between genotypes by 
conducting a genotype (WT vs KO) by session (14 levels) repeated measures ANOVA 
of a magazine time discrimination index (i.e. % of the total magazine time that was 
attributable to the CS+ period).  This discrimination index was calculated in the same 
way as described above, except magazine time was used in all components of the equation 
rather than magazine entries. 
Performance during each PIT test was compared by calculating change scores for each 
lever in response to each stimulus presentation (i.e. responses during stimulus period - 
responses during ITI period) and then by comparing these change scores between 
genotypes by conducting genotype (WT vs KO) by stimulus (CS+ vs CS-) by dose (SAL 
vs 2.5 mg/kg MPH vs 5 mg/kg MPH) mixed model ANOVAs for each lever separately. 
Magazine entries during the PIT tests were compared between genotypes by 
conducting a genotype (WT vs KO) by stimulus (CS+ vs CS-) by dose (SAL vs 2.5 mg/kg 
vs 5 mg/kg) mixed model ANOVA.  
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6.3 Results 
6.3.1 Instrumental training 
 
 
 
 
 
 
Fig. 6.1 Active vs inactive lever response rates for WT vs KO mice during training. 
Active lever responses were significantly different across sessions (F(4.69, 103.12) = 
29.28, p = .001) but there were no significant differences between genotypes and no 
significant interaction between genotype and session (Fs = < 1.98, Ps = > .17) (Fig. 6.1). 
Inactive lever responses did not differ significantly across sessions or between genotypes 
(Fs = < 1.94, Ps = > .08) (Fig 6.1). Thus, deletion of DARPP-32 does not impact the 
ability of mice to acquire robust instrumental responding under increasingly sparse 
variable interval schedules of reinforcement.  
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6.3.2 Pavlovian training 
 
  
 
 
 
 
 
 
Fig. 6.2 % total magazine entries occurring during the CS+ for each Pavlovian training session.  
% entries during CS+: there was a significant main effect of session with mice making 
a greater proportion of entries during the CS+ as training progressed (F(13, 286) = 12.62, p 
= .001) (Fig. 6.2). There was unexpectedly a significant main effect of genotype with WT 
mice making a significantly greater proportion of total entries during the CS+ than KO 
mice (F(1, 22) = 4.81, p = .04). There was also a significant session by genotype interaction 
(F(13, 286) = 2.50, p = .003) which was followed up with independent t-tests to compare 
Pavlovian performance between genotypes for each session. These tests revealed that WT 
mice made a significantly greater proportion of entries during the CS+ than KO mice 
during sessions 7 (t(22) = 3.24, p = .004) and 8 (t(22) = 3.25, p = .004) but not during session 
9 (p = .03) and session 12 (p = .06) when adjusting the significance value for multiple 
comparisons. The significance value was constrained to p =.013 by dividing the ordinary 
p = .05 significance value by only those sessions reasonably expected to uncover a 
difference (i.e. 4 sessions (7, 8, 9 & 12)), rather than all 14 training sessions, to control 
for type 2 error. In addition to this, Pavlovian performance was compared across the final 
3 sessions of training by conducting a genotype by session repeated measures ANOVA. 
Whilst this test revealed a significant main effect of session (F(2, 44) = 14.06, p = .001), 
there was no significant main effect of genotype (F(1, 22) = 3.12, p = .09) and no significant 
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genotype by session interaction (F(2, 44) = .81, p = 45). Therefore, whilst there were 2 
sessions during which Pavlovian performance was different between genotypes, this 
difference was a transient occurrence and, crucially, there were no significant differences 
between genotypes in the sessions immediately prior to the PIT tests.  
% magazine time during CS+: The percentage of total time spent in the magazine that 
occurred during CS+ presentations increased as training progressed (F(13, 286) = 26.16, p = 
.001). However, whilst there was no significant main effect of genotype (F(1, 22) = .73, p 
= .40), there was a significant session by genotype interaction (F(13, 286) = 2.04, p = .02). 
Despite this significant interaction, none of the post hoc independent t-tests comparing 
this measure of Pavlovian performance between genotypes separately for each session 
were significant (Ps = > .07) suggesting that deletion of DARPP-32 had no impact on this 
measure of associative learning.  
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6.3.3 Pavlovian-to-instrumental transfer test  
6.3.3.1 Active lever change scores 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.3 Active lever CS+ vs CS- change scores during SAL (A), 2.5 mg/kg MPH (B) & 5 mg/kg MPH (C) 
PIT tests. 
CS+ presentations increased active lever responding significantly more than CS- 
presentations did (F(1, 22) = 7.47, p = .01) (Figs. 6.3A, 6.3B & 6.3C). There was also a 
significant main effect of genotype with WT mice producing significantly higher change 
scores than KO mice (F(1, 22) = 5.46, p = .03). However, the stimulus by genotype 
interaction was not significant (stimulus by genotype interaction (F(1, 22) = .49, p = .49). 
MPH produced no significant main effects nor any significant interactions (Fs = < 1.37, 
Ps = > .27). This was an unexpected result because it implies that both genotypes are able 
to perform PIT. However, inspection of figure 6.3A clearly shows that KO mice showed 
no PIT effect during the SAL condition and there was no real evidence of a PIT effect in 
the 2.5 mg/kg (Fig. 6.3B) or 5 mg/kg (Fig. 6.3C) conditions whereas WT mice showed a 
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clear PIT effect during the SAL condition (Fig. 6.3A), a less robust effect during the 5 
mg/kg condition (Fig. 6.3C) but no real effect during the 2.5 mg/kg condition (Fig. 6.3B).  
This was explored further by conducting a stimulus by dose repeated measures 
ANOVA separately for each genotype. These results revealed a significant main effect of 
stimulus for WT mice (F(1, 11) = 4.92, p = .05) with CS+ presentations elevating active 
lever responses significantly higher than CS- presentations. There was no such main 
effect of stimulus in KO mice (F(1, 11) = 2.58, p = .14) which suggests that WT but not KO 
mice were sensitive to the incentive salience properties of conditioned stimuli. No effects 
of MPH were uncovered in either WT or KO mice (Fs = < 2.41, Ps = > .11).  
6.3.3.2 Inactive lever change scores 
 There was a significant main effect of stimulus with CS- presentations increasing 
inactive lever responses more than CS+ presentations (F(1, 22) = 13.77, p = .001). There 
were, however, no other significant effects of conditioned stimulus presentation on 
inactive lever responding (Fs = < 1.33, Ps = > .27).  
6.3.3.3 Magazine entries 
 
 
 
 
 
 
 
Fig. 6.4 WT vs KO magazine entries during CS+ & CS- periods for all PIT tests. 
Mice made significantly more magazine entries during CS+ presentations than CS- 
presentations (F(1, 22) = 46.34, p = .001) (Fig. 6.4) but there were no significant main 
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effects of genotype or dose (Fs = < 1.59, Ps = > .22). There was a significant stimulus by 
dose by genotype interaction (F(2, 44) = 4.79, p = .01) and a significant stimulus by dose 
interaction (F(2, 44) = 3.12, p = .05). The stimulus by dose by genotype interaction was 
followed up with separate genotype by dose two-way ANOVAs to inspect the effects of 
dose on CS entries for each stimulus separately but neither of these tests produced 
significant main effects or interactions (CS+ genotype by dose ANOVA (Fs = < 1.49, Ps 
= > .24); CS- genotype by dose ANOVA (Fs = < 1.78, Ps = > .18)). Because the main 
effect of dose was not significant for either of these post hoc tests, the stimulus by dose 
interaction was not explored any further. No other significant interaction effects were 
found for magazine entries (Fs = < .43, Ps = > .53). 
 
6.4 Discussion 
There was a modest PIT effect and a significant main effect of genotype which was 
unfortunately smaller than anticipated. Whilst the results from the main statistical 
analysis suggested there was no difference between genotypes in the magnitude of change 
in instrumental responding between the CS+ and CS-, further statistical exploration by 
looking at test performance separately in each genotype established PIT effects in WT 
but not KO mice. Thus, in conjunction with the significant main effect of genotype, it 
appears that KO mice were impaired in incentive salience attribution which rendered 
them insensitive to the instrumental enhancing effects of reward-paired Pavlovian stimuli. 
These results are broadly in keeping with both one’s predictions and previous 
observations recorded by Crombag and coworkers who identified an absence of PIT in 
DARPP-32 KO mice (2008). These results are perhaps also commensurate with results 
obtained using mice with a double mutation to the Ser831 and Ser845 residues of the AMPA 
GluR1 subunit which display a complete absence of PIT (Crombag, Sutton, Takamiya, 
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Holland, et al., 2008). However, although DARPP-32 KO mice were reported to have 
attenuated phosphorylation of both of these residues, the profile by which this occurred 
suggested that the influence of DARPP-32 to affect the Ser831 AMPA GluR1 residue 
occurs in a regionally selective way. For example, Ser845 GluR1 phosphorylation is 
affected by loss of DARPP-32 in a fairly universal way throughout DARPP-32 expressing 
regions. However, attenuated Ser831 GluR1 phosphorylation has been observed in the 
hippocampus but not striatum or PFC of DARPP-32 KO mice (Svenningsson, Tzavara, 
Witkin, et al., 2002). It is therefore unknown as to whether the loss of function in DARPP-
32 KO mice results from a combined disturbance in the Ser831 and Ser845 AMPA GluR1 
phosphorylation residues or from a loss of signalling selectively through the Ser845 GluR1 
pathway. Furthermore, it is possible that diminished function in other DARPP-32 targets 
(e.g. NMDA receptors, Ca2+ channels etc) may have contributed to the failure of 
Pavlovian stimuli to potentiate instrumental responses. Nevertheless, given the widely 
established relationship between the AMPA GluR1 subunit and the attribution of 
incentive salience, as well as its tightly bound relationship with DARPP-32, it is most 
likely that deletion of DARPP-32 promoted disturbances in AMPA GluR1 signalling 
resulting in the failure of Pavlovian cues to enhance instrumental responding.  
Given that methylphenidate was ineffective at all doses, it remains unclear as to 
whether the deficit represents a failure in DARPP-32 KO mice to acquire the entire 
spectrum of conditioned incentive motivational features that occur during Pavlovian 
training or whether it is a failure of the expression of incentive salience. Previous work 
had suggested that increased DA transmission can rescue behavioural deficits in DARPP-
32 KO mice (Fienberg et al., 1998; Heyser et al., 2013). However, there was no 
compelling statistical evidence that the drug restored PIT in DARPP-32 KO mice or that 
it had any effect in potentiating responding in WT mice. There are few published studies 
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involving the use of methylphenidate to enhance incentive motivation in the mouse. 
Whilst Methylphenidate was ineffective at enhancing CRf in C57BL/6J mice along a 
dose-range (2.5 mg/kg, 3.5 mg/kg & 5 mg/kg) similar to the range used in this study, the 
3.5 mg/kg dose, but not the 2.5 mg/kg or 5 mg/kg doses, enhanced CRf in CD-1 mice. 
This raises the possibility that psychostimulant drugs exert differential effects on the 
incentive motivational properties of conditioned stimuli as a function of the background 
strain of the mouse but it also suggests that the response enhancing effects of 
methylphenidate might exist within a fairly narrow dose range.  In addition to the 
possibility that strain differences or dosing parameters might have influenced the ability 
of methylphenidate to elevate incentive salience in the PIT assay, it is important to 
consider the nature of the injection protocol, as well as the possibility that 
methylphenidate might have induced other behaviours such as stereotypy or 
hyperlocomotion, which might have disrupted methylphenidate’s effects on incentive 
salience. With regards to the timing of the injections, Heyeser et al (2013) injected 
DARPP-32 KO mice 20 min prior to a test of novel object recognition on the basis that 
methylphenidate’s effects have been shown to be highest in rodents 20 min post IP 
injection, with drug effects persisting for a total of 80 min (Gerasimov et al., 2000). 
Heyser et al (2013) successfully rescued novel object recognition in the DARPP-32 KO 
mouse using this protocol. Therefore, it seems unlikely that the drug was ineffective 
because it was injected 20 min pre-test. Nor does it seem likely that repeated testing might 
have diminished the efficacy of methylphenidate. Browne and colleagues (2014) 
repeatedly tested their subjects using multiple doses of methylphenidate and found dose-
dependent CRf responding in CD-1 mice. However, given that methylphenidate has been 
shown to induce its maximal response 20 min post-injection, it raises the possibility that 
subjects were in their maximal state of hyperlocomotion or stereotypy at the 
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commencement of the test. This might have had the unintended consequence of disrupting 
the attribution of incentive salience. Unfortunately, no measures of locomotor activity or 
stereotypy were recorded in the chambers during test.  On this basis, the presence of 
competing behaviours cannot be wholly discounted as an alternative explanation for the 
failure of methylphenidate to potentiate responding during PIT. Nonetheless, Browne and 
coworkers (2014) reported higher levels of locomotor activity in the CD-1 group than in 
the C57BL/6J group to doses of methylphenidate during their CRf study that were similar 
to the doses administered in this study. If competing behaviours such as methylphenidate-
induced locomotor activity are a potential cause of disrupted incentive salience attribution 
one might expect, then, that a group of mice undergoing higher levels of locomotor 
activity would experience diminished not elevated CRf, yet this was not the case in the 
Browne study. Lastly, there are no existing studies – to the author’s knowledge – which 
have shown that methylphenidate is effective at enhancing PIT in rodents. Further 
research is therefore required in order to establish whether this psychostimulant is 
effective at enhancing PIT in rodents. 
One other important consideration that warrants discussion concerns the nature of the 
PIT arrangement employed in this study. General PIT is neurobiologically underpinned 
by the NAcC and the CeA and, as previously suggested, there is a dissociation in the 
expression of DARPP-32 within subcompartments of the amygdala (see chapter 2). That 
is, DARPP-32 is present in the CeA but not the BLA of the mouse amygdala. Thus, one 
might reasonably expect that the loss of DARPP-32 within the mouse amygdala is a 
contributing factor to the failure of Pavlovian cues to potentiate instrumental responding 
in DARPP-32 KO mice. It has been suggested that the CeA might interact indirectly with 
the NAc, most likely via the medial thalamus, to augment instrumental responding during 
the presentation of reward associated stimuli (El-Amamy & Holland, 2007; Holland & 
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Gallagher, 2003). Further work is needed, however, to establish whether the expression 
of DARPP-32 in the CeA mediates the Pavlovian enhancement of instrumental 
responding. To test this proposal, it would be beneficial to interfere with DARPP-32 
expression in a regionally selective way either with antisense oligonucleotide probes or 
by viral mediated knockdown. Given the reported anatomical dissociation of amygdala 
subcompartments in the production of the general and reinforcer selective varieties of 
PIT, it would be additionally beneficial to identify whether DARPP-32 KO mice are able 
to produce reinforcer selective but not general PIT. One notes, however, the difficulties 
in isolating selective PIT in the mouse. To the best of the author’s knowledge, there is 1 
published report of selective PIT in the mouse (Wiltgen et al., 2007).  
Finally, although there was a significant main effect of genotype during Pavlovian 
training when using % CS+ entries as a measure of performance, this difference 
predominantly reflected brief genotype differences in specific sessions of training. 
Importantly, there were no significant differences during Pavlovian training sessions prior 
to the PIT tests. Thus, Pavlovian performance was comparable between genotypes prior 
to testing and there were no differences in Pavlovian performance between genotypes 
using any of the other measures. Furthermore, previous studies examining conditioned 
behaviours (e.g. CRf and PIT) in DARPP-32 KO mice have not reported any disturbances 
in conditioned approach (Crombag et al., 2008). Therefore, it is unlikely that the failure 
of DARPP-32 KO mice to display a PIT effect arose from a deficit in the acquisition of 
conditioned approach. Nor do DARPP-32 KO mice possess deficits in instrumental 
responding as assessed by progressive ratio or interval schedules of reinforcement. 
Clearly, data regarding the acquisition of conditioned associations are not altogether 
instructive about the attribution of incentive salience.  
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In summary, DARPP-32 KO mice are impaired in the ability of reward-paired 
Pavlovian stimuli to enhance instrumental responding in the general PIT arrangement. 
These findings add to previous studies identifying a link between DARPP-32 and the 
attribution of incentive salience.  
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Chapter 7 
Amphetamine psychomotor sensitisation 
7.1 Introduction 
So far, we have examined the effects of DARPP-32 deletion on intertemporal and 
probabilistic choice patterns, as well as its effects on PIT, and the motivation to respond 
for food during a progressive ratio task. In this chapter, we will directly examine the role 
of DARPP-32 deletion in the acquisition and expression of d-amphetamine psychomotor 
sensitisation. Prior work has established a role for DARPP-32 in the acquisition of 
cocaine psychomotor sensitisation (Hiroi et al., 1999; Valjent et al., 2005; Zachariou et 
al., 2006) and reports citing unpublished data have also suggested that DARPP-32 KO 
mice display locomotor impairments to an acute dose of amphetamine (as cited in 
Fienberg et al., 1998). In addition to this behavioural evidence, DARPP-32 mutant mice 
display abnormalities in amphetamine induced gene expression (Fienberg et al., 1998). 
However, there are no published reports assessing the role of DARPP-32 deletion in the 
acquisition and/or expression of amphetamine psychomotor sensitisation.  
Psychomotor sensitisation is underpinned by the coincident activity of midbrain DA 
and cortical glutamate projections converging on striatal MSNs. For instance, intra-VTA, 
intra-striatal injections or systemic blockade of either the DA or glutamate systems is 
sufficient to attenuate or abolish cocaine- or amphetamine-induced psychomotor 
sensitisation (Vanderschuren & Kalivas, 2000). DAergic projections from the VTA to the 
NAc undergo a series of changes in response to repeated psychostimulant administration. 
For instance, repeated psychostimulant treatment enhances/sensitises psychostimulant 
induced extracellular DA in the ventral striatum (Kalivas & Duffy, 1993). Glutamatergic 
projections to the VTA and NAc undergo similar drug induced adaptations following 
repeated psychostimulant treatment. In similar fashion to drug-induced changes in 
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extracellular DA, repeated cocaine treatment sensitises NAc glutamate release (Reid & 
Berger, 1996). Furthermore, systemic or intra-VTA microinjections of NMDA receptor 
antagonists block the acquisition of cocaine and amphetamine induced psychomotor 
sensitisation (Kalivas & Alesdatter, 1993; Vezina & Queen, 2000).  
To recapitulate the importance of co-incident DAergic and glutamatergic signalling as 
effectors of DARPP-32, striatal DA and glutamate transmission is directed towards the 
post-synaptic regulation of gene expression and plasticity in MSNs. Post-synaptic DA 
and glutamate activity influence distinct molecular tracts that eventually undergo 
considerable convergence at DARPP-32. As previously mentioned, DARPP-32 mediates 
some key electrophysiological characteristics of MSNs such as LTD and LTP (Calabresi 
et al., 2000), AMPA (Yan et al., 1999) and NMDA channel currents (Flores-Hernandez 
et al., 2002) and phosphorylation of AMPA GluR1 (Snyder et al., 2000) and NMDA NR1 
(Snyder et al., 1998) glutamate receptor subunits. These 2 glutamate receptor subunits are 
important aspects of psychostimulant sensitisation (Beutler et al., 2011; Boudreau & 
Wolf, 2005). Acute and chronic drug treatment stimulate dynamic changes in the 
phosphorylation of DARPP-32 and its downstream targets. The phosphorylation of 
DARPP-32 is bi-directionally affected by dose chronicity; acute psychostimulant 
treatment induces a concomitant increase in Thr34 phosphorylation and a decrease in Thr75 
phosphorylation whereas this pattern is reversed following repeated treatment (Bibb et 
al., 2001; Nishi et al., 2000). Repeated cocaine-stimulated increases in Thr75-DARPP-32 
phosphorylation are mediated by activity at the mGluR5 receptor (Scheggi et al., 2007). 
Co-administration of the mGluR5 antagonist MPEP with cocaine reduces stereotypy in 
cocaine sensitised animals and restores the DARPP-32 profile (e.g. PP-1 inhibitory form) 
to that observed in previously cocaine naïve animals to a challenge dose of cocaine. 
Furthermore, psychostimulant-induced phosphorylation of the AMPA GluR1 and NMDA 
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NR1 subunits is absent in rats repeatedly treated with cocaine and this effect is similarly 
restored following MPEP pretreatment (Scheggi et al., 2007). In addition to these 
molecular effects, DARPP-32 KO mice (Hiroi et al., 1999) or Thr34-alanine knockin 
mutant mice (Zachariou et al., 2006) display exaggerated cocaine sensitisation to an 
extended injection protocol, whilst cocaine sensitisation is blocked in Thr75-alanine 
knockin mutant mice (Zachariou et al., 2006), and two-injection protocol cocaine 
sensitisation is blocked in Thr34-DARPP-32 mutant mice (Valjent et al., 2005).  
In comparison to the breadth of literature describing the relationship between cocaine 
administration and DARPP-32, little is known about the corresponding relationship 
between amphetamine administration and DARPP-32, particularly the role of DARPP-
32 in facilitating amphetamine sensitisation. Amphetamine-evoked GABA efflux is 
attenuated in synaptosomes and striatal slices derived from DARPP-32 KO mice 
(Fienberg et al., 1998). Acute amphetamine-induced striatal c-fos expression is also 
severely affected by DARPP-32 deletion (Fienberg et al., 1998) and it has also been 
reported that DARPP-32 KO mice are impaired to the acute locomotor activating effects 
of amphetamine (as cited in Fienberg et al., 1998). Like cocaine, acute amphetamine 
administration increases Thr34-DARPP-32 and decreases Thr75-DARPP-32 
phosphorylation, and also promotes increases in Ser845-GluR1 phosphorylation 
(Svenningsson et al, 2003; Valjent et al., 2005). It was recently shown that selective 
blockade of CK1 prevents the acute locomotor activating effects of acute intra-accumbal 
amphetamine and associated increases in Thr34-DARPP-32 and Ser845-GluR1 
phosphorylation (Li et al., 2011). The reader is reminded that CK1 phosphorylates Ser130-
DARPP-32 which opposes the dephosphorylation of Thr34-DARPP-32 by PP-2B. 
Selective interference with Ser845-GluR1 subunit phosphorylation similarly blocks the 
locomotor activating effects of accumbal amphetamine (Li et al., 2011). However, as 
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suggested, there are no known data to have established the role of DARPP-32 deletion in 
the acquisition of amphetamine sensitisation. The purpose of the present study was to 
address this lacuna.  
7.2 Methods 
7.2.1 Subjects 
Eighteen DARPP-32 KO mice (15 males), aged between 8 and 47 weeks old, (9 mice 
were aged > 30 weeks) and 16 WT littermates (14 males), aged between 8 and 47 weeks 
old, (8 mice aged > 30 weeks) were used as subjects for this study. As before, animals 
were genotyped using the protocol described in chapter 2. All animals used in this study 
were at least the 4th generation of backcrossed mice bred from a C57BL/6J background 
in the manner previously reported. Mice were given ad libitum access to food and tap 
water in their home cages and were singly housed in a temperature (21°C +/-1.5°C) and 
humidity (50% +/-10%) controlled environment, with lights maintained on a 12 hr 
dark/light cycle (lights on 7am).  
7.2.2 Apparatus  
Locomotor testing was conducted in 9 identical circular runways constructed from 
polypropylene (H = 25.5cm, D = 24.5cm). Locomotor cylinders were placed atop a semi-
transparent plexiglas table and behavioural data were recorded via a camera located 
directly underneath the plexiglas table (Mead, Vasilaki, Spyraki, Duka & Stephens, 
1999). Locomotor data were quantified from video recordings using Matlab (Version 15, 
The MathWorks Inc., Natick, Mass, USA) and computed as the total distance travelled 
(m) during each session.  
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7.2.3 Drug  
All substances were administered IP at a volume of 5ml/kg. d-amphetamine 
hydrochloride (AMPH) (Sigma Aldrich, Dorset, United Kingdom) was dissolved in 0.9% 
SAL.  
7.2.4 Procedure 
 At the start of the experiment, equal proportions of each genotype were 
pseudorandomly designated to either SAL (control) or AMPH pretreatment group. 
Animals first underwent 2 60 min sessions on separate days, during which all received a 
SAL injection in the locomotor cylinders, to habituate them to the treatment protocol. All 
subsequent sessions commenced with 30 min habituation during which subjects were 
placed into the locomotor cylinders and no drug was administered. Animals received their 
designated treatment immediately afterwards and were then returned to their locomotor 
cylinder for a further 60 min, during which their locomotor activity was recorded. Mice 
were returned to their colony room immediately after each daily session. For session 1, 
AMPH pretreatment subjects received 1.0mg/kg. However, owing to a relatively poor 
locomotor response to this dose of AMPH, the dose for all subsequent training sessions 
was increased to 2.0 mg/kg. Mice next received a total of 10 daily injections of SAL or 
2.0 mg/kg AMPH before undergoing a within-session dose-response test following a 7 
day washout period. During this test, all subjects first received 30 min habituation as 
before. Immediately after the 30 min habituation period, all animals received SAL 
injections and were returned to the locomotor apparatus for 60 min. Animals were then 
treated with escalating doses of AMPH (0.5mg/kg, 1.0 mg/kg and 2.0 mg.kg) 
administered at approximately 65 min intervals.  
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7.2.5 Data analysis 
 Habituation data were subjected to a mixed genotype (WT vs KO) by session (first 
habituation session vs final habituation session) by pretreatment (SAL vs AMPH) 
ANOVA. Habituation data from the dose-effect test were analysed separately with a 
genotype (WT vs KO) by pretreatment (SAL vs AMPH) repeated measures ANOVA. 
 Only data from training sessions using the 2mg/kg dose (i.e. sessions 2 to 11) were 
analysed. Any reference to sensitisation refers explicitly to the sensitisation of locomotor 
responding to the adjusted 2.0 mg/kg dose.  
The acquisition of psychomotor sensitisation was analysed by conducting a genotype 
(WT vs KO) by session (second vs last) by pretreatment (SAL vs AMPH) mixed factorial 
ANOVA on data representing the total distance covered during these training sessions.  
The acquisition of AMPH sensitisation was also compared between groups by 
calculating regression slope values derived by fitting a line to values representing the total 
distance covered during each session of training for each mouse. Higher slope values 
indicate a more rapid and pronounced acquisition of sensitisation. These values were then 
subjected to a two-way genotype (WT vs KO) by pretreatment (SAL vs AMPH) two-way 
ANOVA. 
The expression of AMPH sensitisation in WT and DARPP-32 KO mice was assessed 
by comparing the distance travelled during each treatment administered in the dose-effect 
test. To this end, a mixed genotype (WT vs KO) by pretreatment (SAL vs AMPH) by 
dose (SAL vs 0.5 mg/kg vs 1 mg/kg vs 2mg/kg) ANOVA was conducted.  
Because of the broad age range of subjects used in this study, mice were allocated to 
1 of 2 groups based on their age and additional analyses were conducted (data not 
included) to inspect the impact of using a population of mixed age mice on the acquisition 
and expression of AMPH sensitisation as a function of genotype and pretreatment. 
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Animals aged < 30 weeks were designated as normal aged adults whereas animals aged > 
30 weeks were designated as elderly. No significant age effects were uncovered.  
7.3 Results 
7.3.1 Habituation 
 
Fig. 7.1 Distance travelled (m) during habituation for each treatment group.  
Mice increasingly habituated to the test apparatus as training progressed (F(1, 30) = 
48.40, p = .001). Although both AMPH and SAL pretreated mice habituated to the test 
apparatus, AMPH pretreated animals travelled significantly further than SAL pretreated 
animals during the final habituation session suggesting the development of conditioned 
locomotion in AMPH pretreated mice (session by pretreatment interaction (F(1, 30) = 7.90, 
p = .01); post hoc independent t-test comparing distance travelled during the final 
habituation session between AMPH and SAL pretreatment groups (t(32) = -2.85, p =.01). 
However, there were no significant main effects of genotype or pretreatment and no 
significant interactions involving genotype, pretreatment and/or session (Fs = < 2.72, Ps 
= > .11) (Fig. 7.1).  
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7.3.2 Acquisition of amphetamine sensitisation 
 
Fig. 7.2 Distance travelled (m) during each training session. 
As expected, AMPH but not SAL pretreatment robustly induced psychomotor 
sensitisation (main effect of pretreatment (F(1, 30) = 85.61, p = .001); session by treatment 
interaction (F(1,30) = 53.79, p = .001)); post hoc paired t-tests comparing total distance 
covered in session 2 with session 11 in AMPH pretreated (t(16) = -7.45, p = .001) and SAL 
(t (16) = .28, p = .78) pretreated mice (Fig. 7.2). There were, however, no other significant 
main or interaction effects (Fs = < .82, Ps = > .37). These results therefore suggest that 
deletion of DARPP-32 has no significant impact on the acquisition of amphetamine 
sensitisation at the doses used in this study.  
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7.3.3 Amphetamine sensitisation acquisition slope values 
 
Fig. 7.3 Slope values of AMPH and saline pretreated WT and KO mice.  
In light of the non-significant difference between AMPH pretreated WT and KO 
animals in the total distance travelled during session 11, potential group differences 
concerning the rate at which animals acquired psychomotor sensitisation were assessed 
by analysing the regression slope scores of each animal during the acquisition phase of 
this experiment. Slopes were subjected to logarithmic transformation and statistical 
analysis was conducted on these transformed values. All reported descriptive statistics 
represent the non-transformed values. The results from the slope analysis were consistent 
with those from the analysis of raw distance travelled. AMPH pretreated mice developed 
robust sensitisation (F(1, 30) = 160.10, p = .001). There was no significant difference 
between genotypes in slope values, and no significant difference between AMPH 
pretreated KO mice and AMPH pretreated WT mice (Fs = < 3.32, p = > .08) (Fig. 7.3). 
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7.3.4 Dose-effect test habituation  
 
Fig. 7.4 Distance travelled during dose-effect test habituation.  
AMPH pretreatment group mice travelled significantly further than SAL pretreatment 
group mice during the habituation phase prior to the dose-effect test indicating the 
presence of conditioned locomotion in these mice (F(1, 30) = 10.11, p = .003) (Fig. 7.4). 
However, DARPP-32 deletion had no significant effects in either SAL or AMPH 
pretreated mice on distance travelled during this phase of the experiment (Fs = < .69, Ps 
= > .41). 
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7.3.5 Dose-effect test following 7 day wash-out period 
 
Fig. 7.5 Distance travelled (m) to each treatment during dose-effect test 
Results from the dose-effect test were consistent with results from the acquisition 
phase. A significant main effect of pretreatment (F(1, 30) = 60.15, p =.001) and a significant 
dose by treatment interaction (F(1.18, 35.40) = 44.05, p = .001) revealed that AMPH 
pretreated mice travelled significantly further than SAL pretreated mice (Fig. 7.5). Post 
hoc independent t-tests indicated that the magnitude of locomotor responding was 
significantly greater in repeated AMPH pretreated animals at all levels of dose, including 
SAL, than animals that were SAL pretreated during the training sessions (SAL (t(17.43) = 
-4.99, p = .001); 0.5 mg/kg (t(18.65) = -7.24, p = .001); 1 mg/kg (t(19.15) = -6.23, p = .001); 
2.0 mg/kg (t(26.72) = -7.94, p = .001). The significantly greater locomotor responding in 
AMPH pretreated mice compared to SAL pretreated mice following SAL administration 
additionally identifies the expression of conditioned locomotor responses in AMPH 
pretreated mice. A significant main effect of dose (F(1.18, 35.40) = 118.88, p = .001) indicated 
that animals, when collapsing across pretreatment and genotype, displayed dose 
dependent increases in locomotor responding to AMPH administered during the test 
compared with SAL treated distances (Bonferroni post hoc tests (Ps = < .001)). There 
were no other significant main or interaction effects, indicating that regardless of 
pretreatment and/or the test dose administered, DARPP-32 deletion had no significant 
186 
 
 
effect in mediating the expression of AMPH psychomotor sensitisation (Fs = < 1.25, Ps 
= > .28). These data establish the robust expression of psychomotor sensitisation in 
AMPH pretreated animals but also show that DARPP-32 deletion does not mediate the 
expression of AMPH sensitisation at the dose(s) and/or the treatment protocol recruited 
in this study. 
7.4 Discussion 
Deletion of the DARPP-32 gene did not alter the acquisition or expression of 
psychomotor sensitisation to amphetamine in the current study.  These results are the first 
known data – to the author – to establish that global deletion of the DARPP-32 gene has 
few consequences for amphetamine psychomotor sensitisation.  This was a surprising 
finding given the augmenting effects of DARPP-32 deletion on cocaine psychomotor 
sensitisation (Hiroi et al., 1999). This absence of between groups differences in 
amphetamine psychomotor sensitisation, along with the data reported elsewhere in this 
thesis, indicates that global DARPP-32 deletion does not drastically impair reward-based 
learning and performance. Nevertheless, interpreting the results of psychomotor 
sensitisation studies recruiting DARPP-32 mutant mice is a complicated task. For 
example, Valjent and colleagues (2005) reported that cocaine sensitisation is abolished in 
Thr34-DARRP-32 alanine knockin mice using the two-injection protocol sensitisation 
procedure, whilst Zachariou et al (2006) reported that Thr34-DARPP-32 mutant mice 
show enhanced cocaine sensitisation using an extended injection protocol, similar in 
nature to the one recruited in this study. Valjent and collaborators (2005) similarly 
showed that cocaine sensitisation in a two-injection protocol is blocked in the DARPP-
32 KO mouse whilst Hiroi et al (1999) reported potentiated cocaine sensitisation using 
an extended treatment protocol. One possible explanation for this effect is that it is a time-
dependent process. However, closer inspection of these studies reveals that Thr34-
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DARPP-32 knockin mice and DARPP-32 KO mice displayed cocaine sensitisation to the 
second dose of cocaine in the studies by Zachariou et al (2006) and Hiroi et al (1999). 
Furthermore, Valjent et al (2005) administered their second dose of cocaine at 2 different 
time points. One group received their second dose the day after their first treatment and 
another group received their second treatment 7 days after their first treatment; neither 
acquired psychomotor sensitisation. Thus it is difficult to reconcile these discrepancies 
with a simple time-dependency explanation. One notes, therefore, that the interpretation 
of the results in this chapter, as well as those of some previous studies, are difficult to 
reconcile on the basis of a common, unifying explanation. The expectation was to observe 
enhanced amphetamine sensitisation in KO mice but, rather than observe a potentiation 
or even a loss of amphetamine sensitisation, DARPP-32 KO mice displayed normal 
amphetamine sensitisation. A potential explanation for this result concerns the dose-
dependent locomotor activating effects of psychostimulants in DARPP-32 mutant mice. 
It has been reported that DARPP-32 mice display dose dependent impairments to acutely 
administered psychostimulants (Fienberg et al., 1998), therefore, there is presumably a 
dose range whereby these mutants might acquire sensitisation normally. It would, thus be 
beneficial, if future studies examined the relationship between dose and the magnitude of 
psychomotor sensitisation in DARPP-32 mutant mice.  
 In addition to this, impairments in DARPP-32 KO mice to the acute locomotor 
response of drugs of abuse do not always translate to impairments in sensitisation. For 
example, DARPP-32 KO & Thr34-DARPP-32 alanine knockin mice are impaired to the 
acute locomotor activating properties of morphine but display morphine sensitisation that 
is indistinguishable from WT mice when exposed to an extended administration protocol 
(Borgkvist et al., 2007). In contrast to these reports, however, Valjent et al (2010) reported 
that morphine sensitisation was blocked in Thr34-DARPP-32 mutant mice. Previous 
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unpublished results (as cited in Fienberg et al., 1998) suggest that the locomotor 
activating effects of acutely administered amphetamine are attenuated in DARPP-32 
KOs. Unfortunately, the absence of more detailed methods (especially dose) and results 
makes comparison with the current study difficult. In this chapter, there was no increase 
in locomotor activity, relative to SAL, in either wildtype or knockout mice following the 
first (1.0 mg/kg) dose of amphetamine and the dose was accordingly increased to 2.0 
mg/kg. Both acute locomotor activity and robust psychomotor sensitisation occurred in 
response to this dose but there were no differences between genotypes in the distance 
travelled following acute 2.0 mg/kg treatment.  
Whilst broad similarities exist between cocaine and amphetamine in the neural 
circuitry these drugs influence to establish psychomotor sensitisation, subtle differences 
in the processes these drugs stimulate to produce psychomotor sensitisation do exist (see 
Vanderschuren & Kalivas, 2000 and Wolf & Ferrario, 2010). Whilst speculative, 
differences between the effects that repeated cocaine and repeated amphetamine 
treatment have in stimulating modifications in the AMPA GluR1 subunit might account 
for the observations in this study. Cocaine sensitisation is associated with a variety of 
post-synaptic modifications to AMPA GluR1 receptor properties, including AMPA GluR1 
receptor surface expression and GluR1 subunit phosphorylation in the nucleus accumbens 
(Wolf & Ferrario, 2010). The latter of these modifications is partially regulated by 
DARPP-32. Whilst recurrent cocaine treatment has been found to up-regulate AMPA 
GluR1 surface expression in accumbal neurons 21 days post withdrawal, this finding was 
not replicated in animals repeatedly treated with amphetamine suggesting that the role of 
AMPA receptors in promoting psychomotor sensitisation might diverge as a function of 
drug type (e.g. cocaine vs amphetamine) (Boudreau & Wolf, 2005; Nelson, Milovanovic, 
Wetter, Ford & Wolf, 2009). In light of these findings, it was proposed in a review by 
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Marina Wolf, in which she and her colleague outlined the relationship between AMPA 
receptor plasticity and behavioural assays commonly used to investigate drug related 
behaviours, that cocaine and amphetamine might differ in the mechanisms they stimulate 
to influence experience-dependent changes in AMPA receptor function (Wolf & Ferrario, 
2010).  
Despite the divergent mechanisms that cocaine and amphetamine stimulate to induce 
experience-dependent changes in the AMPA receptor, the extent to which these drug 
induced changes in the AMPA GluR1 subunit contribute to differences in the acquisition 
and expression of psychomotor sensitisation is not yet fully understood. Much of the work 
describing the different capabilities of these 2 kinds of psychostimulant to modify the 
AMPA receptor has been conducted following a significant withdrawal period and it is 
not yet known whether post-withdrawal GluR1 modifications have a causal role in the 
acquisition of psychomotor sensitisation, whether they are a component of the long-term 
expression of psychomotor sensitisation, or if they are solely a consequence of drug 
withdrawal distinct from the sensitising effects of psychostimulants. 
In the current study, mice were subjected to a 7 day withdrawal period prior to 
administering a dose-effect test. However, in the study conducted by Hiroi in which they 
examined the relationship between DARPP-32 deletion and cocaine sensitisation, mice 
were not exposed to a challenge dose of cocaine following a withdrawal period. As a 
result, it was not known whether DARPP-32 influenced the expression of already 
acquired psychomotor sensitisation following a withdrawal period. There were no 
differences between KO and WT amphetamine pretreated mice to escalating doses of 
amphetamine during the dose-effect test in this experiment. It should be noted that 
animals were exposed to a 7 day withdrawal period in the current study but experience-
dependent modifications to repeated psychostimulant administration may continue to 
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occur beyond this point (Boudreau & Wolf, 2005). Therefore, it would be instructive to 
directly examine whether DARPP-32 deletion mediates the AMPA GluR1 modifications 
that occur in response to repeated psychostimulant administration by including a number 
of withdrawal periods (e.g. 0 days vs 7 days vs 14 days vs 21 days) prior to implementing 
a psychostimulant challenge. 
In addition to the dosing parameters, the apparatus used in this study warrants 
discussion. A low-moderate dose of amphetamine was selected on the basis that the 
locomotor apparatus used for this experiment do not allow one to capture psychostimulant 
induced stereotypy. Higher doses of amphetamine are associated with the induction of 
significant stereotyped motor responses and even repeatedly administered moderate (2.5 
mg/kg) doses can produce stereotypic responding in rodents (Rebec & Segal, 1980). 
Furthermore, metabotropic glutamate receptor antagonist mediated reductions in 
stereotypic responding in cocaine sensitised rats correlate with changes in DARPP-32 
phosphorylation (Scheggi et al., 2007). On the basis that psychomotor sensitisation can 
involve the induction and expression of stereotyped responses as well as locomotor 
enhancements, it is impossible to exclude a possible role for DARPP-32 in mediating 
sensitisation to the stereotypy inducing effects of amphetamine.  
Although somewhat speculative, age-dependent effects may also account for some of 
the observed differences between the current study and those reported by Hiroi and co-
workers. Mice were aged between 2-5 months in the experiment conducted by Hiroi, 
whereas mice were aged between 2-10 months in the current study. Many correlates of 
neuroplasticity such as LTP undergo developmental transformation over the lifespan (see 
McCutcheon & Marinelli (2009) for a short review on age-dependent effects in common 
behavioural neuroscience assays). Age-dependent effects have been reported in many 
behavioural assays aimed at investigating addictive behaviours in the rodent. Indeed, 
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younger mice are more susceptible to the sensitising effects of repeated amphetamine 
administration but these sensitivities were reported in mice considerably younger than 
those recruited in either this study or the study conducted by Hiroi and colleagues 
(Kameda et al., 2011). However, to the best of the author’s knowledge, there have been 
no reported age-dependent differences in the capability of psychostimulants to influence 
the phosphorylation of DARPP-32 or any age-dependent changes in the efficacy of 
DARPP-32 to mediate psychostimulant induced gene expression and receptor 
modifications. Furthermore, the average age of mice used in the respective groups in this 
study was equal and statistical analysis (data no shown) uncovered no age-dependent 
effects. 
In summation, DARPP-32 has previously been shown to mediate the locomotor 
augmenting effects of recurrent cocaine treatment yet, in the current study, no such role 
for DARPP-32 in the psychomotor sensitising effects of amphetamine was observed.  
This discrepancy might reflect subtle differences in the post-synaptic modifications that 
occur between repeated cocaine and repeated amphetamine treatment. It might, however, 
also reflect variations in the procedures used (e.g. dose, age of mice etc.). Additional work 
is required to fully understand whether DARPP-32 has distinct roles in facilitating 
cocaine but not amphetamine sensitisation. Such work could recruit mice with targeted 
disruptions of specific phosphorylation residues to attempt to overcome the limitations 
inherent in using mouse models with global protein deletion. In addition to this, cre-
recomibanse technology can be used to selectively delete DARPP-32 in specific 
populations of striatal MSNs (in D1 vs D2 expressing MSNs). A more specific disruption 
of DARPP-32 phosphorylation residues might be possible following the development of 
a virus to knockdown DARPP-32 in discrete nuclei known to underpin psychomotor 
sensitisation. For instance, selective disruption of the NMDA NR1 gene Grin 1 in D1 
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receptor expressing MSNs attenuated amphetamine psychomotor sensitisation whereas 
widespread virally-mediated striatal disruption of Grin 1 rescued amphetamine 
sensitisation (Beutler et al., 2011). Therefore, region specific genetic deletion or 
regionally selective viral-mediated knockdown of DARPP-32 may advance one’s 
understanding of any role this protein has in amphetamine psychomotor sensitisation.  
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Chapter 8 
Summary of findings and general discussion 
8.1 Introduction 
Despite the widespread enrichment of DARPP-32 throughout brain regions 
underpinning incentive learning and motivation, in many ways, the DARPP-32 KO 
mouse is a remarkably normal animal capable of learning/performing interval and ratio 
schedules of reinforcement and of learning Pavlovian associations. In an ecological 
setting, however, the relations between reinforcement contingencies and the outcomes 
they produce are rarely predictable but change on an ongoing basis. For example, one 
might wait in the queue in a hamburger outlet for 30 seconds before being tended to on 
one occasion but, on the subsequent occasion, one might experience a wait of 5 min, and 
on another occasion one might wait 10 min before deciding that the hamburger is not 
worth waiting any longer for. Similarly, the prudent investor has to be sensitive to the 
inherently uncertain and fluctuating nature of the stock market lest they face financial 
ruin. Likewise, the effort costs associated with reinforcement often fluctuate rather than 
remain fixed, predictable costs. With this in mind, optimising reinforcement requires 
animals to rapidly integrate a multitude of information concerning investment costs (e.g. 
time, risk and effort) and to also integrate information conveyed by reward-predictive 
cues. The integration of this information allows animals to make flexible cost-benefits 
decisions about competing choices and to adapt behaviour when presented with 
information (e.g. reward paired stimuli) which predicts the presence of impending 
reward. Although the nature of the behavioural disturbances reported in this thesis were 
not always straightforward, there is some indication that DARPP-32 is involved in the 
efficient allocation of behaviour under environmentally changing conditions. Two studies 
reported in this thesis suggest that DARPP-32 is needed to rapidly adapt to unpredictable 
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changes in delay parameters in the intertemporal discounting task and to adapt flexibly to 
uncertain reinforcement in the probability discounting assay. Furthermore, prior research 
(Crombag et al., 2008), as well as work contained in this thesis, suggests that DARPP-32 
is intimately involved in the multiplicative enhancement of instrumental reward value 
that occurs when Pavlovian cues are superimposed over the presence of instrumental 
response devices during the general PIT test. Prior work has also shown that mice with a 
targeted interference of the Ser97-DARPP-32 phosphorylation residue are less capable of 
adapting their behavioural output following increases in the effort costs needed to achieve 
reinforcement (Stipanovich et al., 2008) and that DARPP-32 KO mice are less responsive 
to external change (Heyser et al., 2000; Heyser et al., 2013). Overall, these data suggest 
that DARPP-32 is involved in behavioural adaptation following reward related change, 
either in response to changes in the task, or to the Pavlovian inflation of reward value that 
occurs during PIT.  
8.2 DARPP-32 and intertemporal discounting 
 
Although the results pertaining to this chapter identified a significantly different 
intertemporal choice profile in DARPP-32 KO mice at long delays, there is reason to 
believe that this difference might represent a failure to rapidly integrate changes in the 
task rather than a true genotype difference in the sensitivity to delayed reinforcement. As 
discussed earlier, DARPP-32 KO mice were, for the most part, capable of executing 
similar intertemporal choice profiles to WT mice. However, KO mice were relatively 
inflexible following changes in task parameters (e.g. when the delay order was reversed 
and when delays were increased significantly). Moreover, DARPP-32 KO mice achieved 
comparable performance to WT mice following extended testing at long delays. These 
data are in accordance with the suggestion that the accumbens mediates the sensitivity to 
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unpredictable changes in delays (Acheson et al., 2006), as well as learning about time-
based action outcome contingencies (Cardinal & Cheung, 2005) and in mediating certain 
kinds of behavioural flexibility (Annett et al., 1989; Haluk & Floresco, 2009).  
Cardinal et al (2003) suggested that, in non-human subjects, it is important to 
dissociate the learning of task parameters from the performance of the task once the 
contingencies have been fully learned. The data in this study exemplify their point by 
showing that changes in the task parameters can induce transient disturbances in 
intertemporal choices which eventually disappear with extended experience. To the best 
of one’s knowledge, these data are the first to identify a role for DARPP-32 in the 
intertemporal discounting task. 
8.3 Probability discounting 
In contrast to the previous chapter, the data captured during this experiment identified 
a persistent performance difference between DARPP-32 WT & KO mice during 
probability discounting. DARPP-32 WT and KO mice were initially indistinguishable in 
their probabilistic choices but, later in the experiment, KO mice became significantly less 
tolerant of uncertainty than WT mice. An interesting finding from this experiment is that 
by the end of the study, DARPP-32 KO mice were less capable of optimising 
reinforcement in high probability blocks but better at executing choices in low probability 
blocks than WT mice. These data indicate that, in comparison to WT mice, DARPP-32 
KOs were executing an inflexible strategy which consisted of avoiding uncertainty, rather 
than an optimal pattern of choices that would entail maximising the acquisition of the 
large reinforcer in high probability blocks but avoiding it in low probability blocks. These 
data make a novel contribution to the literature by identifying a role for DARPP-32 in the 
rodent probability discounting task and they also provide a certain degree of translational 
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relevance by producing parallel findings to those observed in humans which have also 
identified a role for DARPP-32 in a probabilistic learning task (Frank et al., 2007).  
8.4 Progressive ratio 
In this chapter, deletion of DARPP-32 had no effect on the willingness of mice to 
invest effort to acquire a food reinforcer. DARPP-32 KO mice achieved comparable 
performance with WT mice throughout all periods of the experiment and between 
genotypes instrumental performance was unaffected by changes in the reinforcement 
schedule (e.g. making the schedule shallower or steeper). This finding suggests, that in 
comparison to mice with a targeted interference of the DARPP-32 gene (Stipanovich et 
al., 2008), global deletion does not induce deficits in instrumental motivation and that 
DARPP-32 KO mice are able to adapt rapidly to changes in effort costs. However, 
because DARPP-32 is a complicated intracellular signalling protein, and on the basis of 
previous work comparing the effects of targeted interference of specific phosphorylation 
residues on specific behaviours (e.g. psychomotor sensitisation) (Valjent et al., 2005; 
Zachariou et al., 2006), one can reasonably predict that different effects might occur 
depending on the method taken to disrupt DARPP-32 (e.g. global deletion vs 
phosphorylation residue specific disruption). It is clear, therefore, that DARPP-32 is 
involved in the provision of instrumental motivation. However, global deletion of the 
DARPP-32 protein does not induce any significant deficits in this measure of 
instrumental motivation. 
8.5 Pavlovian-to-instrumental transfer 
Although the effects were much smaller than anticipated, the data presented in this 
chapter lend support to previous findings indicating that DARPP-32 KO mice do not 
perform the general form of PIT (Crombag et al., 2008). Whilst WT mice increased their 
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response rates during the presentation of the CS+ significantly above baseline, KO mice 
displayed no evidence of such an effect. The precise nature of this disturbance, however, 
is not yet known. For example, it is not clear whether the failure to perform PIT represents 
a failure of the acquisition of incentive salience or its expression. These data could 
indicate a disturbance in Pavlovian incentive motivation which would be entirely 
commensurate with the role of DA in this process. However, an alternative interpretation 
of these results is that DARPP-32 KO mice could lack the behavioural flexibility 
necessary to modify their behaviour when cues are superimposed over the presence of the 
instrumental manipulanda.  
Mice were also administered MPH during this experiment in an attempt to rescue this 
deficit in DARPP-32 KO mice. However, MPH had clear no effects on either WT or KO 
mice which makes it impossible to determine whether acute administration of DAergic 
compounds can or cannot rescue this deficit in KO mice. Nonetheless, these data are the 
first to show that MPH does not rescue general PIT in DARPP-32 KO mice at the doses 
administered. 
8.6 Amphetamine psychomotor sensitisation 
Unlike previous findings which have established that repeated administration of 
cocaine induces a more profound psychomotor sensitisation in DARPP-32 KO mice 
(Hiroi et al., 1999), repeated amphetamine treatment did not induce different levels of 
sensitisation between genotypes. DARPP-32 KO mice were indistinguishable from their 
WT counterparts in both the acquisition and expression of psychomotor sensitisation. 
This was unexpected. However, and as noted earlier, the findings relating to psychomotor 
sensitisation in mice with disruptions to the DARPP-32 gene have been inconsistent and 
also vary as a function of the administration protocol. It might also be that repeated 
cocaine treatment stimulates subtly different molecular adaptations compared to repeated 
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amphetamine treatment (e.g. AMPA GluR1 subunit changes). However, without 
additional work it is impossible to determine the precise mechanisms responsible for the 
different abilities of cocaine and amphetamine to promote psychomotor sensitisation in 
DARPP-32 KO mice.  
8.7 DARPP-32 and the effect of motivational shifts 
Because previous reports had suggested that Ser-97-DARPP-32 mutant mice displayed 
impairments in the motivation to exert effort (Stipanovich et al, 2008), and because 
DARPP-32 is expressed in brain regions associated with habit formation and the 
sensitivity to reinforcer devaluation, mice were exposed to a variety of devaluation 
manipulations to directly assess the impact of inducing motivational shifts on 
reinforcement choices (e.g. intertemporal or probabilistic choice) and the motivation to 
exert effort. Whilst these manipulations significantly reduced the motivation to initiate 
trials during the intertemporal and probabilistic choice tasks, and also the breaking point 
of responding during the progressive ratio experiment, they did not differentially affect 
the motivation to initiate trials between genotypes and nor did they differentially affect 
intertemporal or probabilistic choices. Nor did reinforcer devaluation differentially affect 
breaking points of responding during the progressive ratio experiment. Overall, these 
results indicate that DARPP-32 KO mice do not possess significant deficits in 
instrumental incentive motivation. Therefore, one can reasonably infer that the 
abovementioned findings are broadly indicative of learning impairments rather than 
motivational disturbances. However, as noted above, this does not imply that DARPP-32 
has no role in provisioning instrumental incentive motivation but, rather, that the method 
taken in this thesis (e.g. global deletion), did not induce any discernible differences in 
motivation between genotypes in the behavioural tasks recruited in this thesis.  
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8.8 Behavioural conclusion 
In many ways, DARPP-32 KO mice are remarkably normal animals apparently 
capable, for the most part, of learning and performing numerous motivated behaviours. 
The deficits that are apparent in these mice, most especially those deficits which do not 
involve tasks supported by drug-reinforcement, appear to be subtle and might involve 
failures to rapidly reorganise behaviour in environmentally dynamic conditions (e.g. 
when task parameters are altered or when Pavlovian cues are superimposed over 
instrumental devices). In the broadest of senses, the data in this thesis indicate that unlike 
their wildtype littermates, DARPP-32 KO mice lack the behavioural plasticity necessary 
to rapidly reorganise or modify their behaviour under changing circumstances. This 
conclusion is based on the findings that 1) DARPP-32 KO mice were slow to update their 
intertemporal choice profiles in response to changes in the task parameters. 2) DARPP-
32 KO mice developed a less flexible strategy during the probability discounting task 
which consisted of avoiding the LU lever significantly more than WT mice in the blocks 
where reinforcement following the selection of the LU was most uncertain. 3) Mice 
lacking DARPP-32 failed to flexibly modify instrumental responding during the 
presentation of Pavlovian cues in the PIT tests. 4) Findings from previous research 
indicates that DARPP-32 KO mice lack novel object recognition and are impaired during 
simple instrumental reversal learning. These latter 2 tasks directly measure the response 
to external change. Overall then, DARPP-32 KO mice are less capable of integrating 
reward-related information to flexibly modify their behaviour in environmentally 
fluctuating conditions.   
Finally, the failure to observe differences between WT & KO subjects in amphetamine 
psychomotor sensitisation raises additional questions about the role DARPP-32 might 
have in incentive motivational processes. Repeated amphetamine treatment has been 
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shown to potentiate incentive motivation (Mead et al., 2004; Wyvell & Berridge, 2001). 
This is entirely consistent with the DAergic influence of amphetamine and its subsequent 
effects on incentive motivation.   However, the absence of between-group differences in 
locomotor responding to repeated amphetamine, as well as the indistinguishable 
performance of WT & KO subjects in progressive ratio of reinforcement testing, and the 
subtle group differences reported in this thesis, suggests that global deletion of DARPP-
32 has a relatively modest impact on reward-based learning and performance.  
8.9 Biological considerations and limitations 
Drawing firm conclusions, especially conclusions which precisely elucidate the 
underlying molecular mechanisms and the biological loci responsible for the behavioural 
perturbations that were reported earlier is a difficult, if not impossible task, given the 
nature of the experimental approach taken to interfere with DARPP-32 (e.g. global 
deletion). Phosphorylation residue specific mutants can produce different effects to global 
mutants and studies performing targeted deletion of DARPP-32 in the direct vs indirect 
pathway suggest that DARPP-32 may have differential consequences for behaviour 
depending on the nature of the DA receptor which is present on MSNs. Selective deletion 
of DARPP-32 in the direct striatonigral pathway diminishes baseline locomotor activity 
and cocaine’s hyperlocomotive effects, whilst deletion of DARPP-32 in striatopallidal 
neurons increases baseline locomotor activity and attenuates haloperidol’s cataleptic 
effects (Bateup et al., 2010). Global deletion has no effect on baseline locomotor activity 
but dose-dependently affects cocaine’s hyperlocomotive effects (Fienberg et al., 1998). 
The distinction between D1 and D2-expressing MSNs has important psychological 
consequences. For instance, D1-expressing MSNs are believed to be important for reward 
related incentive learning (Beninger & Miller, 1998) and limited forms of behavioural 
flexibility such as set-shifting (Haluk & Floresco, 2009), whilst D2-expressing MSNs are 
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important for aversive learning, reward omission and behavioural flexibility in the 
domain of learning to overcome previously rewarded contingencies which are no longer 
so (e.g. reversal learning) (Nakanishi, Hikida & Yawata, 2014).  
Although the most plausible explanation for the differential probability discounting is 
due to the absence of DARPP-32 in D1-expressing accumbal MSNs, this task is also 
mediated by both D1 and D2 receptors in the mPFC (St Onge et al., 2011), rendering 
precise mechanistic conclusions impossible. The complex nature of disturbances in the 
intertemporal discounting task and the approach taken to interfere with DARPP-32 also 
makes it difficult to understand precisely whether some of the disturbances in that task 
arose from disruptions to DARPP-32 in D1-expressing MSNs, D2-expressing MSNs or a 
combination of both. Little is known about the anatomical locus of receptor populations 
responsible for intertemporal discounting.  However, systemic administration of either 
D1 (Koffarnus et al., 2011) or D2 (Wade et al., 2000) receptor antagonists alters delayed 
reinforcement choices. General PIT is also affected by either D1 or D2 receptor antagonists 
(Lex & Hauber, 2008). The regional pattern of DARPP-32 expression also precludes 
precise neurobiological conclusions because, in addition to being expressed in both 
striatal D1 and D2-expressing MSNs, DARPP-32 is expressed in PFC (mPFC, OFC & 
ACC) regions and the CeA, and the behavioural tasks in this thesis are underpinned by 
the striatum and one or more of these regions. Therefore, on the basis of the data presented 
in this thesis, it is impossible to determine which DARPP-32 null region(s) or which 
phosphorylation residues were responsible for the deficits in any given task. 
8.10 Disturbances in the electrophysiological properties of DARPP-32 expressing 
neurons 
As discussed previously, DARPP-32 deletion has been shown to disrupt the 
electrophysiological properties of MSNs in both D1 and D2 expressing populations 
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(Bateup et al., 2010; Calabresi et al., 2000; Fienberg et al., 1998). For example, NMDA 
(Fienberg & Greengard, 2000) and AMPA subunit phosphorylation (Snyder et al., 2000), 
as well as NMDA (Flores-Hernandez et al., 2002) and AMPA (Yan et al., 1999) channel 
currents, Ca2+ and Na+ channel currents and D1 receptor mediated changes in Na
+, K+ 
ATPase activity (Fienberg et al., 1998) are disturbed in MSNs from DARPP-32 KO mice. 
Striatal MSNs from DARPP-32 KO mice also lack both LTD and LTP (Calabresi et al., 
2000) and regionally selective deletion of DARPP-32 disrupts LTP in either the direct or 
indirect pathway (Bateup et al., 2010). It has been suggested that co-incident DA and 
glutamate activity converging on MSNs stimulates synaptic alterations (e.g. LTP & LTD) 
which are crucial to reinforcement learning, action selection and perhaps underlie the 
transition from controlled to compulsive drug use (Hyman, Malenka & Nestler, 2006; 
Redgrave, Vautrelle & Reynolds, 2011; Wickens, 2009). Computational models of 
DARPP-32 function have suggested that brief glutamate stimulated Ca2+ influx 
strengthens DA stimulated cAMP-PKA signalling leading to PP-1 inhibition and the 
insertion of AMPA receptors into the surface membrane and eventually LTP (Lindskog, 
Kim, Wikström, Blackwell, & Kotaleski, 2006). It is most likely that most if not all of the 
disturbances in DARPP-32 KO mice arise from failures in neuroplasticity and associated 
disturbances in the electrophysiological properties of DARPP-32 expressing neurons. As 
noted elsewhere, the balance of neural activity within distinct populations of striatal 
MSNs may differentially affect behavioural output. However, it is not yet clear which 
processes and which regions mediate the distinct disturbances reported in this thesis. 
In summary, DARPP-32 KO mice display reward-related learning and memory 
impairments, as well as disturbances in biological correlates of memory and associated 
electrophysiological processes. The balance of neural activity through direct and indirect 
basal ganglia networks are important determinants of goal-directed behaviour. DARPP-
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32 is a molecular pivot that can influence the balance of neural activity throughout both 
the direct and indirect pathways and, in light of the data presented in this thesis, it seems 
that this function, in some instances, facilitates adaptation to change, most probably by 
integrating coincident DA and glutamate signals that are crucial to reward related learning 
and memory. These experience-dependent electrophysiological changes in striatal MSNs 
allow for the coherent and coordinated control of basal ganglia output signals and, 
accordingly, the generation of efficient and rewarding goal-directed behaviour. 
8.11 Limitations  
The most obvious limitations of the work conducted in this thesis concern the use of a 
mouse model that involved global deletion of a protein that is 1) widely distributed 
throughout incentive motivational regions involved in the behaviours that were examined, 
thus making precise neurobiological conclusions difficult 2) that is expressed in different 
populations of DA receptor expressing cells which, to a certain degree, have different 
physiological and behavioural responses to DA 3) that has such a complicated 
phosphorylation profile. These limitations were discussed in greater detail above.  
Some limitations relating to the behaviour also merit discussion. In particular, the 
results from the intertemporal discounting task were difficult to interpret. This was mainly 
due to the fact that the experiment was not designed to uncover differences in the ability 
of mice to flexibly adjust behaviour following unpredictable (to the subjects) changes in 
the parameters, but to establish whether there were consistent differences in within-
session discounting. Some of the behavioural differences were either smaller than 
anticipated (e.g. general PIT) or transient (e.g. intertemporal discounting) which 
prevented the generation of strong conclusions.  
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8.12 Human relevance 
Studies conducted in humans have established a role for DARPP-32 in the updating of 
outcome-expectancies (Hämmerer et al., 2013) and performance in complex probabilistic 
reinforcement tasks (Frank et al., 2007/2009). The work in this thesis is broadly 
commensurate with those studies in that DARPP-32 KO mice showed disturbances in the 
probability discounting task and disturbances following the changes in task parameters in 
the intertemporal discounting task. A preference for risk is associated with pathological 
gambling (Kräplin et al., 2014), ADHD (Groen et al., 2013) and addiction (Bornovalova 
et al., 2005; Brand et al., 2008). Likewise, a preference for instant gratification is a 
hallmark of addiction (Petry, 2001), ADHD (Scheres, Lee & Sumiya, 2008), bipolar and 
schizophrenia (Ahn et al., 2011). Thus understanding instrumental decisions along 
dimensions of risk and time has relevance for clinical populations. In addition to this, the 
relatively inflexible profile of DARPP-32 KO mice suggests this protein might have 
clinical relevance for compulsive disorders such as OCD and addiction. On the basis that 
prior research has identified a role for conditioned associations in the stimulation of drug 
craving (Carter & Tiffany, 1999) and, on the basis that it has been suggested that reward-
paired cues might contribute to relapse (Jentsch & Taylor, 1999; Robinson & Berridge, 
1993), the findings from the PIT experiment indicate relevance for DARPP-32 in 
addictive behaviour.  
8.13 Recommendations for future research 
8.13.1 Regional specific targeting of DARPP-32  
Given that the work in this thesis has identified a number of disturbances which add 
to a growing literature suggesting that DARPP-32 assists in the rapid and flexible 
modification of reward-related behaviour, it would be beneficial to establish the 
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neurobiological regions where DARPP-32 expression is essential for the normal 
performance of the behaviours examined in this thesis. This could be achieved by 
selectively interfering with DARPP-32 in distinct regions by introducing antisense 
oligonucleotides to disrupt the translation of DARPP-32 or by disrupting DARPP-32 by 
viral mediated knockdown. This approach could allow one to compare the behavioural 
effects of regional interference of DARPP-32. In addition to this, recruitment of mice 
with targeted interference of specific phosphorylation residues or mice with receptor 
population specific (e.g. D1 vs D2 expressing populations) deletion of DARPP-32 would 
help identify the molecular and regional bases of these behaviours.  
8.13.2 DARPP-32 and intertemporal choices 
Owing to the nature of the task and the behavioural differences that were uncovered 
between DARPP-32 KOs and WT mice, it would be beneficial to implement a between-
session discounting procedure similar to the one adopted by Acheson and coworkers 
(2006) in which the delays were manipulated between sessions pseudorandomly. If 
DARPP-32 KO mice are impaired in the rapid integration of changes in delay parameters, 
then they should be less sensitive to unpredictable between session changes in delays than 
WT mice. In ecological settings, intertemporal reinforcement choices are not fixed and 
can fluctuate during any particular instance. Therefore, DARPP-32 might contribute to 
the extent that animals can make rapid and efficient intertemporal choices in a fluctuating 
environment. 
8.13.3 DARPP-32 and probabilistic reinforcement choices 
Prior research has suggested that certain behavioural disturbances in DARPP-32 KO 
mice can be rescued by increasing DA transmission (Fienberg et al., 1998; Heyser et al., 
2013). It would be interesting then, to train DARPP-32 KO mice on a probability 
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discounting task until differential performance emerges between genotypes. After 
establishing differential performance, the introduction of DAergic compounds might then 
return choice patterns in DARPP-32 KO mice to patterns comparable to WT mice when 
tested drug free.  
8.13.4 DARPP-32 and the exertion of effort 
Prior work has established a role for Ser97-DARPP-32 alanine knockin mice in the 
provision of instrumental effort (Stipanovich et al., 2008) and changes in DARPP-32 
phosphorylation have been reported in the NAc in relation to the magnitude of effort in 
an effort-based task (Randall et al., 2012). It might therefore prove fruitful to establish 
whether genetic interference with DARPP-32 disrupts complex effort-based choice 
procedures, such as the T-Maze effort-based choice task or the concurrent choice task. 
DARPP-32 is also expressed in the ACC and this structure has been implicated in effort-
based decisions rather than the exertion of effort (Schweimer & Hauber, 2005). In 
addition to this, it might be beneficial to examine whether DARPP-32 has a role in 
mediating the effort-choice altering effects of DAergic compounds such as haloperidol 
and in mediating the exertion of effort in response to DAergic compounds in progressive 
ratio testing. 
8.13.5 DARPP-32, incentive salience and incentive sensitisation 
Whilst some of the behaviour in this thesis and, many of those previously reported as 
disturbed in DARPP-32 mutant mice, involve the adaptation of behaviour in response to 
change, the absence of general PIT in DARPP-32 KO mice indicates that DARPP-32 is 
involved in the attribution of incentive salience. It would be beneficial to establish 
whether DARPP-32 is involved in the performance of outcome-selective PIT. Given the 
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absence of DARPP-32 in the BLA and its presence in the CeA, these mice might exhibit 
a dissociation in the ability to perform the outcome-selective and general forms of PIT. 
 It would also be interesting to examine whether DARPP-32 is involved in other forms 
of Pavlovian incentive learning such as autoshaping. Autoshaping is sensitive to both 
DAergic and glutamatergic manipulations (Dalley et al., 2005) and DARPP-32 is 
expressed in 2 nuclei (e.g. NAcC and CeA) which are necessary for the normal acquisition 
of autoshaping.  
Finally, whilst DARPP-32 KO mice display normal CRf, they develop an exaggerated 
sensitisation to repeated cocaine administration. Because of these 2 features, it could be 
beneficial to establish whether the exaggerated psychomotor sensitisation reported in 
DARPP-32 KO mice translates to a significantly greater sensitisation of responding 
during the CRf test than WT mice. 
Conducting these studies would help us understand whether the disturbances in 
DARPP-32 KO mice broadly represent a failure to rapidly adjust to changing conditions 
or whether these mice also display broad-ranging disturbances in incentive salience. For 
example, autoshaping does not involve a change in a previously learned arrangement in 
the way that PIT does. Prior to the PIT test, the animals have never experienced the cue 
in the presence of the instrumental devices and, in order to perform PIT, mice must adapt 
to the change in the environmental circumstance. However, if DARPP-32 KO mice 
possess disturbances in autoshaping and/or the potentiation of CRf by drug, then it is most 
likely that these animals are both impaired in the rapid-updating of behaviour and in 
acquiring/expressing incentive salience. 
8.13.6 DARPP-32 and behavioural flexibility 
In light of previous findings (Heyser et al., 2000), as well as those reported in this 
thesis, it might be beneficial to examine a broader range of behaviours using the DARPP-
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32 KO mouse in the domain of behavioural flexibility. These experiments could include 
set-shifting, as well as probabilistic and/or serial reversal learning.  
8.14 Conclusion 
In an ecological setting, where the relations between costs and benefits frequently 
change, maximising reinforcement requires the flexible and efficient allocation of 
resources by executing profitable cost-benefits computations, by integrating information 
conveyed by conditioned associations and by modifying reinforcement choices in an 
environmentally fluctuating setting. Both prior work and the work presented in this thesis 
suggests that DARPP-32 might be involved in some of these processes. For example, 
DARPP-32 KO mice struggled to flexibly adapt their intertemporal choices in response 
to task changes and these mice were also less willing to invest risk during instrumental 
choice tasks. In addition to this, DARPP-32 KO mice lack the incentive salience driven 
potentiation of instrumental responding which entails the presentation of Pavlovian 
stimuli in the general PIT test. Prior work has also established that DARPP-32 mutant 
mice are less flexible to external change and less capable of summonsing the motivation 
needed to achieve reinforcement in progressive ratio testing. Overall, these data suggest 
that DARPP-32 contributes to reinforcement optimisation by allowing animals to make 
flexible reward-based decisions and investments and to integrate Pavlovian associations, 
and to use the information conveyed by such stimuli to modify instrumental responding. 
Disruptions to the electrophysiological properties of MSNs most plausibly account for 
these deficits. Future work should focus on clarifying the nature of these behavioural 
disturbances and on disentangling the molecular pathways and anatomical locations 
where DARPP-32 mediates reward-based decision making and incentive salience 
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